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Antibiotic resistance is a major public health problem. The increase in 
antibiotic-resistant bacteria and decline in the approval of newer antibiotics has 
prompted the need for novel therapeutic approaches. In the environment and in 
the human body, microbes are exposed to varying spatial landscapes. Further, 
bacteria assemble into multicellular assemblies called biofilms, which possess 
intricate spatial structure. Inherent to this spatial structure, microbial communities 
also possess population structure, characterized by cell density, spatial 
organization, and different cell types. This dissertation has three main goals: i) to 
study the effect of microbial population structure on the survival of antibiotic 
resistant mutants, using P. aeruginosa, an opportunistic human pathogen as a 
model organism, ii) to evaluate the therapeutic potential of using bicarbonate to 
enhance the efficacy of aminoglycoside antibiotics, first-line agents for P. 
aeruginosa infections, and develop an improved method of analysis of drug 
interactions iii) to develop a low-cost, hands-on, educational module to 
characterize antimicrobial compounds using an interdisciplinary, biophysical 
approach.  
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Chapter 1:  Introduction 
 
1.1 A BRIEF OVERVIEW OF THE MAIN TOPICS  
 
 
The following chapter will review two main topics discussed in this 
dissertation. The first part of the chapter will provide an overview of the structure 
of microbial communities, including its effect on function and key microbial 
processes. This is followed by a detailed account of our model organism and the 
opportunistic human pathogen Pseudomonas aeruginosa. The second part of the 
chapter will review the importance and need for interdisciplinary research 
experience as part of science education, and introduce the hands-on, 
interdisciplinary educational module we have developed and executed as a 
science outreach tool. 
1.2  PHYSICAL AND SPATIAL STRUCTURE IN MICROBIAL COMMUNITIES  
 
 
1.2.1 Microbial communities possess spatial structure  
 
 
Much of our current understanding of microbiology derives from 
laboratory-based studies of pure, well-mixed cultures. Such reductionist 
studies have contributed greatly to our understanding of microbes. However, it is 
increasingly being recognized that in a majority of environments, microbes exist 
as interacting, spatially-structured communities [1].  
 2 
1.2.1.1 Spatial structure in environmental microbial communities 
 
In these real-world landscapes, microbial populations experience differing 
environmental conditions within areas that would be classified as single habitats 
[2]. Biotic and abiotic factors such as cell density, nutrient availability and toxic 
metabolites, vary substantially over space. This results in a heterogeneous 
environment, where physical and spatial structure exists over different length 
scale [3]. The existence of spatial structure in the environment has been shown 
to have profound effects on a range of biological phenomena [4, 5]. In aquatic 
environments inhabited by phytoplankton, energy inputs of thermal, mechanical, 
gravitational, chemical and even radioactive origins are found. The spatial and 
temporal heterogeneity of energy inputs leads to the formation of spatial 
discontinuities, or interfaces between two environments, in homogeneous zones 
[3, 6]. In the soil, these heterogeneities and discontinuities are the result of 
physical, geochemical and biological processes [7]. The spatial structuring of the 
physical environment induces similar heterogeneities of biological organisms, 
generating diversity in communities of biological populations. As shown in Figure 
1.1, a spatially complex soil system shows an assemblage of microbes with 
different morphologies (round spores versus string-like mycelia) [8]. Similarly, 
Figure 1.2, depicts the spatial structure of microbial communities in granular 
sludge. In this sludge structure, bacteria from the first layer ferment sucrose to 
short-chain fatty acids such as propionic acid, acetic acid, and butyric acid. The 
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second layer of the sludge comprises of methanogens, which covert these fatty 














Figure 1.1 Illustration of a spatially complex soil arrangement brings out the 
diversity and complexity of the system.  
 
This image depicts an assortment of microbes with different morphologies, for 
example, round spore-forming microbes versus string-like mycelia.  

















Figure 1.2 Schematic drawing showing the spatial structure of granular sludge 
from a bioreactor.  
 
The sludge is seen to consist of three layers: an outer layer containing mainly 
bacteria, a second layer composed of microcolonies of methanogens, and a 
central core consisting of cavities, inorganic materials and methanogenic 









1.2.1.2 Spatial structure in human microbial communities 
 
In the human body, microbial communities inhabit matrices with intricate 
spatial structure [10]. For example, microbes encounter spatial structure between 
different patient groups, within different organ systems in a single host, as well as 
within different tissues within a single organ. As shown in Figure 1.3, infecting 
strains of a bacterium (Pseudomonas aeruginosa) genetically adapt to produce a 
chronic sinus infection, following which adapted strains migrate to the lungs 
where they produce chronic lung infection. In this process, the infecting strain 
encounters different spatially-structured environments in the sinuses and lungs 
[10]. Another example of spatial structure is observed in dental plaque - a 
complex organization of microbial communities found in the human mouth 
(Figures 1.4 and 1.5). Oral bacteria in plaque exist as coordinated, spatially 
organized and fully metabolically integrated microbial community [11] . Structural 
analysis of dental plaque revealed that this community is dominated by species 
of Streptococcus, Prevotella, Actinomyces, and Veillonella. Further, cells of the 
genera Prevotella and Actinomyces showed the most interspecies interactions, 
suggesting a role for this association in maintaining the structure and/or function 
of the biofilm matrix [12]. It is also known that a wide-range of factors such as 
oxygen and nutrient availability, toxic metabolic products, and biomolecules 
influence the composition and spatial organization of dental plaque, leading to a 









Figure 1.3 Typical course of P. aeruginosa infection in the Cystic Fibrosis airway, 
in which it encounters different spatial-structures. 
 
The bacterium Pseudomonas aeruginosa most often invades the airway of 
patients with cystic fibrosis from the environment. Colonization can occur both in 
the paranasal sinuses and in the lungs. Compared to in the lungs, the immune 
response and antibiotic-mediated stress in the sinuses are less severe, providing 
a protected niche for bacterial colonization. During waves of antibiotic treatment 
and host immune responses, P. aeruginosa can be eradicated from the lungs. 
Subsequently, the lungs can be recolonized by the same P. aeruginosa 
genotype, which has survived the immune and antibiotic attacks in the sinuses. 




















Figure 1.4 Interactions of bacterial cells in human dental plaque.   
 
Dental plaque was hybridized with fluorescent probes targeting 15 groups 
(genera or families) of oral bacteria. Each small dot or rod is a single bacterial 
cell.  Bacteria hybridizing to 6 different probes are seen in this 
image:  Pasteurellaceae (dark orange), Streptococcus (yellow), Actinomyces 
(magenta), Porphyromonas (green), Neisseriaceae (blue), and Fusobacterium 
(peach).  Several kinds of corncob structures, in which dot-like cells surround a 
central filament, can be seen in the upper part of the image, including multilayer 
corncobs in which the filament is surrounded by Streptococcus (inner ring) and 
Pasteurellaceae (outer ring), as well as single-layer corncobs composed of 
Porphyromonas and of Neisseriaceae.   






Figure 1.5 Spatial analysis of human dental plaque.  
 
The area of the circle represents the relative abundance of each taxon. Lines 
connecting the two taxa indicate that cells of the lower-abundance taxon of any 
pair were observed to associate with cells of the higher-abundance taxon more 








Microbes are also known to self-assemble into highly organized, naturally 
occurring communities known as biofilms [14, 15]. The structure of these 
microbial communities ranges from thin layers of scattered single cells to thick 
structures of macroscopic dimensions. Biofilms consist of a matrix of 
microcolonies, extracellular polymeric substance (EPS), and channels, which 
shape and determine the inherent spatial structure of these ordered communities 
(Figure 1.6). In addition to these fundamental elements, a number of additional 




Table 1.1 Summary of factors influencing biofilm formation 
Adapted from [16].  
 
Genotypic factors Specific genotype of the microbial populations 
Expression of genes encoding surface properties 
Expression of signaling systems 
Organism growth dynamics 
Physicochemical factors Substratum composition 
Temperature, pH, pressure, oxygen, radiation 
Mechanical processes  
Shear due to laminar and turbulent flow conditions 
Stochastic processes Initial colonization, attachment, detachment  
Changes in biotic and abiotic factors  
















Figure 1.6 Different phases of biofilm formation in vitro.  
 
1) Initial attachment of a cell to a surface is the starting point for biofilm formation. 
Bacteria attach to the surface using surface structures such as pili and flagellum, 
and start to produce extracellular polymeric matrix (EPS) 2) Within 24 hours, 
microcolony formation occurs over several rounds of cell division. Increased 
expression of EPS strengthens the association of the cells to the surface. 3) Over 
the next 24 – 72 hours, continued growth leads to the formation of the mature 
biofilm structure. The microcolony acquires a heterogenous landscape of water 
channels and mushrooms towers with distinct subpopulations of cells resulting 
from nutrient, oxygen, and signaling gradients. 4) In the late stage of a biofilm, 
external and internal cues lead to detachment of cells from the outer surface of 









Therefore, spatial structure is an integral component of microbial 
communities both in the environment and in the human host. However, the 
influence of physical and spatial structure on the pathogenesis and virulence of 
microbial populations is poorly understood. 
 
1.2.2 Spatial structure and antibiotic resistance 
 
 
As discussed previously, in the natural world, microbial populations are 
often dispersed over a heterogeneous spatial environment [3]. When bacteria are 
inoculated into this habitat, this ecological landscape provides bacterial 
communities with a distinct array of niches, in which populations can coexist. 
This results in a collection of interacting populations inhabiting a spatial 
landscape. This spatial landscape has been shown to have implications on 
microbial evolution and adaptation in spatially-structured systems [18]. 
 
1.2.2.1 Source-Sink Systems 
 
Source-sink systems are the most commonly studied type of spatial 
structure in ecology [19]. A species’ habitat is defined as a ‘source’ if it 
possesses a fundamental set of environmental conditions that permits a 
population to persist and where the growth rate exceeds the death rate. Any 
habitat outside this fundamental niche where the death rate exceeds the growth 
rate and which cannot be sustained without immigration from a source is called a 
‘sink’. To populate the sink habitat, bacterial populations have to migrate into the 
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sink and acquire mutations that enable them to reproduce there [20]. Growth in 
the sink population indicates that the new environment has been incorporated 
into the fundamental niche of the organism and the new habitat now changes 
from a ‘sink’ to a ‘source’. Widely studied in ecology, habitat conservation and 
animal behavior, source-sink systems are also known to have implications in the 
evolution of antibiotic resistance in microbial pathogens [21, 22]. 
 
1.2.2.2 Source-Sink Systems in relation to antibiotic resistance 
 
In community and clinical settings, source-sink systems can result from 
the transmission of pathogens between healthy individuals, livestock and 
inanimate reservoirs (sources) and patients on antibiotic therapy (sinks) [23]. In a 
single individual on antibiotic therapy, drug levels vary between different organ 
systems, creating sources and sinks within a single host [24]. In patients with 
cystic fibrosis, antibiotic levels are lower in upper airway sites such as the 
paranasal sinuses as compared to the lungs. Sinuses serve as protective niches 
for bacterial colonization, after which adapted strains with increased fitness can 
migrate and establish chronic infection in the lower airway [10]. In a single organ 
system exposed to antimicrobial agents, differences in drug uptake between 
healthy and damaged tissue can introduce source-sink dynamics. In cystic 
fibrosis, heterogeneous antibiotic distribution in the lung is reminiscent of a 
source-sink like system, where regions with minimal drug concentrations could 
serve as sources from which bacteria could migrate to higher drug 
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concentrations or sinks [25]. Further, microbes self-assemble into biofilm 
structures, where several factors such as thickness, viscosity, density, nutrient 
availability, polymeric matrix and dead cells result in uneven antibiotic 
distribution; imposing source-sink dynamics on inhabiting populations [26]. 
 
1.2.2.3 Recent physics-based, source-sink models of antibiotic resistance 
 
Recent, physics-based models have analyzed the dynamics of bacterial 
adaptation to vastly different source-sink environments [27, 28, 29]. In the 
simplest model of source-sink dynamics, an environment consists of two distinct 
habitats - one in which bacterial populations are well-adapted (the ‘source’) and 
one in which they are unable to reproduce (the ‘sink’) [29]. In this model, bacterial 
populations assume one of two possible genotypes, wild-type or mutant, and 
adaptation consists of two parts, arrival of a viable mutant into the sink and 
establishment of a population. In the predominant scenario, mutants arising in 
the sink are the result of a neutral mutation in the source, which by chance 
migrated into the sink. Such a mutant can be successful even if it does not have 
a competitive advantage in the source; it is sufficient if the mutation allows it to 
colonize the sink. This environment assumes no spatial gradient between the 
source and the sink and a spatially uniform drug concentration in the sink. 
However, in clinical situations, this binary source-sink scenario is unlikely to exist 
and drug concentrations are actually seen to vary in space [30]. Furthermore, 
evolving microbial populations often contain multiple, coexistent lineages 
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following different mutational pathways and competing for resources until one 
gains a new, better mutation allowing it to dominate [31]. This has been 
examined in other physics-based models, which analyze the effect of spatial 
gradient on the development of antibiotic resistance [28, 29]. In these models, an 
array of spatially-connected, increasingly disadvantageous sink microcosms 
result in a series of successive mutations and a genetic pathway to antibiotic 
resistance. Antibiotic-resistant mutants arise in the sink as a consequence of 
selection pressure, resulting in waves of increasingly better-adapted mutants 
invading the sink environment in a step-wise manner. Experimental evolution has 
a rich history in studying basic evolutionary processes as well as applied topics 
such as the evolution of antibiotic resistance [32]. Previous experimental studies 
on evolutionary adaptation using P. aeruginosa have employed spatially-uniform 
antibiotic concentrations [23, 33]. However, this scenario appears highly 
improbable in real-world contexts. Recent experimental work with E. coli 
indicates that the evolution of antibiotic resistance is greatly accelerated in spatial 
gradients, a mode of adaptation impossible in uniform environments [34].  
 
1.2.3 Population structure in microbial communities  
  
 
A major component of spatial structure in microbial communities is the 
consortium of cohabiting, interacting microbial species. For pathogenic microbes, 
the interaction of these communities with the human host is of high biomedical 
significance. Population dynamics in mixed microbial communities depend on 
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external selection pressures such as environmental conditions and intrinsic 
selection pressures such as strain competition and kin selection [35]. This 
heterogeneity confers population structure on microbial communities, which 
varies over spatial and temporal scales [36]. The existence of this population 
structure is likely to impact interactions between coexisting microbial populations, 
such as the evolution of antagonistic relationships and altruistic behaviors [37]. 
While a single cell can exert only a minimal influence on its surroundings, 
strength via numbers (cell density) and privileged location in space (spatial 
organization) can significantly amplify the impact of microbial populations. While 
the influence of spatial structure on antibiotic resistance has been addressed, the 
impact of this microbial population structure remains to be elucidated.  
 
Microbial population structure can be defined in terms of the cell density, 
spatial organization, and cell types in the microbial community. 
  
1.2.3.1 Cell density as a type of population structure  
 
 
Density-dependent processes are widely known in microbial populations 
and cell density constitutes a type of population structure [38]. Positive density-
dependence describes a situation where the population growth or gain rate is 
facilitated by increased population density levels [39]. An example is the 
inoculum effect on antibiotic efficacy; the rate of antibiotic killing declines at 
higher densities of bacterial populations [40]. Bacterial cellular components such 
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as membrane lipids, extracellular DNA and periplasmic glucans are known to 
sequester antibiotic molecules, lowering the effective antibiotic concentration [41] 
[42]. Negative density-dependence describes a situation in which population 
growth or gain rate is curtailed by crowding, predation and competition [43]. An 
example of this is density-dependent contact inhibition, seen in stationary phase 
populations of E. coli, where an evolved mutant inhibits its ancestral strain [44].  
 
1.2.3.2 Spatial organization as a type of population structure 
 
Microbial behaviors are increasingly being recognized as ‘multicellular’, 
resulting as a consequence of intercellular interactions [45, 46]. Spatial 
localization of cell groups is known to influence microbial relationships resulting 
in stable bacterial communities, programmed pattern formations and the 
evolution of ‘cheater’ populations [47, 48, 49]. New insights into antibiotic 
resistance suggest a role for spatial organization in a population-based 
resistance mechanism. For example, highly resistant mutants are seen to 
improve the survival of neighboring less-resistant strains, allowing mixed-
populations to resist antibiotic concentrations beyond that achievable by a 
population in isolation. The mechanism was related to the production of the 
signaling molecule indole, which upregulated drug efflux pumps and oxidative 
stress protection [50]. It was recently demonstrated using 3D printing of microbial 
populations that a localized shell of P. aeruginosa afforded substantial protection 
to an encapsulated core of Staphylococcus aureus against ampicillin [51]. The 
 17 
mechanism is related to the production of the enzyme "-lactamase by P. 
aeruginosa that degraded ampicillin, thereby protecting S. aureus [51]. Thus, 


































































Figure 1.7 Spatial organization in a microbial community impacts the 
development of antibiotic resistance.  
 
Cut-section of a 3D printed microcolony revealing a nested S. aureus community 
(blue) surrounded by P. aeruginosa [51]. Confined microcolonies of S. aureus 
display resistance to ampicillin via the action of " – lactamase produced by 










1.2.3.3 Cell types as a component of population structure 
 
As seen in the case of spatial organization, species of P. aeruginosa alters 
the antibiotic susceptibility of the population as a whole [51]. In the above 
example, a susceptible strain of S. aureus is protected from ampicillin by its close 
proximity with P. aeruginosa. Production of the enzyme "-lactamase by P. 
aeruginosa destroys ampicillin, rendering the population resistant.  
 
In recent work from our laboratory, optical trapping and stamping were 
used to create artificial structures of P. aeruginosa and S. aureus, to probe 
interspecies interactions [52]. In coculture with P. aeruginosa, S. aureus counts 
are observed to decline after an initial rise, which does not happen in S. aureus 
monoculture. Further, we observe S. aureus grows more poorly in the proximity 
of P. aeruginosa [52]. We attribute these effects to antagonism by P. aeruginosa. 
These findings are consistent with observations that P. aeruginosa increases the 
expression of virulence factors that lyse S. aureus, upon sensing of 
peptidoglycan from this Gram-positive species [53, 54]. This demonstrates that 
cell type is an important component of population structure, affecting microbial 































Figure 1.8 Interspecies interactions, resulting from different cell types, influence 
the structure of the microbial population.  
 
(A) Optical trapping was used to create artificial structures of P. aeruginosa and 
S. aureus. (B) Proximity to P. aeruginosa delays the growth of S. aureus (solid 
red lines), whereas S. aureus in monoculture grows unaffected (dashed yellow 
lines). (C) Doubling time of S. aureus in coculture also demonstrates that it grows 
more slowly in the immediate presence of P. aeruginosa. Figure from [52]. 
________________________________________________________________ 
Hutchison J, Rodesney C, Kaushik K, Le HH, Hurwitz DA, Irie Y, Gordon VD. 2014.Single-cell 
control of initial spatial structure in biofilm development using laser trapping. Langmuir. 30, 4522-






1.2.4 P. aeruginosa as a model organism to study physical and spatial 
structure   
 
 
P. aeruginosa is a Gram-negative, rod-shaped bacterium that is ubiquitous 
in the environment, living in the soil, and in water, and on plant and animal 
tissues [55]. In the hospital, P. aeruginosa can be isolated from a variety of 
sources, including respiratory therapy equipment, antiseptics, soap, sinks, mops, 
medicines, and physiotherapy and hydrotherapy pools [56]. Community 
reservoirs of this organism include swimming pools, whirlpools, hot tubs, contact 
lens solution, home humidifiers, and vegetables [57].  
 
1.2.4.1 Clinical relevance of P. aeruginosa 
 
In recent years, P. aeruginosa has emerged as a major opportunistic 
human pathogen. An estimated 51,000 healthcare-associated P. aeruginosa 
infections occur in the United States each year, and cost billions of dollars of 
healthcare costs annually [58]. A leading nosocomial (or hospital-associated) 
pathogen, Pseudomonas aeruginosa is responsible for ~10% of all hospital-
acquired infections [59]. In immunocompromised hosts such as those with severe 
burn wounds, HIV/AIDS, and cancer, P. aeruginosa infections often result in 
severe and life-threatening bacteremia and sepsis [60].  It is also a significant 
cause of pneumonia in Cystic Fibrosis patients and ventilator-associated 
individuals, urinary tract infections in catheterized patients, post-surgical wound 
infections, and ocular infections in contact-lens wearers [60]. Limited 
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susceptibility to antimicrobial agents and the high frequency of emergence of 
drug resistance further contribute to severe adverse outcomes [61].  
 
1.2.4.2 P. aeruginosa biofilm assemblies   
 
P. aeruginosa is well-known to self-assemble into multicellular, spatial 
structures called biofilms. As described previously, biofilms are complex 
organizations of bacterial microcolonies embedded in a matrix of extracellular 
polymeric substance (EPS), composed of a complex mixture of polysaccharides, 
extracellular DNA (eDNA), and proteins [15]. P. aeruginosa is known to form 
biofilms on a wide variety of biotic and abiotic surfaces including the Cystic 
Fibrosis lung, contact lenses, chronic wounds as well as industrial equipment and 
hospital niches [62]. In P. aeruginosa, biofilm formation is a multicellular process 
involving environmental signals and concerted regulatory networks, such as 
quorum sensing, a well-known bacterial cell-cell communication system [63].  
Therefore, in biofilms, P. aeruginosa populations display properties that are 
physiologically-distinct from their free-living, planktonic counterparts [14].  
 
P. aeruginosa biofilms possess inherent spatial structure which is shown 
to be dependent on several factors such as their polymicrobial nature, the spatial 
distribution of cells, signaling state of the cells, the availability and transport of 
nutrients, and diffusion of oxygen [64]. For example, P. aeruginosa biofilm 
formation is dependent on the carbon source used to support growth. A flat P. 
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aeruginosa biofilm is seen to form when citrate, benzoate, or casamino acids are 
used as a carbon source, and a heterogenous P. aeruginosa biofilm with 
mushroom-shaped multicellular structures is formed when glucose was used as 
the carbon source [65].   
 
It is thus not surprising that P. aeruginosa is a model organism for biofilm 
research. Given its propensity to form spatially-structured biofilms, the 
recalcitrant nature of these sessile communities, and their contribution to chronic 
and persistent infections, studying the spatial structure of P. aeruginosa could 
open novel strategies that target or harness the effects of spatial structure as a 
therapeutic approach.  
 
1.2.4.3 Population structure in P. aeruginosa infections  
 
Following primary infection, for example in the cystic fibrosis lung, P. 
aeruginosa diverges into a population of multiple, coexisting variants, derived 
from the single, ancestral strain [66]. Genetically diverse mutants, particularly 
those resistant to multiple antimicrobial agents result in a heterogeneous 
population [67]. A similar scenario occurs in biofilm assemblies, where multiple 
cell groups with different physiological states (including antibiotic susceptibility) 
are seen to coexist [68]. This coexistence of heterogeneous P. aeruginosa 
lineages in the cystic fibrosis lung underscores the importance of population 
structure in intra-strain interactions. Determining the impact of population 
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structure on antibiotic resistance in P. aeruginosa will allow for novel therapeutic 
options that account for the effects of population structure. 
 
1.2.4.4 P. aeruginosa is a well-developed model organism  
 
In addition to the above features, P. aeruginosa is a well-developed model 
organism [69]. The laboratory strains PA14 and PAO1 have fully sequenced and 
annotated genomes [70] [71]. The tractability of the P. aeruginosa genome to 
genetic manipulations has resulted in a library of transposon-insertion mutants 
[71], which are available for use upon request. In addition, a vast amount of data 
is available on the metabolic networks of this organism, including detailed 
information on metabolic substrates, enzymatic steps, and end-products [72]. 
 
All the above considerations make P. aeruginosa a well-suited model 
organism to study the effects of physical and spatial structure on microbial 
populations.  
 
1.2.5 Infections caused by P. aeruginosa  
 
 
An opportunistic human pathogen, P. aeruginosa causes a range of 
infections in the human host from dermatitis to life-threatening septicemia. This 





1.2.5.1 Infections in Cystic Fibrosis  
 
Cystic fibrosis (CF) is the most common genetic disorder in the western 
world; and in the United States alone about 1000 new cases are diagnosed each 
year [73]. The disorder results from mutations in the Cystic Fibrosis 
Transmembrane Conductance Regulator (CFTR) gene, which encodes the 
CFTR membrane protein. These mutations possibly impact the synthesis, 
processing, and transport of the of the CFTR protein to the apical surface of 
cells. Absence of this protein in its correct cellular location results in a failure to 
secrete chloride and bicarbonate into and out of the cell. In the lungs, the CFTR 
protein is expressed in the submucosal glands and ciliated epithelial cells [74]. 
Normally, mucociliary transport is facilitated by hydration of airway surface liquid 
(ASL) that lines the respiratory tract. Absence or dysfunction of CFTR leads to a 
lack of chloride efflux and hyperabsorption of sodium ions, causing ASL 
dehydration, increased mucoviscosity and impaired mucociliary clearance 
Further, the absence of CFTR leads to defective secretion of bicarbonate in 
airway epithelial cells [75]. This has shown to result in decreased ASL pH and 
impaired function of innate antimicrobial factors. Restoration of ASL pH by 
aerosolization of sodium bicarbonate was seen to improve the activity of these 
antimicrobial factors [76]. Infact, in recent developments, aerosolized bicarbonate 
is being evaluated as a therapeutic strategy for CF lung disease. This would 
possibly enhance innate antimicrobial activity, as well as facilitate the unfolding of 
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mucins (via chelation of cations that hold highly-compacted mucins) and release 
of mucous, thereby increasing mucociliary clearance [77].  
 
P. aeruginosa is a major pathogen in the CF lung. In these patients, 
infection with this opportunistic pathogen leads to causes chronic, persistent, life-
threatening pulmonary infections, which are notoriously recalcitrant to antibiotic 
therapy [78]. Conversion to the mucoid phenotype and formation of biofilms and 
believed to be the two main mechanisms by which this organism gains such a 
strong foothold [79]. Notably, in the cystic fibrosis lung, spatial structure is 
imposed on P. aeruginosa by structural airway remodeling resulting in a 
heterogeneous distribution of nutrients and antibiotics [80].  
 
1.2.5.2 Chronic wound infections  
 
P. aeruginosa is well-known to cause biofilm-based chronic infections, and 
a number of studies have demonstrated that P. aeruginosa is frequently present 
in chronic wounds [72]. Evidence suggests that formation of biofilms in these 
wound sites is a key factor contributing to the increased severity and delayed 
healing observed in these infections [65]. This is of particular relevance to 
diabetic foot ulcers, pressure ulcers, and venous leg ulcers [72]. Chronic wound 
infections are often polymicrobial, and S. aureus is a common co-pathogen with 
P. aeruginosa in this setting [81]. Examination of the spatial organization of S. 
aureus and P. aeruginosa in chronic wounds using reveals a nonrandom 
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distribution of these species [81], with P. aeruginosa localizing to the deeper 
regions of the wound and S. aureus remaining closer to the wound surface 
(Figure 1.9). Such insights into the spatial organization and population structure 














Figure 1.9 Nonrandom distribution of P. aeruginosa and S. aureus in chronic 
wounds.  
 
The centers of mass of the P. aeruginosa aggregates were located at a distance 
of 50-60 µm from the wound surface, whereas the centers of mass of the S. 
aureus aggregates were located at a distance of 20-30 µm from the wound 
surface. This indicates the presence of spatial organization in polymicrobial 






1.2.5.3 Acute (often planktonic) infections  
 
While a great deal of research focuses on biofilm-associated chronic P. 
aeruginosa infections, opportunistic infections with this pathogen can also be 
acute in nature [82]. Examples of acute infections are typically skin and soft 
tissue infections such as acute (burn or post-surgical) wounds, dermatitis, 
cellulitis, and ocular infections such as conjunctivitis, keratitis (infection of the 
cornea) and endophthalmitis, although systemic infections such as acute 
pneumonia, urinary tract infections and bloodstream infections (sepsis) also fall 
into this category. Interestingly, burn wound infections with P. aeruginosa often 
deteriorate rapidly leading to systemic dissemination and septicemia [72].   
 
1.2.6 Antibiotic resistance in P. aeruginosa  
 
 
1.2.6.1 Rising trends in antibiotic resistance to antipseudomonal agents  
 
Treatment of P. aeruginosa infections poses a serious challenge, and 
selection of appropriate antibiotics is essential to gaining a positive outcome [57]. 
Unfortunately, the increasing drug resistance of P. aeruginosa strains 
complicates this selection of appropriate antibiotic. Infections caused by drug-
resistant P. aeruginosa are associated with significant increases in morbidity, 
mortality, need for surgical intervention, length of hospital stay and chronic care, 
and overall costs of treatment [61]. Even more problematic is the development of 
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resistance during the course of therapy, a complication which has been shown to 
double the length of hospitalization and overall cost of patient care [57]. P. 
aeruginosa can develop resistance to antibiotics either through the acquisition of 
resistance genes on mobile genetic elements (i.e., plasmids) or through 
mutational processes that alter the expression and/or function of chromosomally-
encoded mechanisms [83]. Both strategies for developing drug resistance can 
severely limit the therapeutic options for treatment of serious infections. As 
shown in Figure 1.10, hospital and Intensive Care Unit (ICU) strains of P. 
aeruginosa show resistance to several antipseudomonal drugs, including 
aminoglycosides [57]. Though not inclusive of all published data on P. 
aeruginosa resistance, this summary highlights the fact that P. aeruginosa strains 

















Figure 1.10 Rates of antibacterial resistance among P. aeruginosa isolates from 
hospitals and ICUs after 2000.  
 
P. aeruginosa exhibits resistance to all three main classes of antipseudomonal 









1.2.6.2 Multidrug-resistant (MDR) P. aeruginosa   
 
Not only are rates of resistance to individual drugs or drug classes a 
concern, but the prevalence of multidrug-resistant strains (resistant to three or 
more drug classes) is an even more serious therapeutic challenge [84]. 
Multidrug-resistant (MDR) strains of P. aeruginosa have been designated as a 
‘serious’ level threat by the CDC AR threat report [58]. As seen in Figure 1.11, of 
the total P. aeruginosa infections, ~13% are caused by multidrug-resistant 









Figure 1.11 Increasing prevalence of multidrug resistance among P. aeruginosa 







1.2.6.3 Aminoglycoside resistance in P. aeruginosa    
 
Aminoglycosides are an important component of antipseudomonal 
therapy. The majorities of aminoglycosides are bactericidal and often act in 
synergy with other antimicrobials, properties that make them valuable as anti-
infectives. Aminoglycosides are hydrophilic sugars that possess several amino 
and hydroxyl functionalities (Figure 1.12). The amine moieties are mostly 
protonated in biological situations; hence, these antibiotics can be considered 
polycationic species [85]. Since they are polycationic, they display a binding 
affinity for nucleic acids, which is the basis for their mechanism of inhibition. 
Aminoglycosides are known to bind to the 30S ribosome and inhibit protein 
synthesis [86]. Specific mechanisms include perturbation of peptide elongation, 
giving rise to inaccurate mRNA translation and truncated biosynthesis of 
proteins. Further, a subset of these aberrant proteins may get incorporated into 
the bacterial cell membrane leading to altered membrane permeability. However, 
before exerting their lethal effects, aminoglycosides have to traverse the bacterial 
cytoplasmic membrane. Previous work has shown that the transport of 
aminoglycosides is an energy-requiring process; depending on the electrical 














Figure 1.12 Structure of Tobramycin showing several amino and hydroxyl 
functionalities.  
 













Resistance to aminoglycosides is very common, and several possible 
mechanisms have been implicated [88]. Table 1.2 lists the summary of 
mechanisms known to mediate the resistance of P. aeruginosa strains to 
aminoglycosides.  
 
Table 1.2 Summary of mechanisms mediating aminoglycoside resistance in P. 
aeruginosa. Adapted from [89].  
 
 
Modifying enzymes Modification by enzymes that 
phosphorylate, acetylate or adenylate 
aminoglycosides 
Impermeability Often most common resistance 
mechanism in CF isolates 
Reduced uptake due to decreased 
permeability 
Adaptive resistance Reduced level of aminoglycoside 
accumulation; disappears after removal 
of antibiotic  
Efflux MexXY efflux pump (RND family) 
Outer membrane components  OprH-PhoP-PhoQ operon that modifies 
lipid A portion of LPS 
LPS component of the OM implicated 
in resistance (related to 
aminoglycoside binding prior to uptake) 
Ribosomal changes  Reduced ribosomal affinity of the drug 









1.2.6.4 Resistance in P. aeruginosa biofilms  
 
Resistance to antimicrobial agents is an important feature of P. 
aeruginosa biofilm infections. It has been postulated that the biofilm 
exopolysaccharide component provides an effective barrier that restricts the 
penetration of antibiotics [88].  
 
Differences in environmental conditions within the biofilm structure result 
in a non-uniform access to resources for the residing bacterial population. As a 
consequence, bacteria located in the periphery of the biofilm have better access 
to nutrients and oxygen than those located deeper in the community, resulting in 
differences in metabolic activity among the bacterial population [90], influencing 
their susceptibility to antibiotics.  
 
P. aeruginosa cells in the biofilm state are also known to have distinct 
changes in physiology, gene expression, and protein regulation [64], resulting in 
a phenotype that is unique to these populations. Induction of this biofilm-specific 
phenotype could lead to the activation of mechanisms that are critical for the 
development of antibiotic resistance. Alternatively, it has been proposed that a 
small fraction of biofilm cells known as ‘persister’ variants is responsible for the 
high level of resistance in biofilms [89]. Based on these results it has been 
suggested that the most of the cells in a biofilm are as susceptible to antibiotics 
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as their planktonic counterparts and this persister subpopulation allows the 
population to survive.  
 
Other mechanisms for resistance proposed are activation of a generalized 
stress response, and expression and overproduction of multidrug-resistant efflux 
pumps [88]. Therefore, resistance of biofilms to antibiotics is most likely 
multifactorial and the precise contribution of each of these mechanisms warrants 












Figure 1.13 Mechanisms of biofilm antibiotic resistance.  
Resistance to antimicrobial agents in biofilms is multi-factorial and mediated by 




1.2.7 Need for novel therapeutic approaches to combat P. aeruginosa 
infections  
 
Rising concern about the impact of antibiotic resistance in P. aeruginosa 
has prompted the search for novel strategies. Approaches include the use of 
quorum sensing (QS) inhibitors, iron chelators, and bacteriophages [91]. 
Antibiotic adjuvants, agents that act alongside a co-administered antibiotic, 
potentiating its action, are considered a possible future approach. This would not 
only delay the development of resistant strains, but also limit the dosage and 
toxicity of antibiotics (further details on toxicity and adverse effects specific to 














1.3 INTERDISCIPLINARY RESEARCH INITIATIVES  
 
1.3.1 Importance of Interdisciplinary Research  
 
 
Collaboration across disciplines has played a pivotal role in understanding 
and advancing science. However, formal education or training that extends 
across scientific disciplines is hard to obtain [92]. This is often due to the inherent 
challenges of interdisciplinary research such as attitudinal resistance, 
impediments to funding, scarcity of academic programs, and the perceived lack 
of career opportunities [93]. However, despite these barriers, the wide-ranging 
scope and benefits of interdisciplinary research have been recognized [94, 95]. 
Collaboration across disciplines fosters innovative thinking, widens a scientists’ 
repertoire of techniques, offers greater insight into complex scientific problems 
than that achievable by a single discipline, and can open new fields for scientific 
research [96]. Therefore, it is important to promote interdisciplinary initiatives at 
all levels of teaching and research, including at science outreach and community 
education programs. 
 
1.3.2 Need for Hands-on, Interdisciplinary training 
 
Using the terms “interdisciplinary” and “hands-on”, we searched previously 
published educational modules in the education series section of PLoS biology 
(as of 11-20-2015) and analyzed the top 10 articles found (Table 1.3). Based on 
our analysis, only 6 out of the 10 modules had a ‘hands-on’ training component, 
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4 out of the 10 modules demonstrated interdisciplinary science, and only 2 out of 
the 10 modules possessed both hands-on and interdisciplinary aspects. There is 
thus a need for science modules that are both hands-on and interdisciplinary, 
and that can be executed at a relatively low-cost to make them tractable for 
science outreach programs. 
 
1.3.3 Focus of our interdisciplinary, hands-on, low-cost educational module  
 
We have developed a hands-on, experimental module that uses an 
interdisciplinary approach, combining biology experiments and a physics-based 
analytical model, to address the problem of antibiotic resistance. This module 
was first implemented at the Hands-on Research in Complex Systems School 
held at The Abdus Salam International Centre for Theoretical Physics (ICTP), 
Trieste, Italy from 29th June – 11th July 2014.  In our experience, this module was 
robust, reproducible, resource-efficient, and cost-effective. These serve as 
favorable features in taking this module to diverse settings such as 
undergraduate research manifestos, STEM camps, school programs, and 
laboratory training workshops. Given the paucity of structured training or 
education programs that integrate diverse scientific fields, this module can 





Table 1.3 Analysis of educational modules from PLoS Biology using the search 
terms “hands-on” and “interdisciplinary”. The top ten modules generated by the 






A wee lesson in science (2004) Yes No 
Biology by numbers – introducing 
quantitation into life science education 
(2005) 
         No Yes 
Ask a Biologist: Bringing science to the 
public (2010) 
No No 
Creative Research Science experiences 
for high school students (2010) 
Yes No 
It’s elementary: science buddies bring 
biology to life (2009) 
Yes Yes  
Rethinking outreach: teaching the process 
of science through modeling (2009) 
Yes Yes 
Breaking down the stereotypes in science 
by recruiting young scientists (2004) 
Yes No 
Workshops without walls: broader access 
to science across the world (2011) 
No Yes  
Discovery-based science education: 
functional genomic dissection in 
Drosophila by undergraduate researchers 
(2005) 
Yes  No 
“Deconstructing” scientific research: A 
practical and scalable pedagogical tool to 







1.4 DISSERTATION OBJECTIVES  
 
The goal of this proposal is to understand approaches to overcome 
antibiotic resistance in microbial populations using an interdisciplinary 
perspective. We approach this by elucidating the effects of physical and spatial 
structure on microbial populations. This approach would not only provide 
additional insights into the structure and functions of microbial communities, but 
also open possibilities of harnessing these effects as novel treatment strategies. 
We address this by using insights from our work on microbial population structure 
to enhance the efficacy of antibiotics, and develop a method of analysis of drug 
interactions that goes extant traditional approaches. Further, we use insights 
from our work to develop a hands-on educational module that can provide 
valuable interdisciplinary research experience in science outreach initiatives. 
 
This dissertation is comprised of five chapters. Chapter 1 is an overview of 
the physical and spatial structure of microbial communities, including a 
description of microbial population structure, inherent to these communities. This 
population structure is further discussed in the context of our model organism 
Pseudomonas aeruginosa, along with a description of this pathogen and 
associated infections. Chapter 2 describes the study of the effect of population 
structure (cell density, cell types, and spatial organization) on the survival of 
antibiotic resistant mutants of P. aeruginosa. We find that an alkaline, metabolic 
by-product of amino acid catabolism acts synergistically with the aminoglycoside 
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antibiotic tobramycin to enhance its efficacy against antibiotic-resistant mutants. 
Chapter 3 is an assessment of a novel therapeutic approach to combat P. 
aeruginosa infections using insights from our study on the effect of population 
structure on antibiotic resistance. Here, we evaluate the therapeutic efficacy of a 
combination of the antibiotic tobramycin and an alkaline compound sodium 
bicarbonate against planktonic and biofilm states of P. aeruginosa. Chapter 4 is a 
description of a low-cost, hands-on, educational module to study antimicrobial 
compounds using an interdisciplinary approach. This module uses a standard 
microbiology experiment called the disc-diffusion assay together with a diffusion-
based analytical model to evaluate the efficacy of antimicrobial compounds and 
determine the physical characteristics of the active antimicrobial component. 
Chapter 5 is a discussion of the conclusions from my work on the impact of 
physical and spatial structure on microbial populations, and I present possible 
future directions that could be pursued beyond my work related to Chapters 2 - 4. 
Finally, I also present an account of specific advances made in the field as a 







Chapter 2:  The spatial profiles and metabolic capabilities of 





Understanding how populations of antibiotic-susceptible bacteria give rise 
to resistant strains is essential to designing treatments that prevent or delay the 
development of antibiotic resistance [98]. Recent work has shown that 
heterogeneity in the spatial distribution of antibiotic in the environment can 
accelerate the evolution of genetically based antibiotic resistance [21, 28, 29, 34]. 
While these studies examine the impact of spatial structure in the microbial 
environment, the role of the spatial distribution of the microbial population itself 
remains to be further explored.  In the context of microbes, spatial structure of 
the population includes cell density, population composition, and spatial 
organization of cell types. Most microbial communities consist of interacting, 
heterogeneous, multispecies populations [99, 100]. The per-strain spatial 
structure of microbial populations is a primary determinant of inter- and intra-
species interactions. The simplest parameter characterizing spatial structure is 
the number density of a disordered population.  To date, few studies have 
examined the effects of microbial density on the development of antibiotic 
resistance [40, 51, 101].  
aThis chapter was adapted from reference [102]. Kaushik KS, et al (2015). J. Roy. Soc. Interface 
(12): 20150018. 
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An exception is the case of bacterial biofilms, which are multicellular 
bacterial aggregates embedded in an extracellular matrix [15]. Typically, a 
bacterial infection begins with a low-density inoculum of planktonic cells, which 
may then develop into a chronic, high-density biofilm infection [15]. High cell 
density can promote phenotypic antibiotic resistance [40, 51]. However, the 
impact of a microbial population’s spatial distribution on the development of 
genotypic antibiotic resistance remains to be explored. Unlike biofilm-based 
phenotypic antibiotic resistance, genetically based antibiotic resistance can play 
a role in planktonic cells as well as in biofilms and has the potential to be 
inherited and spread to descendent populations.  
 
Here we show that at cell densities lower than those found in biofilms and 
therefore corresponding to those in many initial infections, increasing cell density 
can impair the survival of antibiotic-resistant mutants in the presence of 
aminoglycoside antibiotics. We term this negative impact “inhibition”. The 
antibiotic-resistant mutants in this study are strains of Pseudomonas aeruginosa, 
a common nosocomial pathogen that affects burned, wounded, and ventilator-
assisted patients, and also one of the leading proximate causes of death in 
patients with the genetic disorder Cystic Fibrosis (CF). We observe inhibition with 
two different aminoglycoside antibiotics: tobramycin, a front-line drug for 
treatment of P. aeruginosa infections, and gentamicin, used in the treatment of a 
wide range of Gram-negative bacterial infections [103, 104]. Furthermore, we find 
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that a wide range of microbial species can produce inhibition. Our results indicate 
that this is because the molecular agent of inhibition is a by-product of native 
bacterial metabolism and that the mechanism of inhibition involves an alkaline 
change in the pH of the environment.  
 
We examine both heterogeneous and well-mixed systems, and find that 
inhibition can act over long ranges by diffusion. We describe heterogeneous 
systems with a model, which considers the diffusion of the inhibitory molecule 
from regions of high density to regions of low density, and estimate the molecular 
weight of the agent of inhibition. We additionally develop a stochastic model of 
inhibition in a well-mixed system, which considers microscopic variation in cell 
density. This model quantitatively describes our observations and offers an 
explanation of the apparently contradictory observation that high-density mutant 
colonies are capable of growth in the presence of antibiotics.    
 
Our work indicates that microbial population structure might be a target 
for, or a tool in, novel therapeutic approaches to combat antibiotic resistance, 
and that the lifetime of current antibiotics might be extended with the use of 





2.2 MATERIALS AND METHODS  
 
2.2.1 Bacterial strains and growth conditions  
 
 
P. aeruginosa PA14 was used as the wild-type (WT) strain (gift from 
Marvin Whiteley, UT Austin). WT overnight cultures, grown in antibiotic-free 
media, were plated on tobramycin 8 µg/mL agar. Spontaneous antibiotic-resistant 
mutants grew colonies and were archived in 20-30% glycerol at -80°C. Upon 
subsequent plating, samples that showed mixed colony types were re-isolated.  
 
To generate mutants in the presence of antibiotic, WT were passaged in 
twofold increasing tobramycin concentrations, starting at 0.3 µg/mL, for eight 
successive days. Samples were archived at -80°C daily.  
 
Transposon-insertion mutants were obtained from the PA14 nonredundant 
transposon library [71]. P. aeruginosa strain PAO1, seventeen clinical 
Pseudomonas isolates [105], Pseudomonas sandgrass isolate, P. fluorescens, 
Methicillin-resistant S. aureus Mu50 [106], E. coli DH5#, Burkholderia cepacia 
and $phz1/2 mutant [107] (gifts from Whiteley, UT Austin), Serratia marcescens 
(gift from Rasika Harshey, UT Austin) and Saccharomyces cerevisiae S288C (gift 
from Edward Marcotte, UT Austin)  
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All bacterial strains were grown in Luria-Bertani broth or on LB agar 
except where otherwise indicated (Miller). Saccharomyces cerevisiae was grown 
in Yeast-Peptone-Dextrose (YPD) broth or agar except where otherwise 
indicated [108].  Overnight cultures were shaken at 180 rpm for 16-18 hours at 
37°C, except P. fluorescens and B. cepacia were grown at 30°C.  When 
indicated, agar incorporated tobramycin (Indofine Chemical Company, NJ) or 
gentamicin (Fisher Scientific, NJ). Except when indicated otherwise, the 
concentrations used were 8 µg/mL. 
2.2.2 Determination of Minimum Inhibitory Concentrations (MICs) 
 
 
MICs to antibiotic tobramycin and gentamicin were measured using broth 
microdilution methods as recommended by CLSI [109]. 
2.2.3 Whole-Genome Sequencing  
 
 
Except when stated otherwise, one spontaneous mutant strain was used 
for all experiments. This mutant strain was characterized using whole-genome 
sequencing. Sequences were deposited in the National Center for Biotechnology 
Information Short-Read Archive http://www.ncbi.nlm.nih.gov/sra (accession no. 
SRP042054). Three single-nucleotide polymorphisms (SNPs) unique to the 
antibiotic-resistant mutant strain were identified. 
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2.2.4 Experiments in spatially-mixed systems  
 
106-1011 cells in 3 mL of 0.6% LB agar were overlaid on tobramycin-
containing agar (4 µg/mL). Number of cells was found from optical density 
(OD600) of the overnight cultures (Nanodrop 2000c, Thermo Scientific), using the 
conversion factor OD 1 is 0.8X109 cells/mL. Plates were incubated at 37°C for 48 
hours and colonies were counted (ImageJ v.1.47 [110]).  
 
2.2.5 Disc diffusion assay for spatially-structured systems 
 
To form uniform lawns of antibiotic-resistant mutants on the surface of 
antibiotic agar, we used an overlay agar technique. ~108 mutants, unless 
otherwise stated, were added to 3mL of 0.6% (soft) LB agar and overlaid on 
antibiotic-containing LB agar.  
 
For deposition onto discs, overnight cultures (32 mL) were centrifuged to 
form a pellet (4000 rpm, 20 min), washed 3x by removing supernatant and 
adding sterile media, and resuspended in 100 µl of fresh, sterile LB broth. From 
this, 10 µl (~109-1010 bacteria, ~1011-1012 yeast, unless otherwise stated) was 
deposited on sterile 7-mm diameter filter discs (Whatman) on the agar. We used 
the conversion factor OD 1 is 0.8X109 cells/mL for bacteria and 3X107 cells/mL 
for yeast. Plates were incubated at 37°C for 24-48 hours, after which the width of 
inhibition ( X ) was measured. 
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2.2.6 Creating structured agar plates 
 
To create agar with spatially-structured composition, agar was poured and 
allowed to cool as usual.  Then, cores of different diameters (7, 10 and 15-mm) 
were created with a sterile metal punch. Wells were filled with agar containing a 
different set of nutrients or antibiotic, and allowed to set. As soon as the cores set 
(within 10 min), filter discs were placed on the core and WT cells were deposited.  
 
2.2.7 Using pH change to probe the nature of the released inhibitory factor 
 
Bromthymol blue (BTB) was added to agar at a final concentration of 
0.002%. 32 mL of overnight microbial cultures were deposited as above.  Plates 
were incubated at 37°C and observed every hour for an alkaline or acidic change 
around the filter discs. Images were taken immediately after deposition (for 
nutrient-free BTB agar) or 2 hours after deposition (for LB-tobramycin BTB agar) 
or after overnight incubation (for antibiotic-resistant mutant lawns).  
 
2.2.8 Testing the effect of different nutrient conditions of overnight growth 
media on inhibition 
 
In LB and YPD, WT PA14, S. aureus and E. coli grew to a density of ~109 
cells / mL. In YPD, S. cerevisiae grew to a density of ~108 cells / mL. S. 
cerevisiae grew poorly in LB medium, to a density of ~107 cells / mL. The pH of 
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the cell cultures and of filter-sterilized supernatant was measured using pH 
indicator strips (Cardinal Health, IL).  
 
Overnight cultures were centrifuged (4000 rpm, 20 min), washed 3x, and 
resuspended in fresh, sterile LB or YPD broth (100 µL). ~109 cells were 
deposited on filter discs. Filter-sterilized supernatant from each culture condition 
and sterile, fresh LB and YPD broth were also deposited onto filter discs. Plates 
were incubated and pH change monitored as above. 
 
2.2.9 Deposition of exogenous alkali compounds  
 
10 µL of ammonium hydroxide (NH4OH) (14.8M, 7.4M, 4.9M, 3.7M, 2.9M, 
2.4M), sodium hydroxide (NaOH) (1M, 0.5M, 0.33M, 0.25M, 0.2M), sodium 
bicarbonate (NaHCO3) (1M, 0.5M, 0.33M, 0.25M, 0.2M) and 1M ammonium 
chloride (NH4Cl) were deposited on agar plates.  Plates were incubated and pH 
change monitored as above.  10 µL of exogenous alkali compounds (2.1M 
NH4OH, 0.5M NaOH and 0.5M NaHCO3) were also deposited on decreasing 
dilutions (108 to 105 cells) antibiotic-resistant mutant lawns overlaid on antibiotic-
free LB agar.  
 
2.2.10 Detection of ammonia and/or amine emission  
 
An ion-selective electrode (Orion 920A, Thermo Scientific) was used to 
detect ammonia or amine emission. LB-tobramycin agar filled 20 mL sterile, 
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narrow-necked glass vials almost filled to capacity. This reduced the headspace 
available between the upper meniscus of the agar and cap of the vial. Cells were 
deposited on the filter discs placed on the upper surface of the agar and the vials 
were immediately capped. The electrode was calibrated using 0.1, 0.5, 1, 2.5 and 
5 mg/L concentrations of ammonium sulfate. While measuring ammonia levels 
for calibration and in the experiment vials, the electrode was held at a distance of 
1 cm. above the upper surface of the media (gaseous phase). All measurements 
were conducted at 37°C.  
 
2.2.11 Modeling diffusion of the IF in a spatially-structured system 
 
The disc diffusion assay can be modeled using diffusion laws. In this 
system, a finite quantity of IF is released by cells at the disc and diffuses into a 
cylindrical agar volume with radius much larger than height.  A system with this 
geometry has been solved with a non-closed form solution [111]. However, this 
solution has been shown numerically to be approximated by the solution of one-
dimensional diffusion from a constant source [111]:  
                        (1)
 
where  is the concentration of IF as a function of distance from the disc , 
time , the initial concentration at the disc , and the diffusion coefficient .  
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At the critical time  when zone size is set, the distance =  defines 
the region in which the concentration of IF exceeds the critical concentration 
.  Assuming the amount of IF produced is proportional to the number of cells 
on the disc gives Equation (1). If the mutant overlay is pre-incubated for a set 
time  before the disc is placed, the zone size X is given by:  
 
where  is the number of cells placed on the disc and  is the minimum 
number of cells on the disc required to produce a zone of inhibition. The diffusion 
coefficient of a molecule is inversely proportional to its radius. To first order, a 
molecule’s volume and therefore its molecular weight  scales as the cube of 
its radius. Thus for IF and a molecule : 
 
 
2.2.12 Measurement of the critical incubation time Tc  and the diffusion 
coefficient D  of the IF 
 
Increasing numbers of WT cells (107 to 1011 in 10 µL) were deposited on 
filter discs.  A linear regression of ( X 2 ) as a function of ln(N0 ) , where X is the 
zone size and is the number of cells placed on the disc, was performed using 




















In parallel, to measure critical time Tc , antibiotic-resistant mutants were 
overlaid onto antibiotic agar and then pre-incubated. At set increments of pre-
incubation time, WT cells (~1010) were placed on filter discs. To estimate the time 
after which no zone of inhibition would be formed, a linear regression of X 2  as a 
function of pre-incubation time was used to find the X 2 = 0 intercept.  This is Tc . 
Corresponding experiments were performed for tobramycin as a molecular 
weight calibrator. 
 
2.2.13 Modeling the effect of small fluctuations in population density of 
antibiotic-resistant mutant survival in a spatially-mixed system 
 
We model the probability of mutant survival  in spatially-mixed systems 
by , where  is the average cell density,  is an 
effective volume in which cells reduce antibiotic quantities per cell, and  and  
are lumped parameters. The function  is defined for densities in which 
 is a positive integer , such that  must be equal to . We 
linearly interpolate between values of which satisfy this condition to generate 
a continuous function .  Model parameters were estimated using a non-linear 
least squares regression of the colony counts in replicate 1, Figure 1B (R v2.15.2 




































2.2.14 Statistical Tests 
 






















2.3 RESULTS AND DISCUSSION 
 
2.3.1 In a spatially-mixed system, increasing cell densities negatively 
impact the survival of antibiotic-resistant mutants 
 
 
We grew P. aeruginosa PA14 cultures overnight and then plated portions 
of the resulting populations onto Luria-Bertani (LB) agar containing tobramycin at 
4 %g/mL.  This is approximately four times the minimum inhibitory concentration 
(MIC) for wild-type (WT) PA14 cells. The overnight cultures consisted of a 
mixture of WT PA14 cells and spontaneously-generated antibiotic-resistant 
mutants. We used each overnight culture to prepare multiple agar plates, varying 
the density of bacteria spread on the plate over four orders of magnitude. The 
number of antibiotic-resistant colonies that grow on antibiotic agar is the product 
of (1) the number of antibiotic-resistant mutants plated and (2) the probability that 
an antibiotic-resistant mutant will grow after plating. The first number, will linearly 
increase as more of each culture is plated. 
 
However, we find that the number of antibiotic-resistant colonies that grow 
depends non-monotonically on the initial density of the plated population. These 
data show a maximum, or ‘sweet spot’, for the number of plated mutants that 
survive antibiotic exposure and grow into colonies (Figure 2.1A). The fraction of 
the plated culture that gives rise to mutant colonies, aka the “mutation frequency” 
[112], decreases monotonically with increasing cell density (Figure 2.1B). 
Therefore, the probability of a mutant growing into a colony must also decrease 
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with increasing cell density. Since there are orders of magnitude more WT than 
antibiotic-resistant mutant cells present in the initially-plated cultures, we 
















































Figure 2.1 In a spatially-mixed system, high cell densities negatively impact the 
survival of antibiotic-resistant mutants in the presence of antibiotic.  
 
Different cell densities from overnight PA14 cultures, containing WT cells and 
antibiotic-resistant mutants, were plated on LB-tobramycin 4 µg/mL agar. (A) The 
number of growing antibiotic-resistant mutant colonies varies non-monotonically 
with cell density. N = 3. (B) The fraction of the plated culture that grows into 
antibiotic-resistant colonies decreases monotonically with increasing cell density. 
N = 3.  In (A) the red line shows our analytical model, derived using a Poisson 
distribution to describe random fluctuations in density that describes the number 
of surviving antibiotic-resistant mutants as a function of cell density. In (B) the red 
line shows the analytical model describing the frequency of mutant colonies as a 
function of cell density. R2 = 0.78. Model parameters: Ve = 0.004, !  = 1.164, !  = 
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For all further experiments we used the same spontaneously-generated 
mutant strain and tobramycin at 8 %g/mL, except when stated otherwise. To 
investigate the role of WT cells in inhibition, we overlaid antibiotic-resistant 
mutants onto LB-tobramycin agar, placed filter-paper discs onto this background, 
and deposited WT PA14 cells onto the filter discs. This system offers a simplified 
model to examine inhibition in populations exhibiting macroscopic heterogeneity 
in cell density, and is inspired by the disc diffusion assay often used to evaluate 
antibiotic susceptibility [113]. After growth of the antibiotic-resistant mutant lawn, 
we observed circular zones of inhibition surrounding the filter discs (Figure 2.2). 
Sterile LB broth produced no inhibition. From these experiments, we conclude 






















Figure 2.2 Inhibition is produced by WT PA14 cells, but not by sterile LB broth.  
 
WT PA14 cells and sterile LB broth (control) were deposited on antibiotic-
resistant mutant lawns on LB-tobramycin 8 µg/mL agar. (A) WT PA14 cells 
produce inhibition of antibiotic-resistant mutants. (B) Sterile LB broth does not 
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2.3.3 Inhibition is not dependent on cell-to-cell contact or proximity 
 
Other researchers have described contact- or proximity-dependent 
bacterial inhibition that depends on close positioning between cells [114-117]. In 
the disc diffusion assay, we considered the possibility that motile WT PA14 cells, 
initially deposited on the filter disc, could move out into the surrounding agar 
containing antibiotic-resistant mutants, thereby allowing contact- or proximity-
mediated inhibition to take place. P. aeruginosa shows four types of motility: 
swimming, twitching, swarming and sliding [118]. The first three of these motility 
modes involves one or both of the motility appendages, flagellae or pili.  To rule 
out the possibility of motility mediating cell-to-cell contact, we used fliC, fliA, and 
pilT mutants [71]. The fliC mutant is defective in the flagellin subunit protein, 
which polymerizes to form the bacterial flagellum [119]. The fliA mutant is 
defective for a sigma factor required for flagellin expression [120]. The pilT 
mutant is defective in type IV pilus retraction [121]. 
 
Swimming motility requires flagellar activity [122, 123]. The inhibition we 
observe with fliC and fliA mutants (fliC X != 5 mm, fliA X  = 5 mm) is comparable 
to that of WT PA14 cells ( X != 5 mm) (Figure 2.3). Further, at the 0.6% agar 
concentration used in the overlay agar, P. aeruginosa does not demonstrate 
swimming motility [124]. Therefore, we conclude that swimming motility does not 
play a role in inhibition. 
At 0.5-1% agar concentrations, P. aeruginosa exhibits swarming or group-
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mediated surface motility [122, 125]. Since swarming requires both flagella and 
type IV pili, fliC mutants show reduced or absent swarming [125]. Inhibition with 
fliC mutants is comparable to that of WT PA14 cells (fliC X != 5 mm, WT PA14 X
!= 5 mm) (Figure 2.3). Therefore, we conclude that swarming motility does not 
play a role in inhibition. 
 
Twitching motility is a form of surface transclocation mediated by type IV 
pili [126] and pilT mutants are defective in twitching motility [121]. Inhibition seen 
with the pilT mutant ( X != 5 mm) is comparable to that seen with WT PA14 cells (
X != 5 mm) (Figure 2.3). Therefore, we conclude that twitching motility does not 
play a role in inhibition. 
 
Finally, sliding motility is a type of surface translocation that is 
independent of both flagella and type IV pili. In fact, the presence of pili abolishes 
sliding motility, possibly by increasing interactions between the cell and the 
substrate [123]. WT PA14, fliC and fliA cells had intact type IV pili, hence sliding 
motility is not involved in inhibition. 
 
Aggregated, these results indicate that bacterial motility is not involved in 










Figure 2.3 Impairing bacterial motility does not impact inhibition, which we 
therefore infer does not depend on cell-to-cell contact or proximity.  
 
Motility-deficient mutants fliC, fliA, pilT, and WT PA14 cells were deposited on 
antibiotic-resistant mutant lawns on LB-tobramycin 8 µg/mL agar. No differences 
in inhibition zone sizes are observed between motility-deficient and WT cells (for 
fliC X  = 5 mm; for fliA X = 5 mm; for pilT X = 5 mm; for WT PA14 X = 5 mm). 









Supplementary Figure 2 
fliC fliA pilT WT PA14 
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2.3.4 Inhibition is not caused by nutrient depletion 
 
 
It has long been recognized that plating an inoculum with high cell density 
will result in fewer colonies than expected [127, 128]. Depletion of nutrients has 
been proposed as a cause for this and nutrient availability has been shown to 
have wide-ranging effects on microbial communities [107, 129-131]. Therefore, 
we considered the possibility that the high density of WT PA14 cells on the filter 
disc locally depletes the agar gel of nutrients, and that this is the cause of the 
inhibition we observe.  
 
To evaluate this possibility, we used a modified disc diffusion assay, in 
which WT PA14 cells were deposited on filter discs placed on LB-tobramycin 8 
µg/mL agar cores containing single-strength nutrients (1X core), double-strength 
nutrients (2X core) and ten-times nutrient strength (10X core), surrounded by 
antibiotic-resistant mutants on LB-tobramycin 8 µg/mL agar. As a control, WT 
cells were deposited on filter discs directly on the antibiotic-resistant lawn (no 
core). If nutrient limitation mediated inhibition, we would expect to see decreasing 
zones of inhibition with increasing nutrient strength of the cores. However, no 
significant difference in inhibition is observed under the different conditions: For 
no core, X = 4 mm; for 1X core X  = 4 mm; for 2X core X  = 4 mm; for 10X core 
X  = 4 mm (Figure 2.4A and B).  
 
Furthermore, we created a nutrient sink in the form of a core containing 
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1.2% agar with tobramycin (8 µg/mL) but without nutrients (no WT cells were 
deposited). If nutrient availability played a role in inhibition, this nutrient sink 
would be expected to produce large zones of inhibition. However, no inhibition is 
observed around the nutrient-free core ( X  = 0 mm) (Figure 2.4B). 
 

































Figure 2.4 Inhibition is not due to nutrient depletion.  
 
(A)  WT PA14 cells were deposited directly on antibiotic-resistant mutants lawns 
(no core) on LB-tobramycin 8 µg/mL agar and on agar cores containing single-
strength nutrients (1X core), double-strength nutrients (2X core), ten-times 
nutrient strength (10X core). Each core was surrounded by a lawn of antibiotic-
resistant mutants on LB-tobramycin 8 µg/mL agar. No significant difference is 
observed in the sizes of inhibition zones produced with different nutrient cores. 
Error bars represent standard error of the mean; N = 3. (B) Representative 
inhibition zones with WT cells deposited: (1) directly on filter discs (no core) ( X  = 
4 mm); (2) on agar cores containing single-strength nutrients ( X = 4 mm); (3) on 
double-strength nutrients ( X  = 4 mm); and (4) on ten-times nutrient strength ( X  
= 4 mm). In [97], cores of agar with tobramycin (8 µg/mL) but without nutrients 
and WT cells, produce no inhibition ( X = 0 mm). Scale bars are 5 mm.  
Supplementary Figure 3 
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2.3.5 Pyocins do not mediate inhibition  
 
P. aeruginosa produces pyocins that exert lethal effects on similar or 
closely-related bacterial species [132]. Pyocin production is regulated by positive 
and negative regulatory genes, prtN and prtR, where the PrtR negative regulator 
represses the activator gene prtN. When stimuli inactivate the PrtR repressor, 
this leads to activation of prtN and production of pyocins [132]. To determine if 
inhibition is mediated by pyocins, we tested a prtN mutant [71] deficient for the 
production of all known P. aeruginosa pyocins. Pyocin-deficient prtN cells 
produce inhibition comparable to WT PA14 cells (for prtN X  = 5 mm; for WT 
PA14 X  = 5 mm) (Figure 2.5). From these results, we conclude that pyocins do 






















Figure 2.5 Pyocins do not mediate inhibition.  
 
Pyocin-deficient prtN cells and WT PA14 cells were deposited on antibiotic-
resistant mutant lawns on LB-tobramycin 8 µg/mL agar. No differences in 
inhibition zone sizes are observed between prtN mutant and WT cells (for prtN 










Supplementary Figure 4 
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2.3.6 Quorum sensing does not play a role in inhibition  
 
Quorum sensing is the regulation of gene expression in response to 
population density [133]. P. aeruginosa has two hierarchically-connected 
quorum-sensing circuits, which regulate the production of acyl homoserine 
lactone (AHL) signaling molecules [134]. The Las and Rhl systems consists of 
transcriptional regulators, LasR and RhlR, and the AHL synthases LasI and RhlI. 
To determine if production of IF was influenced by quorum sensing, we tested 
lasI, rhlI and rhlR mutants. The lasR mutant is not available in the PA14 non-
redundant transposon library [71]. We also tested the Pseudomonas strain PAO-
JP2, which is a double lasI-rhlI mutant [135]. QS mutants produce inhibition 
comparable to WT PA14 cells (for lasI X  = 5 mm; for rhlI X  = 5 mm; for rhlR X  
= 5 mm; for PAO-JP2 X  = 5 mm; for WT PA14 X  = 5 mm) (Figure 2.6). From 

















Figure 2.6 Quorum sensing (QS) does not play a role in inhibition.  
 
QS-mutants lasI, rhlI, rhlR, lasI-rhlI double mutant PAO-JP2 and WT PA14 cells 
were deposited on antibiotic-resistant mutant lawns on LB-tobramycin 8 µg/mL 
agar. No differences in inhibition zone sizes are observed between QS-mutants 
and WT cells (for lasI X  = 5 mm; for rhlI X  = 5 mm; for rhlR X  = 5 mm; for 







Supplementary Figure 5 
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2.3.7 Inhibition is not due to the production of Reactive Oxygen Species  
 
Bacteria produce Reactive Oxygen Species (ROS) as a metabolic by-
product, and it has been suggested that antibiotics exert their effect in part by 
inducing the production of ROS such as hydrogen peroxide (H2O2), superoxide 
(O2-) and hydroxyl radicals (OH-) [136, 137].  
 
To test the role of H2O2 in inhibition, we used catalase, which neutralizes 
the bactericidal effects of hydrogen peroxide by expediting its breakdown to 
water and oxygen [138, 139].  WT PA14 cells were deposited on antibiotic-
resistant mutant lawns on LB-tobramycin 8 µg/mL agar with and without catalase 
(100 µg/mL). No significant difference in the inhibition caused by WT PA14 cells 
is observed between these two cases (Figure 2.7). As a control to establish the 
efficacy of catalase against bactericidal effects of hydrogen peroxide, we 
deposited 10 µl of 30% hydrogen peroxide.  This produces large bacteria-free 
regions on catalase-free agar ( X  = 9 mm) but only small bacteria-free regions on 
catalase-containing agar ( X = 2 mm) (Figure 2.7). From these experiments, we 
conclude that inhibition of antibiotic-resistant mutants by WT PA14 cells does not 
result from the production of hydrogen peroxide. 
 
To further probe the role of ROS, we tested a phenazine-null mutant 
($phz1/2), which is deleted in its two phenazine operons, phzA1-G1 and phzA2-
G2 [140-142]. Phenazines are a distinct group of redox-active compounds, 
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known to exert toxic effects via the production of ROS [143-145]. Following their 
production, phenazines reduce molecular oxygen to hydrogen peroxide (H2O2) 
and superoxide (O2-); H2O2 can further react to produce highly reactive hydroxyl 
radicals (OH-) [143-145]. The phenazine-null mutant ($phz1/2) is deficient for the 
production of H2O2 [143-145]. No significant difference in inhibition is observed 
with the $phz1/2 mutant ( X = 5 mm) as compared to WT PA14 ( X  = 5 mm) 
(Figure 2.7). These experiments indicate that inhibition is not mediated by ROS 










































Figure 2.7 Inhibition is not due to ROS produced by phenazine-mediated 
reduction of molecular oxygen.  
 
(A) Increasing numbers WT PA14 cells were deposited on antibiotic-resistant 
mutant lawns on LB-tobramycin agar with and without catalase (100 µg/mL). No 
significant differences in inhibition zone sizes under the two conditions are 
observed. Error bars represent standard error of the mean; N = 3. (B) Deposition 
of 10 µL of 30% hydrogen peroxide on LB-tobramycin agar produces a large 
bacteria-free region ( X  = 9 mm), which is smaller in the presence of catalase (
X  = 2 mm). No difference is observed in inhibition zones produced by WT cells 
on agar with and without catalase ( X = 5 mm). (C) Phenazine-deficient ($phz1/2) 
and WT PA14 cells were deposited on antibiotic-resistant mutant lawns on LB-
tobramycin agar. No differences in inhibition zone sizes are observed ($phz1/2 
X = 5 mm, WT PA14 X  = 5 mm). Scale bars are 5 mm, N = 3. 
Supplementary Figure 6 
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2.3.8 Changes in the shape of inhibition zones are consistent with 
inhibition being caused by a diffusible factor 
 
 
To probe the physical characteristics of the agent causing inhibition, we 
modified the geometry of the agar surrounding the filter disc using a trench or 
sterile glass barrier.  Upon doing so, the shape of the inhibition zone changes in 
a way consistent with inhibition being caused by a diffusible factor that does not 
stick to glass (Figure 2.8). Many proteins stick to glass with some degree of 
permanence [146], so this suggests that the inhibitory factor is likely not protein 

























Figure 2.8 Modifications in the shape of the inhibition zones are consistent with 
inhibition being caused by a diffusible factor.  
 
(A) WT PA14 cells were deposited near a trench and glass barrier on an 
antibiotic-resistant lawn overlaid on LB-tobramycin agar. In the absence of a 







Near a trench or barrier, inhibition zones show a departure from circularity: 
Trench X  = 5.5 mm, (X1 + X2 ) / 2
X3
=
(5.5+ 5.5) / 2
4
=1.4  
Glass barrier X  = 7.5 mm, (X1 + X2 ) / 2
X3
=
(7.5+ 7.5) / 2
4
=1.9  
Scale bars are 5 mm. 
(B) Schematic representation of measurements to quantify a departure from 
circularity following modification of the geometry of the inhibition zone by a trench 
or glass barrier, where X1 , X2 , X3  and X4  are as shown. 
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2.3.9 The inhibitory factor has a low molecular weight 
 
We model the disc diffusion assay, informed by previous studies modeling 
antibiotic diffusion [147, 148].  
 
Our model assumes:  
1) The IF is released by WT cells to a concentration [IF]
0
at the disc; 
2) The IF diffuses out of the disc with a constant diffusion coefficient D ; 
3) A threshold concentration of IF, [IF]th , is required to inhibit mutant cells; 
and 4) IF no longer causes inhibition after a critical time Tc  of incubation.   
 
Assumption (4) corresponds to an increase in the number of cells in the 
lawn that causes the per-cell concentration of IF to drop to sub-inhibitory levels 
[149]. This agrees with our finding that the size of the inhibition zone decreases 
with increasing initial lawn density (Figure 2.9). The width of the inhibition zone is 
the distance between the edge of the disc and the edge of the inhibition zone, X  
(Figure 2.9). Our model approximates X 2  as: 
                              ( ) ( )
2
04 ln , , c c cX DT N F D T N= + !          (2) 
N0  is the number of WT cells deposited on the disc, which we assume to be 
linearly proportional to the concentration of IF produced. F is a function 
independent ofN0 . Nc  is the minimal number of WT cells that produce 
measurable inhibition. The slope of X 2 !as a function of ln(N0 )  gives the diffusion 
coefficient D , if critical time Tc  is known.  
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To vary !!, we deposited increasing numbers of WT cells on antibiotic-
resistant mutant lawns on tobramycin 4 %g/mL agar and measured X . On a 
semi-log plot, X 2  varies linearly with ln(N0 ) , as predicted by the model (Figure 
2.9). To measure Tc , we pre-incubated the mutant lawn before depositing WT 
cells. X decreases with increasing pre-incubation times until X=0 (Figure 2.10). 
We measure Tc  to be 110±30 minutes and Nc  to be on the order of a million 
cells. 
 
By fitting the model to the data in figure 2 we estimate the diffusion 
coefficient D  of the IF to be 4.5±0.5x10-6 cm2/s. To calibrate the relationship 
between D and the molecular weight of the IF, we performed the disc diffusion 
assay using varying concentrations of tobramycin (MW = 467.5 Da) deposited on 
filter discs on a WT lawn on antibiotic-free agar (Figure 2.11). Fitting these 
results gives a diffusion coefficient for tobramycin of 9.6±0.8x10-7 cm2/s. Using 
the Stokes-Einstein relation, we estimate that the IF has a MW of the order of 10 
Da, indicating it is a small molecule.  
 
We also performed the above experiments using a tobramycin 
concentration of 8 %g/mL in the agar and find D  of the IF is 2.5±0.4x10-6 cm2/s, 
so the molecular weight of IF was again determined to be a few tens of Daltons 
(Figure 2.12). These results very nearly overlap with those taken at 4 %g/mL, and 
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suggest that the size of the IF is near the lower limit of what we can measure 






























































Figure 2.9 In a spatially-structured system, WT PA14 cells inhibit the growth of 
antibiotic-resistant mutants.  
 
WT cells (~109-1010) were deposited on antibiotic-resistant mutant lawns on LB-
tobramycin 8 µg/mL agar. Insert: WT PA14 cells produce inhibition of antibiotic-
resistant mutants ( X  = 4 mm).  The width of inhibition X  is measured from the 
edge of the filter disc to the edge of the inhibition zone. Scale bars are 5 mm. 
Increasing numbers of WT PA14 cells were deposited on antibiotic-resistant 
mutant lawns overlaid on LB-tobramycin 4 µg/mL agar. The square of the width 
of inhibition ( X 2 ) varies linearly with the log of the number of WT cells deposited.  

















































Figure 2.10 Determining the value of Tc    
 
(A) Increasing numbers of WT PA14 cells were deposited on increasing densities 
of antibiotic-resistant lawns on LB-tobramycin 8 µg/mL agar. The size of the 
inhibition zone decreases as the lawn density increases, corresponding to the 
decrease in X  seen with increasing pre-incubation time in (A). Error bars 
represent standard error of the mean; N = 3. Lines serve as a guide to the eye 
only. (B)  Antibiotic-resistant mutants were overlaid on LB-tobramycin 4 µg/mL 
agar at time 0 min and incubated at 37°C. WT PA14 cells were deposited on filter 
discs at different time intervals after the lawn was overlaid. Squares of the width 
of inhibition ( X 2 ) are plotted against corresponding pre-incubation times. From x-
intercept of the fit obtained (R2 = 0.99), the value of Tc  is measured as 108±26 
minutes. Error represents standard error of the mean; N = 3.  
Supplementary Figure 8 
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Figure 2.11 Modeling diffusion of tobramycin.  
 
(A) Increasing concentrations of tobramycin were deposited on WT PA14 lawns 
overlaid on antibiotic-free LB agar. On a semi-log plot, the squares of the width of 
inhibition ( X 2 ) vary linearly with concentration of tobramycin (C0 ), consistent with 
the disc diffusion model (R2 = 0.89). (B) To determine critical time Tc , WT PA14 
cells were overlaid on antibiotic-free LB agar following which tobramycin was 
deposited at different time intervals. Squares of the width of inhibition ( X 2 ) are 
plotted against corresponding pre-incubation times. From the x-intercept of the fit 
obtained (R2 = 0.93), the value of Tc  is measured as 680±50 minutes. Error 
represents standard error of the mean; N = 4. 
Supplementary Figure 9 

































































Figure 2.12 Modeling diffusion of the inhibitory factor on LB-tobramycin 8 µg/mL 
agar.  
 
(A) WT PA14 cells were deposited on antibiotic-resistant lawns on LB-tobramycin 
8 µg/mL agar. The squares of the width of inhibition ( X 2 ) vary linearly with the 
number of WT cells deposited (N0 ), consistent with the disc diffusion model (R
2 
= 0.87). (B) To determine critical time Tc , antibiotic-resistant mutants were 
overlaid on LB-tobramycin 8 µg/mL agar following which WT PA14 cells were 
deposited at different time intervals. Squares of the width of inhibition ( X 2 ) are 
plotted against pre-incubation times. From the x-intercept of the fit obtained (R2 = 
0.96), the value of Tc  is measured as 130±10 minutes. Error represents standard 
error of the mean; N = 4. 
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2.3.10 The inhibitory factor is produced without antibiotic but causes 
inhibition only in the presence of antibiotic 
 
 
When the agar does not contain antibiotic, inhibition does not occur 
(Figure 2.13). This could mean that antibiotic is required for production of the IF, 
the activity of the IF, or both. To dissect this, we developed a set of 
complementary experiments, in which the filter disc was centered on top of a 
cylindrical core of agar with different composition than that of the surrounding 
agar (Figure 2.14).   
 
When the core does not contain antibiotic, tobramycin must diffuse into 
the core from the surrounding agar before reaching the WT cells deposited on 
the filter disc. This introduces a delay before WT cells are exposed to tobramycin 
which increases with increasing core diameter.  Since the timescale for diffusive 
transport over a distance L scales as L2/D, the core sizes we use correspond to 
delays in the range of tens of hours to reach the agar under the center of the disc 
and up to 13 hours to reach the agar under the edge of the disc.  If exposure to 
tobramycin is required for IF production, this delay should act as a pre-incubation 
time and thereby decrease the size of the inhibition zones. To the contrary, we 
find no significant decrease in the size of the inhibition zones with increasing size 
of antibiotic-free cores (Figure 2.14). These results show that antibiotic is not 
required for the production of IF.  
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To evaluate whether antibiotic is required for the activity of IF, we made 
cores of LB-tobramycin agar in antibiotic-free LB agar. With this geometry, we 
find no inhibition even at low lawn densities (Figure 2.14). This confirms that 
antibiotic is required for the IF to cause inhibition. 
 
Collectively, these results indicate that IF is likely a native product of WT 
PA14 cells that is produced without antibiotic but requires the presence of 

















































Figure 2.13 Inhibition does not happen in the absence of antibiotic.  
 
WT PA14 cells were deposited on ten-fold decreasing densities of antibiotic-
resistant mutant lawns (107 to 104 cells) on antibiotic-free LB agar. WT cells grow 
in the region of deposition but do not produce zones of inhibition. Scale bars are 
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Figure 2.14 The inhibitory factor is produced without antibiotic but exerts its 
effect in the presence of antibiotic.  
 
(A) A set of complementary experiments was used to determine the role of 
antibiotic in production and activity of the inhibitory factor. (B) Antibiotic is not 
required for production of the inhibitory factor. WT PA14 cells were deposited on 
agar cores (7, 10 and 15-mm diameters) containing antibiotic-free LB agar 
surrounded by antibiotic-resistant mutants on LB-tobramycin agar. Error bars 
represent standard error of the mean; N = 3. (C) Antibiotic is required for activity 
of the inhibitory factor. WT PA14 cells were deposited on agar cores containing 
LB-tobramycin agar surrounded by dilutions of antibiotic-resistant mutant lawns 
(107 to 104 cells) on antibiotic-free LB agar. Scale bars are 5 mm. 
Supplementary Figure 12 
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2.3.11 A wide range of bacterial species, and a second aminoglycoside 
antibiotic, produce inhibition 
 
 
We find that antibiotic-resistant cells deposited on antibiotic-resistant 
mutant lawns also produce inhibition (Figure 2.15). This is true both for the 
mutants we generated and for PA14 strains that have a gentamicin resistance 
cassette (aacC1) inserted into their genome [71]. These data indicate that 
growing cells also inhibit antibiotic-resistant mutants, and that mutants can inhibit 


























Figure 2.15 Different lines of antibiotic-resistant mutants are susceptible to 
inhibition, which can be produced with different antibiotics and growing cells.  
 
(A) Five different antibiotic-resistant mutants show susceptibility to inhibition on 
LB-tobramycin. WT PA14 cells were deposited on lawns of five different 
antibiotic-resistant mutant strains, three spontaneously-generated in the absence 
of tobramycin (panels 1-3) and two evolved in the presence of tobramycin 
(panels 4, 5). The antibiotic-resistant strain in image 1 was used for all 
experiments in the paper except where otherwise indicated. (B) WT PA14 cells 
inhibit antibiotic-resistant mutants on LB-gentamicin agar ( X = 4 mm). 
Gentamicin, like tobramycin, is an aminoglycoside. (C) Antibiotic-resistant, 
growing strains produce inhibition. (panel 1) Tobramycin- and (panels 2-4) 
Gentamicin-resistant strains were deposited on filter discs on antibiotic-resistant 
lawns on LB-tobramycin or gentamicin agar, respectively. Deposited strains grow 
on antibiotic-containing agar and produce zones of inhibition (For the tobramycin-
resistant strain, X  = 5 mm; for the gentamicin-resistant strains, X = 3 mm). In 
panel 1, the strain used was the spontaneously-generated antibiotic-resistant 
mutant used throughout the paper. Images were taken with an illumination 
source beneath the agar to improve visibility of the inhibition zones.  
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To determine whether IF is produced by organisms other than P. 
aeruginosa strain WT PA14, we evaluated a set of Gram-negative and Gram-
positive bacteria as well as one strain of yeast. These organisms include known 
co-pathogens with P. aeruginosa as well as 17 clinical isolates of P. aeruginosa 
from Cystic Fibrosis patients [105]. All bacteria tested produce inhibition (Table 
2.1, Figures 2.16-2.18). However, the yeast Saccharomyces cerevisiae fails to 
produce inhibition. In the absence of antibiotic in the agar, no inhibition is 
observed with the bacterial strains. This is consistent with the idea that the 
inhibitory factors in these cases are the same as that produced by WT PA14 
cells. Our results suggest that, IF is produced by a wide range of bacterial 
species but not the yeast S. cerevisiae.   
 
We tested five antibiotic-resistant mutant strains with different origins for 
susceptibility to inhibition.  Three of these strains were spontaneously generated 
in antibiotic-free media and two evolved in the presence of increasing tobramycin 
concentrations.  All show similar susceptibility to inhibition (Figure 2.15). 
Therefore, we infer that susceptibility to inhibition likely does not depend 
sensitively on the details of the mutation conferring antibiotic resistance. 
 
The tobramycin-resistant mutants that we generated are also resistant to 
another aminoglycoside, gentamicin (MIC = 9.7 %g/mL). WT PA14 cells 
deposited on antibiotic-resistant mutant lawns on gentamicin agar also produce 
 89 
inhibition. This result demonstrates that inhibition occurs in the presence of two 
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Figure 2.16 A broad range of bacterial species produce inhibition, but yeast does 
not.  
 
P. aeruginosa WT PA14, P. aeruginosa PAO1, P. fluorescens, Pseudomonas 
sandgrass isolate, S. aureus, E. coli, Burkholderia cepacia, Serratia marcescens 
and Saccharomyces cerevisiae (~109-1010 cells for bacteria, ~1012 cells for yeast) 
were deposited on antibiotic-resistant mutant lawns overlaid on LB-tobramycin 
agar. All microbial species tested produce inhibition of antibiotic-resistant 
mutants except Saccharomyces cerevisiae.  For P. aeruginosa WT PA14 X  = 5 
mm; for P. aeruginosa PAO1 X  = 6 mm; for P. fluorescens X  = 5 mm; for 
Pseudomonas sandgrass isolate X  = 6 mm; for S. aureus X  = 4 mm; for E. coli 
X  = 3 mm; for Burkholderia cepacia X  = 4 mm; for Serratia marcescens X  = 5 
mm; for Saccharomyces cerevisiae X  = 0 mm. Scale bars are 5 mm; N = 3. 
Supplementary Figure 14 
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Figure 2.17 Clinical isolates of Pseudomonas aeruginosa from patients with 
Cystic Fibrosis produce inhibition.  
 
For each isolate, ~109-1010 cells were deposited on antibiotic-resistant mutant 
lawns overlaid on LB-tobramycin agar. All strains tested (17/17) produce 
inhibition of antibiotic-resistant mutants Mucoid strains (1) for 0476M X  = 5 mm; 
(2) for 4278M X  = 5 mm; (3) for 5623M X  = 6 mm; (4) for 2159M X  = 6 mm; 
(5) for 5914M X  = 4 mm; (6) for 3639M X  = 6 mm; (7) for 4220M X  = 6 mm; 
(8) for 5912M X  = 7 mm; Dwarf strains (9) for 4219D X  = 5 mm; (10) for 3488D 
X  = 6 mm; (11) for 3640D X  = 7 mm; Classic strains (12) for 4218C X  = 5 mm; 
(13) for 1913C X  = 7 mm; (14) for 0324C X  = 7 mm; (15) for 3470C X  = 6 mm; 
(16) for 2773C X  = 7 mm; (17) for 5913C X  = 5 mm. Scale bars are 5 mm; N = 
3. 
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Figure 2.18 Quantitative representation of the width of the inhibition (!) produced 
by a wide range of bacterial species.  
 
These include S. aureus and B. cepacia, co-pathogens with P. aeruginosa in 
infections of Cystic Fibrosis patients, and seventeen different clinical isolates of 
Pseudomonas from Cystic Fibrosis patients.  Clinical Cystic Fibrosis isolates are 
















































































































































2.3.12 Inhibition is observed when bacterial cells are deposited on media 
devoid of nutrients  
 
 
It is striking that antibiotic-susceptible WT PA14 cells produce inhibition 
even though the antibiotic agar contains an inhibitory concentration of antibiotic. 
This suggests that IF production may not depend on utilization of nutrients from 
the agar. To test this, WT PA14 cells were deposited on “cores” of nutrient-free, 
tobramycin-containing agar (Figure 2.19).  To test for effects of diffusion from the 
surrounding LB agar into the cores, increasing core diameters were used. WT 
PA14 cells produce inhibition even when deposited on nutrient-free cores that is 
comparable to those seen with the “no core” and “LB-tobramycin core” controls 
(Figure 2.19).  These data indicate that the production of IF does not depend on 

























Figure 2.19 Utilization of nutrients in the agar plate is not necessary for 
production of the inhibitory factor.  
 
(A) Cylindrical cores of nutrient-free tobramycin agar were created in LB-
tobramycin agar. (B) WT PA14 cells were deposited on filter discs with no 
underlying core, on cores of LB-tobramycin agar, and on nutrient-free tobramycin 
agar cores with diameters of 7 mm and 10 mm. Each of these was surrounded 
by antibiotic-resistant mutants overlaid on LB-tobramycin agar. Error bars 
represent standard error of the mean; N = 4. (C) Representative images of 
inhibition with P. aeruginosa WT PA14 cells deposited directly on filter discs ( X  
= 6 mm), on cores of LB-tobramycin agar ( X  = 6 mm), on 7-mm nutrient-free 
tobramycin cores ( X  = 6 mm) and on 10-mm nutrient-free tobramycin cores ( X  
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2.3.13 Alkaline metabolic products may play a role in inhibition 
 
Since S. cerevisiae does not produce inhibition but all tested bacterial 
strains do, we infer that the nutritional substrate for microbial growth may be 
linked to the production of IF.  All bacterial strains were grown in LB medium 
[153] but S. cerevisiae was grown in Yeast-Peptone-Dextrose (YPD) medium. In 
LB medium, amino acids are the only significant source of carbon and bacteria 
grow by catabolism, which produces alkaline by-products [153, 154]; overnight 
culture pH~8. In contrast, S. cerevisiae grows in YPD medium using the sugar 
dextrose as a source of carbon [155].  Yeast’s fermentation of sugar produces 
acidic by-products [155]; overnight culture pH~6. To evaluate the relationship 
between pH and inhibition, we used agar plates that incorporated the pH 
indicator bromthymol blue (BTB). BTB has a pH range of 6-7.6, which permits 
detection of slight perturbations from neutral pH.  
 
WT PA14 cells, WT PAO1 cells, S. aureus, E. coli, Serratia marcescens, 
Burkholderia cepacia, Pseudomonas sandgrass isolate, Pseudomonas PAO-
JP2, Pseudomonas !phz1/2 and S. cerevisiae were deposited on nutrient-free 
tobramycin agar and nutrient-containing LB-tobramycin agar containing BTB. To 
quantify changes in color, images were split into red-green-blue (RGB) channels 
and the red intensity profiles were analyzed (Figure 2.20). We define intensity 
ratio as the intensity 2mm from the disc edge divided by the intensity at a 
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distance > 8mm from the disc edge.  With no color change, the intensity ratio is 
expected to be ~1.  
 
When deposited on nutrient-containing BTB agar, bacteria produce an 
alkaline change, with an intensity ratio < 1 (Figure 2.21, 2.22, 2.23). Yeast 
produces a slightly acidic change or no change, with an intensity ratio ! 1. The 
width of inhibition X  and the width of the alkaline color change Xc  are correlated 
(Figure 2.22).  These results agree with the idea that inhibition is caused by the 
alkaline bacterial by-products. Alkaline change on nutrient-free agar (Figure 2.24) 
is consistent with our finding that inhibition does not result from utilization of 
nutrients from the agar plate. Rather, metabolic by-products from cells in the 
























Figure 2.20 Representative measurements of intensity ratio and width of alkaline 
change ( Xc ).  
 
Using intensity plot profiles generated in ImageJ v.1.47, intensity ratios were 
calculated as the gray value at a fixed distance of 2 mm from the edge of the disc 
(A, in the region with color change) divided by the gray value at a distance of 
more than 8 mm for microbial cells, more than 10 mm for NaOH, NaHCO3 and 
NH4Cl, sterile media and supernatant, and more than 40 mm for NH4OH from 
edge of the disc (B, in a region with no color change). To measure the width of 
alkaline change ( Xc ), the distance from the edge of the disc to the edge of the 
alkaline change was measured. For each replicate, Xc represents the average of 
four measurements made along two perpendicular axes. Scale bars are 5 mm. 
Supplementary Figure 18  
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Figure 2.21 Alkaline metabolic by-products from a wide range of bacterial 
species likely mediates inhibition.  
 
Different microbial strains were deposited on nutrient-free tobramycin BTB agar, 
on nutrient-containing LB-tobramycin BTB agar, and on antibiotic-resistant 
mutant lawns overlaid on LB-tobramycin agar. Images were taken immediately 
after deposition (for nutrient-free BTB agar), two hours after deposition (for 
nutrient-containing LB BTB agar) or after overnight incubation (for antibiotic-
resistant lawns on LB-tobramycin 8 µg/mL agar). The width of inhibition ( X ) is 
shown as hatched bars. All bacterial strains produce inhibition of antibiotic-
resistant mutant lawns, however the yeast strain fails to produce inhibition. Error 
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Figure 2.22 Alkaline metabolic by-products from a wide range of bacterial 
species correlate with inhibition.  
 
For different inhibiting strains, when the width of alkaline change ( Xc ) is plotted 
as a function of the width of inhibition ( X ), a correlation is observed (R2 = 0.82 
from a linear fit, Pearson’s correlation coefficient r = 0.9). Intensity profiles were 
used to measure the width of alkaline color change ( Xc ), representing the 
distance from the edge of the disc to the edge of the alkaline color change. For 
each replicate, Xc and X  represent the average of four measurements made 
along two perpendicular axes. Error bars represent standard error of the mean; N 
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Figure 2.23 Representative intensity profiles and images on nutrient-containing 
LB-tobramycin BTB agar.  
 
Bacterial strains and S. cerevisiae were deposited (~109-1010 cells for bacteria, 
~1012 cells for yeast) on LB-tobramycin BTB agar. Images were analyzed using 
ImageJ v.1.47. The width of alkaline change ( Xc ) was measured as the distance 
from the edge of the disc to the edge of the alkaline change. Scale bars are 5 
mm. 
Supplementary Figure 19 
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Figure 2.24 Representative intensity profiles and images on nutrient-free 
tobramycin BTB agar.  
 
Bacterial strains and S. cerevisiae were deposited (~109-1010 cells for bacteria, 
~1012 cells for yeast) on nutrient-free tobramycin BTB agar. Images were 
analyzed using ImageJ v.1.47. The width of alkaline change ( Xc ) was measured 
as the distance from the edge of the disc to the edge of the alkaline change. 




Supplementary Figure 20 
Serratia marcescens Saccharomyces cerevisiae 
P. aeruginosa WT PA14  




Pseudomonas sandgrass isolate 
Pseudomonas PAO-JP2 
Pseudomonas !phz1/2 
Nutrient-free BTB agar with 8 µg/mL tobramycin 
 103 
2.3.14 The mechanism of inhibition is related to the alkaline pH change 
 
To investigate a causative link between alkalinity and inhibition, we test 
exogenous alkaline solutions and find they produce both an alkaline change on 
BTB agar and inhibition of antibiotic-resistant mutants (Figure 2.25, 2.26, 2.27). 
We vary the concentration deposited and use linear regression to determine the 
relationship between concentration and X . From these, we extrapolate that 
deposition of 10 %L of 2.04M NH4OH, 1M NaOH, or 1M NaHCO3 produces 
inhibition of antibiotic-resistant mutants comparable to that seen with WT PA14 
cells (Figures 2.28, 2.29, 2.30, 2.31). On antibiotic-free LB agar, zones of 
inhibition are either absent (with NH4OH and NaHCO3) or markedly reduced (with 
NaOH) (Figure 2.32).  Collectively, these results indicate that alkaline compounds 
can recreate the characteristics we have found for the IF.  
 
Other researchers have shown that alkalinity significantly enhances the 
bactericidal activity of aminoglycosides [156, 157]. At least two possible 
mechanisms have been suggested: (1) enhanced active uptake of 
aminoglycosides [87, 156-158]; (2) more aminoglycosides in their nonionized, 
more-bactericidal form [156]. Thus, we infer that the IF inhibits mutants by 
increasing pH.  
 
We modify Equation 2 to use a threshold pH rather than a threshold IF 
concentration as the determinant of cell survival, thus:  
 104 
                               X
2 = 4DTc ln N0( )+ F D,Tc , pHc , k0 , ! ,!( )          
where pHc is the pH above which cells die, k0 is the IF production by one cell, 
and !  and !  are constants which account for the acid-base properties of the IF 
(electronic supplemental material).  The N0 -dependent portion of this function is 
unchanged from Equation 2.  Therefore, pH-mediated inhibition does not change 
our MW measurements. Further, this model predicts a linear relationship 
between X 2  and the squared size of alkaline color change ( Xc






























Figure 2.25 Exogenous alkaline solutions can recapitulate the phenomenon of 
inhibition.  
 
10 µL of exogenous compounds - 2.4M ammonium hydroxide (NH4OH), 1M 
sodium bicarbonate (NaHCO3), 1M sodium hydroxide (NaOH), WT PA14 cells, 
and 1M ammonium chloride (NH4Cl) - were deposited on LB-tobramycin BTB 
agar and on antibiotic-resistant mutant lawns on LB-tobramycin agar. Images 
were taken 2 hours after deposition (for LB-tobramycin BTB agar) or after 
overnight incubation (for LB-tobramycin agar with antibiotic-resistant mutant 
lawns). BTB color intensity ratios were determined as for figure 3, with the 
baseline gray value measured at a distance of more than 10 mm for NaOH, 
NaHCO3 and NH4Cl and WT PA14 cells, and more than 40 mm for NH4OH. 
Intensity ratios less than 1 indicate an alkaline change, as produced by 
ammonium hydroxide, sodium hydroxide, sodium bicarbonate and WT PA14 
cells. Ammonium chloride produces an intensity ratio ~1. Error bars (in red) 







































































































Figure 2.26 Representative images showing BTB color change and presence or 
absence of inhibition with exogenous alkalis. 
 
2.4M ammonium hydroxide (NH4OH)( X  = 10 mm, Xc = 15 mm), 1M sodium 
bicarbonate (NaHCO3) ( X  = 5 mm, Xc = 5.5 mm), 1M sodium hydroxide (NaOH) 
( X = 5 mm, Xc = 7.5 mm), WT PA14 cells ( X  = 5 mm, Xc = 6 mm) and 1M 


























































































Figure 2.27 Alkaline change and inhibition produced by exogenous alkaline 
compounds.  
 
Decreasing molar concentrations of exogenous alkaline compounds (A) 
ammonium hydroxide (NH4OH), (B) sodium hydroxide (NaOH) and (C) sodium 
bicarbonate (NaHCO3) were deposited on LB-tobramycin BTB agar and on 
antibiotic-resistance lawns on LB-tobramycin agar. Images were taken two hours 
after deposition (for LB-tobramycin BTB agar) and after overnight incubation (for 
LB-tobramycin agar with the antibiotic-resistant lawns). Exogenous compounds 
produce an alkaline change of the surrounding agar and inhibit antibiotic-
resistant mutants in their region of deposition. Scale bars are 5 mm. 
Supplementary Figure 21  
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Figure 2.28 Alkaline change produced by ammonium hydroxide correlates with 
inhibition.  
 
Decreasing concentrations of ammonium hydroxide (NH4OH) was deposited on 
LB-tobramycin BTB agar and on antibiotic-resistant lawns overlaid on LB-
tobramycin agar. Images were analyzed using ImageJ v.1.47. (A) Intensity ratios 
were calculated as the gray value at a fixed distance of 2 mm from the edge of 
the disc (in the region with color change) divided by the gray value at a distance 
of more than of more than more than 40 mm. (B) The width of alkaline change (
Xc ) was measured as the distance from the edge of the disc to the edge of the 
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Figure 2.29 Alkaline change produced by sodium hydroxide correlates with 
inhibition.  
 
Decreasing concentrations of sodium hydroxide (NaOH) was deposited on LB-
tobramycin BTB agar and on antibiotic-resistant lawns overlaid on LB-tobramycin 
agar. Images were analyzed using ImageJ v.1.47. (A) Intensity ratios were 
calculated as the gray value at a fixed distance of 2 mm from the edge of the disc 
(in the region with color change) divided by the gray value at a distance of more 
than of more than more than 10 mm. (B) The width of alkaline change ( Xc ) was 
measured as the distance from the edge of the disc to the edge of the alkaline 
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Figure 2.30 Alkaline change produced by sodium bicarbonate correlates with 
inhibition.  
 
Decreasing concentrations of sodium bicarbonate (NaHCO3) was deposited on 
LB-tobramycin BTB agar and on antibiotic-resistant lawns overlaid on LB-
tobramycin agar. Images were analyzed using ImageJ v.1.47. (A) Intensity ratios 
were calculated as the gray value at a fixed distance of 2 mm from the edge of 
the disc (in the region with color change) divided by the gray value at a distance 
of more than of more than more than 10 mm. (B) The width of alkaline change (
Xc ) was measured as the distance from the edge of the disc to the edge of the 
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Figure 2.31 Determining the molar concentration of ammonium hydroxide that 
produces inhibition comparable to WT PA14 cells.  
 
On a semi-log plot, squares of the width of inhibition ( X 2 ) vary linearly with 
increasing concentrations of deposited ammonium hydroxide (NH4OH), 
consistent with the disc diffusion model (R2 = 0.96). Concentrations of ammonium 
hydroxide represent increasing concentrations normalized to a concentration of 
1M. From the x-intercept of the fit obtained, it was determined that 2.04M of 
ammonium hydroxide produce a width of inhibition ( X = 5 mm) comparable to 
that produced by WT PA14 cells (~1010 cells). Error bars represent standard 






























Figure 2.32 On antibiotic-free agar, exogenous alkaline compounds produce little 
or no inhibition.  
 
Ten microliters of the alkaline compound, ammonium hydroxide (2.1M), sodium 
hydroxide (0.5M) or sodium bicarbonate (0.5M), were deposited on lawns 
initiated by overlaying decreasing numbers of antibiotic-resistant mutants on 
antibiotic-free LB agar. Inhibition observed is either absent (for NH4OH and 
NaHCO3) or markedly reduced (for NaOH), compared to the inhibition produced 
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2.3.15 Biogenic bases are plausible candidates for the inhibitory factor 
 
The biogenic bases ammonia and amines are widespread by-products of 
bacterial catabolism of amino acids [153, 154, 159]. Ammonia has a MW of 17 
Da, consistent with that of the IF. Microbially-produced ammonia and amines can 
mediate long-range intercellular interactions and influence antibiotic resistance 
[160-165]. Gaseous ammonia, from bacterial supernatant, and trimethylamine 
can decrease resistance to the aminoglycoside antibiotics kanamycin and 
spectinomycin [164, 165].  
 
We used an ion-selective electrode to measure ammonia and amine 
emission when bacteria and yeast were deposited onto filter discs on LB-
tobramycin agar. WT PA14 produce an emission nearly 5x that of S. cerevisiae 
(Figure 2.33). In the disc diffusion assay, deposition of 1M ammonium chloride 
(NH4Cl) produces a slightly acidic change and no inhibition (Figure 2.26). Thus, 
we find a correlation between alkaline change and inhibition, but no inhibitory 
effect by the ammonia molecule itself when the pH is acidic. Therefore, we 
attribute inhibition to an alkaline pH change that is mediated, in part or in whole, 



















Figure 2.33 Production of ammonia or amines is associated with inhibition.  
 
Using an ion-selective electrode, ammonia or amine emission was measured 
following deposition of WT PA14 and S. cerevisiae cells on filter discs on LB-
tobramycin agar in vials.  Emission levels are normalized to the PA14 average. 
Significantly higher levels of ammonia or amine emission are detected following 
deposition of WT PA14 cells than following deposition of S. cerevisiae. Error bars 
represent standard error of the mean; N = 3. * P < 0.005 by two-tailed Student t 



















































2.3.16 Nutrient conditions provide a “switch” to control inhibition  
 
Microbes capable of utilizing either amino acids or sugars as carbon 
sources should switch between producing inhibition and not producing inhibition 
depending on the carbon source available. S. aureus and E. coli, which can 
either catabolize amino acids or ferment glucose, P. aeruginosa, which is 
incapable of fermentation, and S. cerevisiae, which ferments glucose.  We grew 
each organism in two culture media – LB, which contains almost entirely amino 
acids as a carbon source, and YPD, which likewise contains copious amino acids 
but is also supplemented with the sugar dextrose. The pH of overnight cultures 
grown in LB was alkaline (pH=9) for all bacterial strains and neutral (pH=7) for 
the yeast strain.  S. cerevisiae grew poorly in LB broth, so we pool cells from 
multiple cultures so that approximately the same number of cells were deposited 
onto filter discs in all cases.  The pH of overnight cultures grown in YPD was 
alkaline (pH=8) for WT PA14, and acidic for S. aureus, E. coli, and S. cerevisiae 
(pH=4, 4, and 5, respectively).  
 
WT PA14, S. aureus and E. coli cultures grown in LB produce an alkaline 
color change and inhibit antibiotic-resistant mutants (Figure 2.34, 2.35, 2.36, 
2.37). S. cerevisiae produces neither a pH color change nor inhibition.  When 
grown in YPD, WT PA14 cells produce an alkaline change and inhibition. 
However, S. aureus, E. coli and S. cerevisiae grown in YPD produce an acidic 
change and no inhibition (Figure 2.34, 2.35). Culture supernatants and sterile LB 
 116 
and YPD media produce no pH color change on nutrient-containing media and 
produce no inhibition (Figures 2.38, 2.39, 2.40, 2.41, 2.42). 
 
From this we conclude that microbial metabolism and the nutrient 

































Figure 2.34 The carbon source used for growth can switch inhibition on or off.   
 
WT PA14, S. aureus, E. coli, and S. cerevisiae were each grown in (A) LB 
medium, for which amino acids are the major carbon sources, and (B) YPD 
medium, which contains both amino acids and sugar. Following growth, cultures 
were deposited onto LB-tobramycin BTB agar and onto antibiotic-resistant 
mutant lawns on LB-tobramycin agar. (A) When grown on amino acids, the first 
three organisms produce both a BTB intensity ratio <1 and inhibition. The yeast 
S. cerevisiae produces no change in pH and no inhibition. (B) When grown in the 
presence of sugars, S. aureus, E. coli, and S. cerevisiae ferment sugars and 
thereby produce an acidic change and no inhibition.  WT PA14 catabolizes amino 
acids, causing an alkaline change and inhibition.  
Figure 6 













































































































Figure 2.35 Representative images of color change and presence or absence of 
inhibition with microbial strains grown in LB and YPD media.  
 
(A) For overnight cultures grown in LB medium, WT PA14, S. aureus and E. coli 
produce an alkaline change and produce inhibition of antibiotic-resistant mutants. 
S. cerevisiae does not produce a color change and fails to produce inhibition. (B) 
For overnight cultures grown in YPD medium, WT PA14 produces an alkaline 
change, and produces inhibition. S. aureus, E. coli and S. cerevisiae produce an 
acidic change and fail to produce inhibition. Scale bars are 5 mm. 
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Figure 2.36 On nutrient-free tobramycin 8 µg/mL BTB agar, cell cultures produce 
a pH color change corresponding to that of seen on nutrient-containing LB-
tobramycin 8 µg/mL BTB agar.  
 
(A) For cultures grown in LB media, WT PA14, S. aureus and E. coli produce an 
alkaline change, indicated by an intensity ratio <1. S. cerevisiae does not 
produce a color change (intensity ratio ~1). For cultures grown in YPD media, 
WT PA14 produces an alkaline change, whereas S. aureus, E. coli and S. 
cerevisiae produce an acidic change (intensity ratio >1). Error bars represent 
standard error of the mean; N = 2. (B) Representative images of pH color change 
following deposition of cell cultures grown in LB and YPD media on nutrient-free 
tobramycin 8 µg/mL BTB agar. Scale bars are 5 mm. 
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Figure 2.37 Production of an alkaline change on LB-tobramycin agar is 
associated with inhibition.  
 
P. aeruginosa WT PA14 cells, filter-sterilized supernatant from WT PA14 cultures 
grown in LB broth, and sterile LB broth were deposited on nutrient-free 
tobramycin BTB agar, LB-tobramycin BTB agar and on antibiotic-resistant mutant 
lawns overlaid on LB-tobramycin agar. (A) On nutrient-free tobramycin BTB agar, 
WT PA14 cells and supernatant produce an intensity ratio < 1, indicating an 
alkaline change. Sterile LB broth produces no color change, as indicated by an 
intensity ratio ~1. Error bars represent standard error of the mean; N = 3. (B) On 
nutrient-containing LB-tobramycin BTB agar, WT PA14 cells produce an alkaline 
change, indicated by an intensity ratio < 1. Supernatant and sterile LB broth do 
not produce a color change, as indicated by an intensity ratio ~1. Error bars 
represent standard error of the mean; N = 3. 
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Figure 2.38 Representative images showing that production of an alkaline 
change on LB-tobramycin agar is associated with inhibition. 
 
WT PA14 cells produce an alkaline change on nutrient-free tobramycin BTB agar 
( Xc = 9 mm) and LB-tobramycin BTB agar ( Xc = 6 mm) and produce inhibition of 
antibiotic-resistant mutants ( X = 5 mm). Supernatant produces an alkaline 
change on nutrient-free tobramycin BTB agar ( Xc = 6 mm), but fails to produce 
both an alkaline change on LB-tobramycin BTB agar ( Xc = 0) and inhibition of 
antibiotic-resistant mutants ( X  = 0 mm). Deposition of sterile, fresh LB broth 
does not produce an alkaline change ( Xc = 0 mm) or inhibition ( X  = 0 mm). 
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Figure 2.39 Supernatant from cultures grown in LB and YPD media on LB-
tobramycin BTB agar and on antibiotic-resistant mutant lawns overlaid on LB-
tobramycin agar. 
 
Supernatant from overnight cultures from LB and YPD media was deposited on 
LB-tobramycin BTB agar and on antibiotic-resistant mutant lawns overlaid on LB-
tobramycin agar. (A and B) On nutrient-containing LB-tobramycin BTB agar or 
antibiotic-resistant mutants, supernatant from WT PA14, S. aureus, E. coli and S. 
cerevisiae grown in LB and YPD media fail to produce a pH color change and 
inhibition ( X = 0 mm). Error bars represent standard error of the mean; N = 3. 
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Figure 2.40 Supernatant from cultures grown in LB and YPD media nutrient-free 
tobramycin BTB agar. 
 
On nutrient-free tobramycin BTB agar, supernatant produces a pH color change 
corresponding to that seen after deposition of cell cultures. Supernatant from WT 
PA14, S. aureus and E. coli cultures grown in LB produce an alkaline change,. 
Supernatant from S. cerevisiae cultures in LB produce no color change. As 
expected, S. cerevisiae grew poorly in LB medium. For cultures grown in YPD 
medium, WT PA14 supernatant produces an alkaline change, whereas for S. 
aureus, E. coli and S. cerevisiae supernatant produces an acidic change. Error 
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Figure 2.41 Deposition of supernatant from overnight cultures grown in LB and 
YPD media. 
 
(A and B) Representative images of absence of pH color change and inhibition 
following deposition of supernatant from LB and YPD cell cultures on LB-
tobramycin 8 µg/mL BTB agar and antibiotic-resistant mutant lawns. Scale bars 
are 5 mm. (C) Representative images of pH color change following deposition of 
supernatant from LB and YPD cell cultures on nutrient-free tobramycin 8 µg/mL 
BTB agar. Scale bars are 5 mm. 
Supplementary Figure 28 
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Figure 2.42 Deposition of sterile liquid media fails to produce a pH color change 
and inhibition, 
 
Sterile LB and YPD media were deposited on nutrient-free tobramycin 8 µg/mL 
BTB agar, LB-tobramycin 8 µg/mL BTB agar and on antibiotic-resistant mutant 
lawns on LB-tobramycin 8 µg/mL agar. (A) On BTB agar, deposition of sterile LB 
or YPD media fails to produce an alkaline or acidic change, as indicated by an 
intensity ratio ~1, and fails to produce inhibition of antibiotic-resistant mutants. 
Error bars represent standard error of the mean; N = 2. (B) Representative 
images of absence of pH color change and inhibition with sterile LB or YPD 
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2.3.17 Spatial fluctuations in population density influence the survival of 
antibiotic-resistant mutants in spatially-mixed populations 
 
 
In the spatially-mixed system, mutant survival probability approaches zero 
with increasing cell density. Similarly, in disc diffusion assays, inhibition zone size 
increases with increasing density of deposited cells. Therefore, it seems 
paradoxical that mutant cells are able to grow into high-density colonies on the 
plate without inhibiting themselves. To resolve this paradox, we examine the 
effect of spatial fluctuations in initial population density on the survival of resistant 
mutants. 
 
It is often found that the molar amount of an inhibitory substance per cell is 
a more accurate determinant of cell survival during exposure than the 
concentration, and therefore higher-density populations of bacteria can survive 
higher concentrations of antibiotics than lower-density populations [166]. In a 
well-mixed, homogeneous system with a constant antibiotic concentration [AB] , 
increasing cell density decreases the moles of antibiotic per cell, {AB} , thereby 
enhancing the resistance of cells to a given [AB] . However, we have postulated 
that the IF released by cells modulates antibiotic resistance by changing pH. 
Moreover, physically realistic spatial distributions of cells will have random 
fluctuations in cell density.  Together, these two observations may lead to non-
trivial probabilities of cell survival as a function of the average cell density.  
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We assume a uniform [AB]  throughout the plate. {AB}  in a small effective 
volume Ve  containing N  cells is thus 
AB!" #$Ve
N
. If {AB}  is less than a critical value
{AB}th , mutant cells in Ve  will grow. Since the number of WT cells is much 
greater than the number of antibiotic-resistant mutants and the volumes in 
question are small, we assume that no more than one mutant will be in Ve  and 
that it will survive if [ ]







+ > , where NWT  is the number of WT inVe .  
We model random deposition of bacteria as a Poisson process. The 
Poisson cumulative distribution function gives the probability that the number of 















= " # .  !WT  is the average 
density of WT on the plate. Since 0WT! !" , where !0  is the total cell density on 
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Previous studies at constant cell density have found an approximately 
exponential relationship between the MIC to aminoglycoside antibiotics and the 
pH [166]. We assume a similar exponential form for , 
where A  and b  are scaling constants, and {AB}min  is the minimum value of 
{AB}th . We approximate the pH !resulting from the release of IF as
, where !  and !  are constants describing the acid-base 
{ } { }10 b pHth minAB A AB! "= " +
[ ]10logpH IF! "= +
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properties of the IF, and [IF]  is the concentration of IF on the plate (electronic 
supplementary material).  Assuming {AB}min  is small compared to{AB}th , the 
condition for mutant survival can be approximated as . If 
[IF]= k0!0 , where k0  is a production constant and !0  is the initial cell density, 
the probability of mutant survival becomes 
        (3) 
where and . !  is a lumped parameter which accounts for the 
alkalinity of the IF and a strain’s production of IF and degree of antibiotic 
resistance; !  accounts for the sensitivity of the antibiotic resistance to changes 
in pH; Ve accounts for the spatial extent over which surrounding cells can  lower 
the {AB}  to which a mutant is exposed. is discrete with respect to , and a 
continuous function  can be approximated from it using linear interpolation.  
 
The function  gives the fraction of plated antibiotic-resistant mutants that 
will grow to form colonies and as a function of the initial density of cells. The 
fraction of the plated culture that grows into antibiotic-resistant colonies, M , is 
thus described by where µ  is the true proportion of mutants in the 












































population. Similarly, the number of colonies formed, C , is given by , 
where Vtot  is the total volume of the plated cell suspension.  
 
We fit this model to our experimental data. A wide range of values of ! , 
Ve , !  and µ result in trends consistent with our measurements in Figure 2.1 
(Figure 2.43). We can estimate physically reasonable values of Ve  by examining 
how an individual cell might impact its surrounding antibiotic concentration. By 
modeling a cell as an antibiotic sink, we estimate the lowest reasonable Ve value 
to be 0.004 nL, corresponding to 1000 times the volume of a cell, or a sphere of 
radius 10 %m (electronic supplementary material). With a Ve  of 0.004 nL, values 
of ! ranging from 0.90 to 2.5, !  ranging from 8x10-6 to 4 nL&-1 and µ  ranging 
from 4x10-7 to 4x10-6, produce reasonable fits to our data, and the least squares 
fit has an ! of 1.186, ! of 0.307 nL&-1 and µ  of 1.02x10-6 (R2= 0.92) (Figure 2.1).  
Additionally, Ve  of 0.04, 0.4 and 4 nL, produce similar trends and fits (Figure 2.43 
and 2.44). Overall, the wide range of parameters values that produce reasonable 
fits reflects a robustness of this model to changes in specific values, and 
indicates that fine-tuning of the parameters is not necessary to match the trends, 
which we observe.  
 
Guided by this model, we postulate that antibiotic-resistant mutants are 
able to grow into high-density colonies on antibiotic-containing agar because they 
are shielded from antibiotics by their WT neighbors. A mutant will grow into a 
0 totC V Pµ!= !
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colony if it is in a region with high local cell density that reduces the {AB}  to 
which it is exposed below a threshold value. However, as the average cell 
density deposited on the plate increases, the resulting increase in [IF] on the 
plate lowers this threshold value by causing an increase in pH, so there is a net 
decrease in mutant survival probability with increasing average density. This 
interpretation implies that small initial fluctuations in density will be magnified as 





























Figure 2.43 A wide range of mixed-system model parameters produce 
reasonable fits to observations.  
 
Parameter estimates of  and µ , as well as the sum of squared residuals 
(SSR), were calculated for the least squares fit to colony counts in Replicate 1 of 
Figure 2.1 for set values of Ve  and ! . A SSR of 1.0x10
6 was estimated to be the 
threshold for reasonable fits, and fits with a SSR greater than this are excluded. 
Plotted are the least squares !estimated as a function of the set values of !  for 
!! of 0.004, 0.04, 0.4 and 4. Diamond points (') represent the fit values of !  and 
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Figure 2.44 Fits of the mixed-system model describe our observations of 
inhibition well.  
 
Least squares regression was performed on colony count data from Replicate 1 
of Figure 2.1 for given values of Ve . The resulting fit parameters were 1) Ve = 
0.004, !  = 1.164, !  = 0.370, µ  = 1.10x10-6; 2) Ve = 0.04, ! = 1.059, != 0.697, µ
= 1.21x10-6; 3) Ve = 0.4, ! = 1.019, != 0.888, µ= 1.26x10
-6; 4) Ve = 4, !  = 1.006, 
!= 0.962, µ= 1.27x10-6. (A) Colony forming unit (CFU) counts fit. R2=0.953 (Ve = 
0.004), 0.955 (Ve = 0.04), 0.954 (Ve = 0.4), 0.954 (Ve = 4). (B) Mutant colony 
frequency (colonies/million cells) fit. R2=0.778 (Ve = 0.004), 0.784 (Ve = 0.04), 
0.766 (Ve = 0.4), 0.759 (Ve = 4). 
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2.3.18 Identification of possible mutations conferring aminoglycoside 
resistance  
 
Table 2.2. Single-nucleotide polymorphisms (SNPs) in the antibiotic-resistant 










741,564 CAC!CGC His!Arg EF-Tu Elongation factor Tu 
3,559,401 AAG!GAG Lys!Glu  phzD Phenazine biosynthesis 
protein 
 




We used one antibiotic-resistant mutant strain of PA14 for all our 
experiments except when specifically stated otherwise.  This strain was 
generated by spontaneous mutation during overnight culture in antibiotic-free 
liquid media.  To identify the possible mutation(s) conferring aminoglycoside 
resistance in this strain, we performed whole-genome sequencing (Illumina 
MiSeq v2) of the antibiotic-resistant mutant and WT PA14 ancestral strain. These 
sequences have been deposited in the National Center for Biotechnology 
Information Short-Read Archive http://www.ncbi.nlm.nih.gov/sra (accession no. 
SRP042054). Using the BRESEQ 0.19 pipeline, we identified three single-




Elongation factor Tu (EF-Tu), a member of the GTPase superfamily of 
proteins, has a crucial role in the elongation phase of bacterial protein synthesis, 
in which it delivers aminoacylated tRNAs (aa-tRNAs) to the ribosome  [167]. After 
delivering the correct aa-tRNA complex to the ribosome, EF-Tu is released, a 
process initiated by GTP hydrolysis. This mechanism is catalyzed by EF-Tu, but 
requires activation by the ribosome [167]. It has been shown that a highly 
conserved histidine residue (His-84 in E. coli and His-85 in Thermus 
thermophilus) in the switch II region of the EF-Tu factor is critical for this catalysis 
[168, 169]. The antibiotic-resistant strain that we sequenced had a histidine-to-
arginine substitution at this residue (H85R) (Table 2.2). Aminoglycoside 
antibiotics inhibit bacterial protein synthesis by targeting the ribosome [86]. 
Mutations in the eukaryotic elongation factor 1 (EF-1), analogous to bacterial EF-
Tu, and other bacterial elongation factors, such as EF-G, have been associated 
with aminoglycoside resistance [170-172], indicating the possibility that the EF-
Tu mutation contributes to antibiotic resistance in this mutant strain. 
 
TrkH is a hydrophobic, membrane protein and a constituent of the 
potassium uptake system, which mediates the symport of potassium and 
hydrogen ions [173]. Mutations in Trk system have been associated with altered 
aminoglycoside susceptibility [171, 174, 175], and in one study 64% of 
sequenced aminoglycoside-adapted populations had trkH mutations [171]. The 
amino acid residue affected by one of these mutations was close to the ion 
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channel, possible leading to increased proton influx and diminished membrane 
potential [171]. Aminoglycosides require the membrane potential component of 
the proton motive force (PMF) for active cellular uptake [87, 176] and adaptation 
to this class of antibiotics frequently proceeds through mutations that diminish the 
generation of PMF [171]. The antibiotic-resistant strain sequenced in our study 
had a serine to proline substitution at residue 226 (S226P) of TrkH (Table 2.2). 
This could possibly lead to increased proton influx, diminished membrane 
potential and PMF, and reduced aminoglycoside uptake.  
 
The phzD2 gene is part of the phenazine biosynthetic cluster, encoded by 
two redundant operons phzA1-G1 and phzA2-G2 [142]. The antibiotic-resistant 
strain in our study had a lysine to glutamic acid substitution at residue 28 (K28E) 
of PhzD (encoded by phzD2) (Table 2.2). To the best of our knowledge, there is 
no direct evidence of phzD mutations conferring aminoglycoside resistance, and 
the redundant nature of this gene, makes its role further likely.  
 
It is thus plausible that acquisition of these mutations, alone or in 








2.3.19 Disc-diffusion model to incorporate a threshold pH 
 
Previous work by others has shown several cases in which the MIC of 
aminoglycoside antibiotics decreases exponentially with increasing pH [166].  
Therefore, we modify the disc-diffusion model of our spatially-structured system 
to incorporate a threshold inhibitory pH instead of a threshold IF concentration.  
For an alkaline IF, the concentration of OH- is approximately [ ]OH A IF !"# $ % &' (  
where A  and !  are constants, and [ ]IF  is the concentration of IF in the media. 
Thus, [ ]10logpH IF! "= + , where 1014 log A! = + . Combining this with equation 1 
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This can be rearranged to: 
[ ] ( ) ( ) ( )2 0
4 ln 10
4 ln 4 ln 4
Dt
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= $ $ $  
If [ ] 0 00IF k N=  where k0  is a production constant and N0  is the number of cells 
on the disc, this becomes:  
( ) ( ) ( )2 00
4 ln 10
4 ln 4 ln
4
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This function gives the point in space x  at which the pH is a given value. 
Assuming there is a critical pH, pHc , over which cells die at the critical time, the 
edge of the zone X will be: 
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( ) ( )2 0 04 ln , , , , c c cX DT N F D T pH k != +  
The N0 -dependent portion of this function is of the same form as the one 
predicted in the model without a pH-mediated IF. As a result, pH-mediated 
inhibition does not change our measurements of molecular weight. 
 
2.3.20 pH-mediated inhibition predicts linear relationship between squared 
sizes of indicator color change and inhibition zone 
 
 
Cells that produce inhibition also cause a blue discoloration in agar 
containing the pH indicator bromthymol blue (BTB). Because the change in color 
of BTB occurs over a narrow range of pH (approximately 6-7.6), the boundary of 
the discolored region will correspond to a specific threshold pH of ~7.6, which we 
term pH
c ,BTB
. Similarly, if inhibition is mediated by a change in pH, then the 
boundary of the zone of inhibition will correspond to a specific threshold pH, 
pHc,IF . Thus, the size of the inhibition zone, XIF , is  
( ) ( ) ( )2 00 ,4 ln 104 ln 4 ln 4IF c IF
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and at the critical time Tc  the size of the zone of color change BTBX  is 
 ( ) ( ) ( )2 00 ,4 ln 104 ln 4 ln 4BTB c BTB




$ %= + & &' () *
 
Thus:  
( ) ( )2 2 , ,4 ln 10cIF BTB c IF c BTBDTX X pH pH!= " "  
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This model therefore predicts a linear relationship between XIF
2  and XBTB
2
, when XBTB is measured around the critical time.  This is consistent with our 
observations (Figure 2.22).  From these data, we can also infer that the threshold 
pH value for inhibition is higher than the threshold pH value for the BTB color 
change.  
 
2.3.21 Inhibition in spatially-mixed populations 
 
We measure the number of colonies formed, C , in a spatially-mixed 
population exposed to antibiotics. Our model predicts 0 totC V Pµ!= !, where P
~
 is 


















= # $  
0!  is average cell density, eV  is an effective volume in which cells reduce 
antibiotic quantities per cell, µ  is the proportion of mutants in the initial 
population, and !  and !  are lumped parameters. We fit this model to our 
observations of C  using least squares regression. A wide range of values of 
values of ! , Ve , !  and µ  result in trends consistent with our measurements in 
Figure 2.1. We can estimate physically reasonable values of Ve  by examining 
how an individual cell might impact its surrounding environment. Ve  is the 
effective volume within which cells reduce the moles of antibiotic per cell acting 
on a cell at the center of the volume. The distance at which a cell no longer 
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effects a noticeable reduction in antibiotic amounts at the center would be equal 
to the radius of a sphericalVe . To estimate this distance, we can model cells as 
antibiotic sinks. The diffusion of antibiotics can by described by Fick’s Second 
Law, [ ] [ ]2d AB D AB
dt
= ! , where [AB]  is antibiotic concentration. Since the 
diffusion of antibiotics is fast relative to the length scale of a cell (tobramycin 
diffusion coefficient D  = 96±8 %m2/s), we can consider the steady state 
distribution of antibiotics around a single cell. Approximating a cell to be 
spherical, the steady state antibiotic distribution around a cell which completely 
absorbs antibiotics [AB]= 0 at the cell surface is described by
[ ] [ ] 1 aAB AB
r!
" #= $% &' (
, where [AB]!  is the antibiotic concentration far from the cell, 
a  is the radius of the cell and r is the distance from the center of the cell.  The 
concentration 10 times the radius of the cell away will be 90% of [AB]! . This 
corresponds to a volume 1000 times the volume of the cell, which we take to be 
a minimum value ofVe . Thus, with a cell volume of approximately 4x10
-6 nL, we 










Table 2.3 Minimum Inhibitory Concentration (in µg/mL) for strains used in this 
study.  
 
Strains Tobramycin Gentamicin 
 
P. aeruginosa WT PA14 1.2 1.2 
P. aeruginosa WT PAO1 1.2 Not tested 
Spontaneously-generated antibiotic-resistant 
mutants (three different strains) 
9.7 9.7 
Continuously evolved antibiotic-resistant mutants 
(two different strains) 
9.7 Not tested 
PA14 transposon mutants 1.2 2500 
$phz1/2  1.2 Not tested 
Clinical cystic fibrosis isolates  
2773C, 1913C, 3488D 
1.2 Not tested 
Clinical cystic fibrosis isolates  
3470C, 3639M, 4278M, 4218C, 0324C, 2159M, 
4220M, 5912M 
0.6 Not tested 
Clinical cystic fibrosis isolates 
4219D, 0476M 
0.3 Not tested 
Clinical cystic fibrosis isolate  
3640D 
0.07 Not tested 
Clinical cystic fibrosis isolate  
5913C 
4.8 Not tested 
Clinical cystic fibrosis isolate  
5623M, 5914M 
2.4 Not tested 
Pseudomonas sandgrass isolate 9.7 Not tested 
S. aureus Mu50  1250 Not tested 
E. coli SM10, E. coli DH5# 2.4 Not tested 
Burkholderia cepacia 2500 Not tested 
Serratia marcescens 4.8 Not tested 
Saccharomyces cerevisiae (done in YPD broth) 1250 Not tested 
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Table 2.4 Mutants from the PA14 non-redundant transposon library that were 
tested for inhibition.   
 
 
Mutant Gene function Width of 
inhibition 
(X)  
prtN Pyocin transcriptional regulator 5 mm 
fliA Motility sigma factor FliA 5 mm 
fliC Flagellin subunit protein 5 mm 
pilH Type IV pilus response regulator 5 mm 
pilT Twitching motility protein 5 mm 
lasI Acylhomoserine lactone synthesis protein 5 mm 
rhlI Acylhomoserine lactone synthesis protein 5 mm 




phzA1 Phenazine biosynthesis protein 5 mm 
phzA2 Phenazine biosynthesis protein 4 mm 
phzB1 Phenazine biosynthesis protein 4 mm 
phzB2 Phenazine biosynthesis protein 5 mm 
phzC1 Phenazine biosynthesis protein 5 mm 
phzE1 Phenazine biosynthesis protein 4 mm 
phzF Phenazine biosynthesis protein 4 mm 
phzG1 Phenazine biosynthesis protein 5 mm 
mucB Negative regulator for alginate biosynthesis 6 mm 
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Table 2.4 (continued) 
 
ndvB Synthesis of periplasmic glucans 6 mm 
rpoS Sigma factor 5 mm 
mdoG Periplasmic glucan biosynthesis protein 4 mm 
algQ Alginate regulatory protein 6 mm 
algU Sigma factor AlgU 4 mm 
alg44 Alginate biosynthesis protein 6 mm 




pqsE Quinolone signal response protein 5 mm 
PA5437 Putative transcriptional regulator, Putative 
transcriptional regulator, LysR family 
 
5 mm 
PA0625 Putative tail length determinator protein 5 mm 
PA0633 Putative major tail protein V 5 mm 
PA0624 Conserved hypothetical protein 5 mm 
PA4754 Conserved hypothetical protein 5 mm 
PA0615 Conserved hypothetical protein 5 mm 
PA0017 Putative tRNA and rRNA cytosine-C5-methylases 5 mm 
mutS DNA mismatch repair protein 5 mm 
mutY Adenine glycosylase / DNA mismatch repair 
protein 
4 mm 
uvrD DNA helicase II 5 mm 
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Table 2.4 (continued) 
 
envZ Two component sensor kinase  5 mm 
mutM DNA glycosylase / DNA mismatch repair protein 4 mm 
mutT DNA mismatch repair protein 5 mm 
aspC Aspartate transaminase 5 mm 
















We have found that bacteria, regardless of their antibiotic susceptibility, 
can inhibit the survival and growth of antibiotic-resistant mutants in the presence 
of aminoglycosides. An alkaline by-product of amino acid catabolism, possibly 
ammonia or amines, mediates this inhibition. Further, these alkaline by-products 
likely mediate this effect by an increase in pH, which enhances the bactericidal 
effect of aminoglycosides. We find that microbial population structure, including 
cell density, spatial distribution and interspecies interactions, can impact the 
growth of pre-existing antibiotic-resistant through this mechanism.  
 
For a favorable mutation (i.e., one that confers a fitness advantage in the 
environment), the probability of fixation in a population increases with decreasing 
population size, which is a measure of the number of competitors. Although our 
liquid cultures are grown without antibiotics, it is possible that the resistance-
conferring mutation(s) conveys some other growth advantage in antibiotic-free 
liquid culture.  In that case, the probability of the mutation fixing would depend on 
whether the mutation occurred early or late in culture growth.  However, this 
possibility does not confound the results we present here because in Figure 2.1 
the ratio of mutants to WT is the same within each experiment, since all the data 
points for each experiment are done for the same overnight culture suspension.  
Therefore, Figure 2.1 measures the probability that a pre-existing mutant will 
grow into a colony, not the fixation of the mutants in a population. 
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Our finding, that increasing bacterial density can increase antibiotic 
susceptibility, is superficially in contrast to previous observations that in compact 
bacterial populations, such as in biofilms, the susceptibility against antibiotics is 
in fact decreased. However, it should be noted that bacteria in biofilms are in a 
different phenotypic state than that of the bacteria we plated from suspension 
onto agar.  Most notably, biofilms are structured by embedding extracellular 
polymers, which can provide protection against aminoglycoside antibiotics.  The 
bacteria in biofilm interiors also have limited access to growth substrates, which 
results in slowed growth and altered metabolic pathways that can protect against 
antibiotics.   
 
Thus, the structure and the phenotypic state of the bacterial population 
need to be considered when designing treatment strategies. 
 
This can easily be seen in the case of Cystic Fibrosis (CF), which is a 
genetic condition that renders the lung unusually susceptible to infection by P. 
aeruginosa and other pathogens. The CF lung contains an abundance of free 
amino acids [177, 178].  In microbes sampled from CF lungs, the genes and 
pathways involved in amino acid catabolism are significantly upregulated [177]. 
In accordance, elevated ammonia levels have been found in CF sputum [177]. 
These observations would seem to suggest that the microbial population in the 
CF lung is well-poised to inhibit each other in the presence of aerosolized 
tobramycin, which is commonly used in the treatment of CF.  
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However, CF results from a genetic defect in the Cystic Fibrosis 
Transmembrane Receptor (CFTR), which causes decreased bicarbonate ion 
transport and acidification of CF airway fluids [76, 179]. This would prevent 
inhibition. Inhaled bicarbonate therapy is a possible remediation for this and is 
already being studied as a therapy for CF because it may help restore the innate 
antimicrobial activity of airway surface fluids as well as facilitate the thinning and 
clearing of airway mucus [76, 77]. Our results suggest a potential additional 
benefit for bicarbonate therapy in CF, where it could augment the activity of 
aminoglycosides and help curtail antibiotic resistance.  Thus, optimizing 
therapeutic benefits of combining aminoglycosides with bicarbonate would 
require further work determining how the physiological environment of the host 
impacts microbial metabolism, pH changes, and pharmacokinetics of base and 
aminoglycoside in the lung.  Moreover, while early infections of the CF lung are 
transient and associated with a planktonic bacterial phenotype, decades-long 
chronic infections are associated with a biofilm phenotype.  Since biofilms have 
phenotypic resistance to aminoglycosides, full realization of the potential benefits 
of the work we present here would require determination of the degree to which 
pH-mediated inhibition is active against clinical biofilm infections. 
 
More broadly, our findings indicate that manipulating the nutritional and 
metabolic environment of the CF lung, chronic wounds, or other sites of infection 
could potentially provide a set of management strategies that are complementary 
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to and synergistic with conventional antibacterial therapies. Developing 
approaches that limiting the availability of sugars, and/or using anti-fungal 
therapy, would promote amino acid catabolism and prevent microbe-caused 
acidification. Because the inhibition we characterize here results from highly-
conserved bacterial metabolic pathways, evolutionary escape is likely to be 
difficult.  In addition, because the IF is produced by bacteria and will therefore be 
localized to infection sites, approaches to treatment that exploit the structure of 
microbial populations may reduce system-wide high concentrations of antibiotics 
and resultant toxicity to patients.  This approach could both help to curtail the rise 
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Chapter 3:  A biophysical approach to novel antibiotic 
strategies: Evaluating the potential of tobramycin and 





Rising trends in antibiotic resistance have prompted the search for newer 
therapeutic strategies [180]. This refers not only to the development of novel 
antimicrobial agents, but also underscores the importance of developing adjunct 
treatment approaches that can extend the lifetime of current antibiotics.  
 
Pseudomonas aeruginosa is an important opportunistic human pathogen, 
and multi-drug resistant strains of P. aeruginosa are on the rise [55]. A major 
cause of hospital-acquired infections, P. aeruginosa affects burned, wounded, 
and ventilator-associated patients, causing both acute and chronic infections 
[55]. Acute P. aeruginosa infections, are usually associated with planktonic or 
free-floating cells, and burn wound infections, surgical-site wound infections, 
urinary tract infections, ocular infections, ear infections, meningitis, and sepsis 
[55]. Infections in burn wounds carry a heavy medical and economic burden and 
are associated with high mortality rates [72]. These infections often deteriorate 
rapidly leading to sepsis and death within few weeks. In surgical-site infections, 
P. aeruginosa often displays increased antibiotic resistance, which delays wound 
healing [83].  
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Chronic P. aeruginosa infections are commonly seen in patients with the 
genetic disorder Cystic Fibrosis [66]. In CF patients, infection with P. aeruginosa 
presents a multi-stage process. Early infection is mediated by planktonic cells, 
and is often transient and intermittent, with antimicrobial therapy initially 
eradicating the infection. Persistence in the respiratory tract leads to chronic 
infection, characterized by the formation of multicellular, aggregates of bacteria 
known as biofilms [15]. In this stage, P. aeruginosa is notoriously recalcitrant to 
antibiotic therapy [83]. In addition, P. aeruginosa biofilm formation plays a major 
role in the pathogenesis of chronic wound infections in patients with diabetic 
ulcers, venous ulcers, and pressure ulcers (bed sores) [181].  
 
For P. aeruginosa infections, aminoglycosides, such as tobramycin, have 
been successfully used as therapy [103]. In CF patients, inhaled tobramycin is 
successfully used to eradicate P. aeruginosa infections [86]. However, 
maintaining clinical benefits often requires long-term therapy [182], which is often 
associated with toxic side effects [183]. Ototoxic side effects include dizziness, 
tinnitus, and leading to irreversible hearing loss. Damage inflicted on the kidneys 
(nephrotoxicity), though reversible, could lead to renal insufficiency, and is 
exacerbated with prolonged duration of therapy [183].  
 
Alkaline pH has been shown to enhance the efficacy of aminoglycosides 
[156, 157]. Our previous work has demonstrated that native alkaline by-products 
of bacterial metabolism enhance the susceptibility of antibiotic-resistant mutants 
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of P. aeruginosa in the presence of tobramycin [102]. This effect was mediated 
by ammonia and or small amines, by-products of amino acid breakdown [102]. 
Further, we also demonstrated that exogenous alkaline compounds such as 
ammonium hydroxide, sodium hydroxide, and sodium bicarbonate could 
recapitulate this phenomenon. This indicates that the effect is likely mediated by 
the pH change produced by these agents in their region of deposition.  
 
Bicarbonate has an important place in the pathology of Cystic Fibrosis 
(CF). In CF patients, a genetic defect in the Cystic Fibrosis Transmembrane 
Conductance Regulator (CFTR) is known to impair the regulation of chloride ion 
transport [184]. However, in addition to this role, CFTR is also shown to transport 
bicarbonate [185]. In CF patients, the absence of bicarbonate secretion is central 
to certain disease manifestations [186]. In a newborn CF pig model, defective 
bicarbonate secretion leads to acidified airway surface liquid (ASL) [76]. Reduced 
ASL pH inhibits the activity of innate antimicrobial factors, leading to reduced 
ability to eradicate S. aureus [76]. Further, aerosolizing bicarbonate into the CF 
lung increased in vivo bacterial killing. This indicates that increasing ASL pH 
might prevent initial infections in CF patients.  
 
Another important feature in CF patients is impaired mucociliary transport 
and the presence of thick, sticky mucous, which promotes the growth of bacterial 
infections. It was recently proposed that bicarbonate plays a role in maintaining 
normal mucin unfolding and function [77]. Highly compacted mucins in 
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intracellular granules are held together by Ca2+ and H+ cations. Removal of these 
cations by bicarbonate is critical for mucin unfolding and expansion. A 
bicarbonate transport defect would result in defective bicarbonate secretion into 
the extracellular milieu, inability to remove the cations, and compacted, poorly 
soluble and transportable mucins.  
 
As a consequence, inhaled bicarbonate therapy is being evaluated as a 
therapeutic approach in CF patients [77]. Given this and based on our previous 
work, we evaluate the potential of bicarbonate as an adjunctive therapy to 
enhance the efficacy of the aminoglycoside antibiotic, tobramycin, against P. 
aeruginosa. We find that the combination of bicarbonate and tobramycin shows a 
strong synergistic effect against planktonic P. aeruginosa cells. We observe this 
effect for a range of P. aeruginosa strains, including laboratory strains, 
spontaneously-generated antibiotic-resistant mutants, and clinical strains from 
patients with CF. For planktonic cells, this effect not only reduces the 
concentration of tobramycin required to kill P. aeruginosa cells but, for certain 
strains also enhances the rate of killing. However, this synergistic effect is not 
observed with biofilm cells of P. aeruginosa, rather the combination appears to 
have an antagonistic effect.  
 
We present a method of analysis of drug interactions using 
analytical dose-response surfaces, which examines drug combinations in greater 
detail than traditional methods [187]. Of its many advantages, this dose-response 
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surface analysis allows us to more accurately estimate synergy regimes and 
make testable predictions of synergy combinations. Further, using predictions 
from Loewe additivity [188], we analyze the difference of the response surfaces 
from those predicted by additivity, resulting in a net outcome of the combination. 
  
Our results indicate that the combination of tobramycin and bicarbonate 
has potential against planktonic infections with P. aeruginosa. This approach 
could enhance the efficacy of tobramycin, reduce the duration of therapy, and 
mitigate dosage-related toxicity and adverse effects. Further studies evaluating 














3.2 MATERIALS AND METHODS  
 
3.2.1 Bacterial strains and growth conditions 
 
 
Bacterial strains used include P. aeruginosa wild-type (WT) laboratory 
strains PA14 and PAO1 and clinical Pseudomonas isolates from patients with 
Cystic Fibrosis (gift from Marvin Whiteley, UT Austin). To generate spontaneous 
antibiotic-resistant mutants, WT overnight cultures, were grown in antibiotic-free 
media, and plated on tobramycin 8 µg/mL agar. Antibiotic-resistant mutants grew 
colonies and were archived in 20-30% glycerol at -80°C. Of the four independent 
antibiotic-resistant mutants (strain #1-4) used in this study, strain 1 was used for 
all experiments in Chapter 2 [102], except when stated otherwise. 
 
All bacterial strains were grown in Luria-Bertani broth or on LB agar [91] 
except where otherwise indicated. Overnight cultures were shaken at 180 rpm for 




Tobramycin (Indofine Chemical Company, NJ) and sodium bicarbonate 
(Fisher Scientific, NJ) were obtained as standard powders. A stock solution of 50 
mg/mL tobramycin was stored at 4°C prior to use. The desired concentration of 
sodium bicarbonate solution was freshly prepared prior to use for each 
experiment. 
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3.2.3 Minimum Inhibitory Concentration determination for planktonic cells 
 
MICs to tobramycin and bicarbonate were measured using broth 
microdilution methods as recommended by CLSI [109]. MICs were determined 
observing visual turbidity and measuring optical density (OD) at 600 nm. The 
lowest concentration that inhibited visual growth, which corresponded to ~90% 
inhibition of bacterial growth (MIC90), was used for further analysis.  
3.2.4 Checkerboard assay for synergy against planktonic cells  
 
 
Standard checkerboard microdilution assays were used to test the 
combined antimicrobial activity of tobramycin and bicarbonate [189] against 
different P. aeruginosa strains. Briefly, an 8 X 8 array of serial two-fold dilutions 
of the two agents were mixed together in a flat-bottom, 96-well microtiter plate 
(polystyrene) such that each row (or column) contained a fixed amount of one 
agent and increasing amounts of the second agent. This resulted in a total of 64 
different combinations. For each assay, the serial dilutions of each individual 
agent were also tested, and control wells containing untreated cells were also 
grown. Bacteria (~105 cells) were added to each well. Each strain was tested in 
duplicate. Plates were sealed with parafilm and incubated at 37°C under static 
conditions. After overnight incubation (16–18 hours), optical density was 
measured at 600 nm (OD600). The fractional inhibitory concentration (FIC) was 
calculated for each well along the growth - no growth interface (corresponding to 
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~90% inhibition in the presence of the combination, with each agent below its 
own MIC). For agents A and B, the FIC of the combination is calculated as [190] 
!!!"#!!! ! !"#! ! !"#!! 
 




An FIC index lower or higher than 1 indicates synergy and antagonism 
respectively. However, because of the two-fold drug dilution scheme and 1-
dilution error of testing methods, we considered an (FIC value of ) 0.5 to 
indicate synergistic interactions; 0.5-1 to indicate an additive effect; > 1 to 
indicate antagonism [190].  
 
The results of the checkerboard assays were represented graphically 
using isobolograms. The no-growth wells correspond to a ~90% inhibition. 
Combinations that fall along the line connecting the MIC values of the two agents 
(line of additivity) are additive interactions. If the combination is synergistic, the 
isobol will be overall concave-up. For combinations that are antagonistic, the 
isobol will be overall concave-down. Further, the magnitude of the overall 
average curvature indicates the degree of synergy or antagonism respectively.  
 
3.2.5 Testing for synergy using LB media supplemented with serum 
To simulate in vivo conditions, checkerboard assays were performed to 
test the combined effect of tobramycin and bicarbonate in LB media containing 
25% bovine serum (Sigma).  
 156 
3.2.6 Time-kill assays 
 
 
To examine the rate of killing of the synergistic combination, time-kill 
assays were performed. Briefly, 96-well microtiter plates were set up using 
synergistic combinations (from the checkerboard assays), and concentrations of 
the individual agents alone. Bacteria (~105 cells) were added to each well. Plates 
were incubated at 37°C for 24 hours under static conditions. Colony-forming units 
per mL (CFU/mL) were enumerated at 0, 2, 4, 6, 8, and 24 hours. To count the 
number of colonies, serial dilutions of the bacterial suspension were plated on LB 
agar. Plates were incubated at 37°C overnight (16-18 hours) and CFUs were 
counted. Each combination or concentration at a given time-point was tested in 
triplicate.  
3.2.7 Planktonic in vitro wound bed model 
 
 
To examine the effects of the synergy on planktonic cells under more in 
vivo like conditions, we developed an in vitro planktonic infection wound model. 
For this model, two-layered LB agar plates were made by overlaying soft (0.6%) 
agar on standard LB agar (1.2%) plates. This resulted in a two-layered agar plate 
with soft agar lying on a base of standard LB agar. Using a sterile metal punch, 
1-cm diameter cavities (“wound bed”) were created in the top (soft) agar layer. In 
a separate plate, soft LB agar (83%), sheep blood (5%), bovine serum (10%) 
was mixed together and bacteria (~107 cells, 2%) were added to the mixture. The 
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mixture was poured and allowed to solidify. A metal punch was used to cut out 1-
cm “wounds” from this layer. These “wounds” were then placed in the “wound 
bed” using a sterile metal forceps. Sterile filter paper pieces (2 X 2 cms) were 
soaked in test solutions (tobramycin, bicarbonate, combination, and sterile 
media) and placed on the “wounds”. Plates were incubated at 37°C for 24 hours. 
After treatment, to enumerate CFUs, the wounds were homogenized in 10 mL 
sterile LB media, serially diluted, and plated on LB agar. Plates were incubated at 
37°C for 24 hours after which CFUs were enumerated.  
3.2.8 Measurement of pH 
 
To examine the pH effect, different concentrations of bicarbonate were 
added to sterile media (LB or LB with 5, 10, 25% serum), and the pH was 
measured using a pH meter (Thermo Scientific). Instrument was calibrated using 
standard solutions of pH 4,7, and 10. 
3.2.9 Testing the effect of the combination against pre-formed biofilms 
 
 
Biofilms were grown in round-bottom, untreated, 96-well microtiter plates. 
Briefly, bacterial (~105 cells) were added to well of the microtiter plate in an 8 X 8 
array to test different combinations of tobramycin and bicarbonate. In addition, 
wells to test serial dilutions of each agent, and control wells to grow untreated 
cells were also set up. Each strain was tested in duplicate. Plates were sealed 
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with parafilm and incubated at 37°C under static conditions for 18-24 hours 
(pvernight). The next day, wells were washed twice with sterile LB medium. 
Different combinations of tobramycin and bicarbonate (dissolved in LB medium) 
were added to the 8 X 8 array, such that each row (or column) contained a fixed 
amount of one agent and increasing amounts of the second agent. To obtain the 
Minimum Biofilm Inhibitory Concentration (MBIC), serial dilutions of each agent 
were also tested alone. The control wells were replaced with sterile LB medium 
without any antimicrobial agent. The plates were sealed with parafilm and 
incubated at 37°C static overnight (18-24 hours). The next day, the wells were 
washed with sterile LB medium twice and effect of the treatment on biofilm cells 
was assessed with the XTT assay and crystal violet staining [191, 192]. 
3.2.10 Crystal violet assay for biofilm mass 
 
 
The crystal violet assay was performed as previously described [192]. 
Briefly, pre-formed biofilms (either treated or untreated) were washed twice with 
sterile LB medium. Cells were fixed at the bottom and sides of the wells by 
treating them with 100% methanol for 15 minutes. Following removal of 
methanol, 0.1% filter-sterilized crystal violet solution (Sigma) was added to the 
well and allowed to stain the biofilm for 30 minutes. Wells were washed in water 
and dye was solubilized using 100% ethanol. 200 µL of well contents were 
transferred to a new, clear, flat-bottom, 96 well plate and absorbance was read at 
600 nm.  
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3.2.11 XTT assay for metabolic activity in biofilms 
 
The XTT assay was performed as previously described [191]. Briefly, pre-
formed biofilms (either treated or untreated) were washed twice with sterile LB 
medium. A solution of LB: XTT: Menadione (79:20:1) was prepared. XTT was 
dissolved to make a stock solution of 1 mg/mL. For Menadione, a 7 mg/mL stock 
solution was prepared in acetone, diluted 1:100 and then used. The solution of 
LB: XTT: Menadione was added to each well, and the plates were incubated at 
37°C in the dark (sealed with aluminum foil) for 4 hours. 200 µL of well contents 
were transferred to a new, clear, flat-bottom, 96 well plate and absorbance was 
read at 492 nm.  
3.2.12 Testing biofilm cells in the in vitro chronic wound infection model 
 
 
Biofilms were grown in an in vitro model resembling the constituents of a 
chronic wound, with certain modifications [193]. Our collaborator Prof. Kendra 
Rumbaugh (Texas Tech University Health Sciences Center, Lubbock, Texas) 
developed this model and recently used it to study synergistic interactions 
between P. aeruginosa and S. aureus (well-known co-pathogens in chronic 
wounds). Known as the Lubbock Chronic Wound Infection model (LCWM), the 
constituents of this media include Bolton broth (45%), laked horse blood (5%), 
bovine plasma (49%), to which bacterial cells (2%) are added. Grown biofilms 
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were treated with combination of tobramycin and bicarbonate and assayed for 
XTT activity as previously described. 
3.2.13 Ex-vivo chronic wound infection murine model 
 
 
To test the effect of combined therapy with tobramycin and bicarbonate in 
vivo, we used a chronic wound infection mouse model [72]. Briefly, wounds on 
the backs of adult Swiss Webster mice were created, infected with P. aeruginosa 
PAO1, and allowed to become chronic. Three-day old infected wounds were 
harvested and cut into four parts. Each part was treated with tobramycin, 
bicarbonate, combination, or sterile medium for 4-6 hours. After ex-vivo 
treatment, the wound parts were homogenized, serially diluted, and plated on 
Pseudomonas Isolation agar (PIA). Plates were incubated at 37°C overnight (18-
24 hours) and CFU/gram were enumerated.  
3.2.14 Response-surface analysis  
 
 
To examine these drug combinations in greater detail than traditional 
methods, we developed a method of response-surface analysis. Using second-
order polynomial interpolation [194] of the checkerboard assays, we 
constructed analytical dose-response surfaces using Mathematica version 9.0. 
When rendered against appropriate MIC threshold planes, the resulting surface 
approximates the continuous set of drug combinations. While traditional 
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isobolograms are often useful to gain some insight into this regime, our 
calculated surface approximates the complex nature of nonlinear drug 
interactions with far greater resolution than allowed by the extant methods. 
Furthermore, we used the empirically observed MICs for both tobramycin and 
bicarbonate to calculate Loewe additivity. These predictions will be tested against 
further checkerboard assays in order determine validity of the fit, and whether the 
model can estimate where strong synergistic combinations may have been 
overlooked by logarithmic sampling. In addition to the clinical focus of MIC-based 
synergy surveys, we also developed a method of finding synergy for any 
combination of drug concentrations by studying the differences between the 
theoretical "Loewe Additivity response surface", and our empirical dose-response 
surfaces. 
3.3 RESULTS AND DISCUSSION 
 
3.3.1 Combination of tobramycin and bicarbonate produces synergy 
against planktonic cells of P. aeruginosa  
 
 
Using checkerboard assays, combinations of bicarbonate and tobramycin 
were tested against planktonic cells of a wide-range of P. aeruginosa strains. 
These included laboratory strains PAO1 and PA14, four spontaneously-
generated antibiotic-resistant mutants, and clinical strains from CF patients. 
Points along the growth-no growth interface were plotted using isobolograms. In 
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addition, the (FIC index for each well along the interface was determined. 
Addition of bicarbonate to tobramycin produces a strong synergistic effect for the 
strains tested (Figures 3.1-3.6). We observe a synergistic to additive effect for all 
strains tested. However, strain-to-strain variation is noted. Summary of the 
results for all strains tested is provided in Table 3.1. Further, in Figures 3.7 and 
3.8, we show this synergistic effect for four select strains with addition of a fixed 
concentration of bicarbonate. As observed, addition of bicarbonate reduces the 





















































Figure 3.1 Isobologram analysis for planktonic cells of P. aeruginosa PAO1. 
 
A strong synergistic-additive effect is observed for the combination of tobramycin 
and bicarbonate against PAO1 cells. Points along the isobologram represent the 
growth-no growth interface. The orange shaded area represents the additive 























































Figure 3.2 Isobologram analysis for planktonic cells of P. aeruginosa antibiotic-
resistant mutant #1. 
 
A strong synergistic-additive effect is observed for the combination of tobramycin 
and bicarbonate against the antibiotic-resistant mutant. Points along the 
isobologram represent the growth-no growth interface. The orange shaded area 

















































Figure 3.3 Isobologram analysis for planktonic cells of P. aeruginosa antibiotic-
resistant mutant #2. 
 
A strong synergistic-additive effect is observed for the combination of tobramycin 
and bicarbonate against the antibiotic-resistant mutant. Points along the 
isobologram represent the growth-no growth interface. The orange shaded area 



























































Figure 3.4 Isobologram analysis for planktonic cells of clinical P. aeruginosa 
strain 5914M. 
 
A strong synergistic-additive effect is observed for the combination of tobramycin 
and bicarbonate against 5914M. Points along the isobologram represent the 
growth-no growth interface.The orange shaded area represents the additive 



















































Figure 3.5 Isobologram analysis for planktonic cells of the clinical P. aeruginosa 
strain 3488D. 
 
A strong synergistic-additive effect is observed for the combination of tobramycin 
and bicarbonate against 3488D. Points along the isobologram represent the 
growth-no growth interface. The orange shaded area represents the additive 



























































Figure 3.6 Isobologram analysis for planktonic cells of the clinical P. aeruginosa 
strain 3470C. 
 
A strong synergistic-additive effect is observed for the combination of tobramycin 
and bicarbonate against 3470C. Points along the isobologram represent the 
growth-no growth interface. The orange shaded area represents the additive 



















































Figure 3.7 Synergy between bicarbonate and tobramycin in killing P. aeruginosa 
antibiotic-resistant mutant strain #1 and the clinical strain 5914M. Error bars 
represent SEM; N = 3. The concentrations here represent the lowest FIC in the 
checkerboard assay. 
 
The combination of tobramycin and bicarbonate displays a strong synergy 
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Figure 3.8 Synergy between bicarbonate and tobramycin in killing P. aeruginosa 
clinical strains 3488D and 3470C. Error bars represent SEM; N = 3. The 
concentrations here represent the lowest FIC in the checkerboard assay. 
 
The combination of tobramycin and bicarbonate displays a strong synergy 












































Table 3.1 Summary of the efficacy of the Tobramycin-Bicarbonate combination against planktonic cells of 
P.aeruginosa 
 













PAO1 2 160 0.37 0.25 – 0.75 Synergistic/Additive 
PA14 2 160 0.37 0.25 – 0.75 Synergistic/Additive 
Antibiotic-resistant mutant #1 8 160 0.49 0.27 - 1 Synergistic/Additive 
Antibiotic-resistant mutant #2 8 160 0.35 0.15 – 0.63 Synergistic/Additive 
Antibiotic-resistant mutant #3 8 160 0.45 0.28 – 0.75 Synergistic/Additive 
Antibiotic-resistant mutant #4 8 160 0.45 0.28 – 0.75 Synergistic/Additive 
3639M 1 160 0.48 0.28 – 0.75 Synergistic/Additive 
4278M 1 160 0.48 0.28 – 0.75 Synergistic/Additive 
5623M 8 80 0.52 0.31 – 0.75 Synergistic/Additive 
5914M 8 80 0.28 0.18 – 0.5 Synergistic/Additive 
0476M 1 80 0.48 0.31 – 
0.625 
Synergistic/Additive 
4220M 2 160 0.49 0.28 – 0.75 Synergistic/Additive 
5913C 8 80 0.67 0.3 – 1 Synergistic/Additive 
3470C 1 160 0.45 0.28 – 
0.625 
Synergistic/Additive 
3488D 4 80 0.51 0.31 – 0.75 Synergistic/Additive 
4219D 2 160 0.21 0.04-0.53 Synergistic/Additive 




3.3.2 Time-kill assays 
 
 
To confirm the synergistic effects observed and to examine the rate of 
killing with the synergistic combination, we performed time-kill assays for strains 
PAO1, D1R4, and the clinical strain 5913C. Combination of tobramycin and 
bicarbonate selected for the time-kill assays represented the concentrations that 
showed the maximum synergy (or lowest !FIC index) along the growth-no 
growth interface, where no growth is defined as MIC90. 
 
For PAO1, treatment with a combination of 0.25 µg/mL tobramycin and 5 
mM bicarbonate eradicated the population by 4 hours; in contrast, each agent 
alone failed to kill the population (Figure 3.9 and 3.12). This confirmed the 
synergistic effect we observed for this combination against PAO1. Notably, this 
effect of the combination was comparable to that observed with 2 µg/mL 
tobramycin, the MIC90 for this strain. This indicates that the combination reduces 
the concentration of tobramycin needed to eradicate the population.  
 
For the antibiotic-resistant strain #1, treatment with a combination of 1 
µg/mL tobramycin and 5 mM bicarbonate killed the population by 6 hours, while 
each agent alone failed to kill the population (Figure 3.10 and 3.13). For this 
strain, treatment with the combination produced a faster rate of killing than that 
observed with 8 µg/mL tobramycin, the MIC90 for this strain. This is an additional 
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benefit to the reduction in the concentration of tobramycin needed to produce the 
effect.  
 
For the clinical strain 5913C, killing with the synergistic combination of 1 
µg/mL tobramycin and 5 mM bicarbonate expectedly produced killing. However, 
the combination showed effect only after 6 hours of treatment and complete 
killing was observed between 12-24 hours. At 8 hours, the killing curve for the 
combination lags behind that of 8 µg/mL tobramycin, the MIC90 for this strain 
(Figure 3.11 and 3.14). However, both treatments eradicate the population at the 
end of 24 hours, with the combination treatment affording a decrease in the 
concentration of tobramycin. These results reiterate that the effect of the 















Figure 3.9 Time-kill assays demonstrating the synergy between bicarbonate and 
tobramycin against P. aeruginosa strain PAO1. 
 
The combination of 0.25 µg/mL tobramycin and 5 mM bicarbonate displays a 
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Bicarbonate 160 mM 
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Figure 3.10 Time-kill assays demonstrating the synergy between bicarbonate 
and tobramycin against P. aeruginosa antibiotic-resistant mutant strain #1. 
 
The combination of 1 µg/mL tobramycin and 5 mM bicarbonate displays a strong 
synergy against antibiotic-resistant mutant strain #1. Error bars represent SEM. 
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Figure 3.11 Time-kill assays demonstrating the synergy between bicarbonate 
and tobramycin against P. aeruginosa clinical strain 5913C. 
 
The combination of 1 µg/mL tobramycin and 5 mM bicarbonate displays a strong 
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Figure 3.12 Time-kill assays demonstrating the comparison between the 
synergistic combination of bicarbonate and tobramycin and the MIC90 of 8 µg/mL 
against P. aeruginosa strain PAO1. 
 
The combination of 0.25 µg/mL tobramycin and 5 mM bicarbonate displays a 
strong synergy against PAO1. Killing is achieved as early as 4 hours, which is 
comparable to that with observed with the MIC90 of 1 µg/mL. Error bars represent 



















Tob 0.25 ug/mL Bicarbonate 5 mM 
Tob 0.25 ug/mL + Bicarbonate 5 mM No treatment  





Figure 3.13 Time-kill assays demonstrating the comparison between the 
synergistic combination of bicarbonate and tobramycin and the MIC90 of 8 µg/mL 
against P. aeruginosa antibiotic-resistant mutant strain #1. 
 
The combination of 1 µg/mL tobramycin and 5 mM bicarbonate displays a strong 
synergy against antibiotic-resistant mutant strain #1. As observed the synergistic 
combination not only reduces the concentration of tobramycin required to 
produce a killing effect, but also enhances the rate of killing in comparison to the 




















Tob 1 ug/mL Tob 8 ug/mL 
Bicarbonate 5 mM Bicarbonate 160 mM 
Tob 1 ug/mL + Bicarbonate 5 mM No treatment 








Figure 3.14 Time-kill assays demonstrating the comparison between the 
synergistic combination of bicarbonate and tobramycin and the MIC90 of 8 µg/mL 
against clinical P. aeruginosa strain 5913C. 
 
The combination of 0.25 µg/mL tobramycin and 5 mM bicarbonate displays a 
strong synergy against 5913C. While the combination appears to exert its killing 
effect later than the MIC90, it reduces the concentration the tobramycin, and both 



















Tobramycin 1 ug/mL Bicarbonate 5 mM 
Tob 1 ug/mL + Bicarb 5 mM No treatment  
Tobramycin 8 ug/mL Bicarbonate 80 mM 
5913C 
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3.3.3 Screen for biofilm formation by P. aeruginosa strains  
 
 
The laboratory strain PAO1 and 17 clinical CF isolates (mucoid, dwarf, 
and classic phenotype) [105], were screened for biofilm formation using the 
microtiter dish biofilm assay and quantified using the crystal violet and XTT 
methods. Using the crystal violet assay, clinical strains 3639M, 4278M, 3470C, 
1913C, 0476M, 4220M, 4219D, and laboratory strain PAO1 show robust biofilm 
formation (Figure 3.15A). Crystal violet is a basic dye that binds to negatively 
charged surface molecules. It thus stains the extracellular matrix, live and dead 
cells of the biofilm. To confirm the presence of metabolic activity (live cells), 
biofilm growth for different strains was quantified using the XTT assay. In live 
cells, XTT is reduced to a water-soluble formazan derivative that can be 
quantified colorimetrically [191]. Strains 3639M, 4278M, 3470C, 1913C, 0476M, 
4220M, 4219D, and PAO1 which showed robust biofilm formation also 
demonstrated the presence of live, metabolically active cells (Figure 3.15B). 
Based on the results of this screen, three strains, PAO1, 4219D, and 3470C, 





Figure 3.15 Screen for biofilm formation and metabolic activity of biofilm cells for 
different P. aeruginosa strains. 
 
(A) Screen for biofilm formation by staining biomass with crystal violet assay and 
(B) XTT assay for metabolic activity in biofilm cells for different strains of P. 
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3.3.4 Combination of tobramycin and bicarbonate fails to produce synergy 
in biofilm cells of P. aeruginosa  
 
The effect of the tobramycin-bicarbonate combination was tested on 
biofilm cells of P. aeruginosa strains PAO1, 4219D, and 3470C. Biofilms were 
grown in microtiter dish wells, treated with each agent alone and in different 
combinations, and the effects were quantified using the XTT assay. For each 
agent alone, the Minimum Biofilm Inhibitory Concentration (MBIC) was 
determined. These results are summarized in Table 3.2. Based on our results, for 
the laboratory strain PAO1, and clinical strains 3470C and 4219D, the 
combination of tobramycin and bicarbonate produces an additive-antagonistic 
effect (Figures 3.16, 3.17 and 3.18). We thus observe that while bicarbonate 
enhances the effect of tobramycin against planktonic cells, this synergistic effect 
is reduced to an additive-antagonistic effect (for 3470C and 4219D). These 
results are summarized in Table 3.3. While we have not yet probed the cause for 
this loss of synergistic effect in biofilm cells, possible explanations include 
acidification of the biofilm environment [16] or limited diffusion into the interior of 
the biofilm [79]. We plan to do a preliminary test for the former by measuring the 


































Figure 3.16 Isobologram analysis for biofilm cells of P. aeruginosa PAO1. 
 
An additive-antagonistic effect is observed for the combination of tobramycin and 
bicarbonate against PAO1 cells, in contrast to the strong synergistic effect 
observed in Figure 3.1. Points along the isobologram represent the growth-no 
growth surface. The orange shaded area represents the additive region and the 





















FIC range =  















FIC range =  





































Figure 3.17 Isobologram analysis for biofilm cells of P. aeruginosa 3470C. 
 
An additive-antagonistic effect is observed for tobramycin and bicarbonate 
against 3470C cells, in contrast to the strong synergistic effect observed in 
Figure 3.6. Points along the isobologram represent the growth-no growth surface. 
The orange shaded area represents the additive region, the green shaded area 






































Figure 3.18 Isobologram analysis for biofilm cells of P. aeruginosa 4219D. 
 
An additive-antagonistic effect is observed for the combination of tobramycin and 
bicarbonate against 4219D. The orange shaded area represents the additive 
region, the green shaded area represents the synergistic region, and the red 
area is the antagonistic
 186 
Table 3.2 Efficacy of the Tobramycin-Bicarbonate combination against biofilm 


















PAO1 2 320 0.65 0.63 – 2.25 Additive 
Antagonistic 
3470C 2 320 1.2 1 – 1.5 Additive 
Antagonistic 
4219D 4 640 1.1 1 – 1.5 Additive 
Antagonistic 
MIBC = Minimum Biofilm Inhibitory Concentration 
* For strains PAO1 and 3470, a maximum of 80-fold reduction, and for strain 4219D, a maximum of 55-fold 
reduction was achievable at this concentration.  
# For strains PAO1 and 3470, a maximum of 80-fold reduction, and for strain 4219D, a maximum of 60-fold 
reduction was achievable at this concentration.  
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3.3.5 Response-surface analysis  
 
Isobolograms are a standard and widely used approach to examine drug 
interactions [187]. While they offer valuable insights, they do have limitations. 
Firstly, using traditional isobolograms we can only obtain estimates of synergy at 
points that have been biologically tested. Given that testing drug combinations is 
both labor-intensive and time-consuming, this imposes inherent limitations to the 
array of synergistic combinations we can estimate.  
 
While testing drug combinations using serial dilutions the minimum 
inhibitory concentration (MIC) of each agent is determined as the lowest 
concentration that produces no growth, however the MIC value may lie anywhere 
between this no-growth concentration and last growth concentration. As 
expected, this results in a tendency to underestimate synergy, since all 
combinations in the intervening points will be considered additive.  
 
Plotting isobolograms from the growth-no growth interface provides no 
information or context about the effect of other combinations over the rest of the 
dose-response surface.  
 
Finally, traditional isolobologram analysis has limited predictive power to 
find untested synergistic combinations, and expanding the array of combinations 
would require additional biological testing.   
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To examine these drug combinations in greater detail than traditional 
methods, we developed a method of response-surface analysis. With data from 
the checkerboard assays, we constructed analytical dose-response surfaces 
using a second-order polynomial fit, given by 
 
where  is the concentration of tobramycin or bicarbonate, , and  are 
undetermined coefficients used to fit parabolas between consecutive points, and 
 is the % change in inhibition. This dose-response surface interpolation 
provides additional insights into the effects of the combination of tobramycin and 
bicarbonate, as compared to standard isobolograms (Figures 3.19, 3.20 and 3.21 
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Figure 3.19 Dose-response surface for planktonic P. aeruginosa strain PAO1. 
 
The dose-response surface (orange) shows the concentrations of tobramycin 
and bicarbonate along the X- and Y- axes, with the percent change in inhibition 
along the Z-axis. The MIC90 of tobramycin for planktonic cells of PAO1 Is circled 
in red. The response-surface interpolation shows a strong synergistic effect at 
sub-MIC concentrations for the combination of tobramycin and bicarbonate. 










Figure 3.20 Dose-response surface for planktonic P. aeruginosa strain PAO1 
showing an intersection at 90% reduction (MIC90 of the combination). 
 
The dose-response surface (orange) shows the concentrations of tobramycin 
and bicarbonate along the X- and Y- axes, with the percent change in inhibition 
along the Z-axis. The grey plane intersecting the dose-response surface shows 
the 90% reduction. At the edge of the intersection is where the synergy achieves 
a 90% reduction (MIC90). Other intersections along the response surface would 






Figure 3.21 Response surface contour plots for planktonic P. aeruginosa strain 
PAO1.  
 
The red line shows the upper bound for synergy for planktonic PAO1 as 
determined by the checkerboard assays. The MIC90 for tobramycin and 
bicarbonate is 2 µg/mL and 160 mM respectively from the checkerboard assays. 
As shown, the contour plot can accurately determine the MIC90 of tobramycin as 
~2.1 µg/mL. The same would apply for bicarbonate (MIC90 not shown here). This 
allows all combinations under these values to be considered synergistic, 






Figure 3.22 Dose-response surface and intersection plane at 90% reduction for 
biofilm cells of P. aeruginosa strain PAO1. 
 
The dose-response surface (orange) shows the concentrations of tobramycin 
and bicarbonate along the X- and Y- axes, with the percent change in inhibition 
along the Z-axis. The grey plane intersecting the dose-response surface shows 
the 90% reduction. The MIC90 of tobramycin for biofilm cells of PAO1 is circled in 
red. The response-surface interpolation shows an antagonistic effect for the 





Figure 3.23 Response surface contour plots for biofilm cells of P. aeruginosa 
strain PAO1.  
 
The red line shows the upper bound for synergy for planktonic PAO1 as 
determined by the checkerboard assays. The MIC90 for tobramycin and 
bicarbonate is 2 µg/mL and 320 mM respectively from the checkerboard assays. 
The contour plot determines the MIC90 for tobramycin as ~1.3 µg/mL. An 
antagonistic effect is observed with the combination of tobramycin and 




3.3.6 Loewe additivity predicted surface analysis  
 
Minimum inhibitory concentration values for tobramycin and bicarbonate 
were used to calculate the lines of Loewe additivity [188] and synergy for 
planktonic and biofilm cells of P. aeruginosa PAO1. Loewe additivity is a 
common reference model to define drug interactions [188]. According to this 
model, the combined effect of two drugs is predicted from the sum of the effects 
of the individual components. 
This is done with the equation, 
 
where  represents the calculated value (% change) for any point on the 
surface as predicted by additivity,  is the maximum effect attainable,  is 
zero effectiveness, is the concentration of tobramycin or bicarbonate,  is 
the MIC50 for tobramycin or bicarbonate, and is the slope of the linear regime 
of the sigmoidal curve. 
 
Further, we plot the difference surface response between the additivity 
predicted surface and observed surface (from the checkerboard assays) to 




E = (Emax ! B)*
(U /U50 )
m



































Figure 3.24 Loewe additivity predicted response surface for planktonic cells of P. 













Figure 3.25 Loewe additivity predicted response surface (colored) and the 
observed surface (orange) based on checkerboard assay results for planktonic 











Figure 3.26 Total difference surface analysis (from the additivity predicted 
response surface and the observed surface) showing a strong synergistic effect 
















Figure 3.27 Loewe additivity predicted response surface for biofilm cells of P. 















Figure 3.28 Loewe additivity predicted response surface (colored) and the 
observed surface (orange) based on checkerboard assay results for biofilm cells 



































Figure 3.29 Total difference surface (from the additivity predicted response 
surface and the observed surface) showing a strong antagonistic effect for biofilm 





3.3.7 Additional data demonstrating the synergistic effect of tobramycin 
and bicarbonate against planktonic P. aeruginosa cells 
 
In addition to the strains demonstrated in Figures 3.1-3.6, we tested 
combinations of tobramycin and bicarbonate for synergy against several other P. 
aeruginosa strains. Isobolograms and FIC values for the different strains are 




















Figure 3.30 Isobologram analysis for planktonic cells of clinical P. aeruginosa 
strains 5913C, 1913C, and 4219D. 
 
A synergistic-additive effect is observed for the combination of tobramycin and 
bicarbonate. Points along the isobologram represent the growth-no growth 
interface. The orange shaded area represents the additive region and the green 




Figure 3.31 Isobologram analysis (based on MICs) for planktonic cells of clinical 
P. aeruginosa strains 3639M, 5623M, 0476M. 
 
A synergistic-additive effect is observed for the combination of tobramycin and 








Figure 3.32 Isobologram analysis (based on FICs) for planktonic cells of clinical 
P. aeruginosa strains 3639M, 5623M, 0476M. 
 
A synergistic-additive effect is observed for the combination of tobramycin and 
bicarbonate. Points along the isobologram represent the growth-no growth 
interface. The orange shaded area represents the additive region and the green 
shade area represents the synergistic region 
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3.3.8 The presence of serum reduces the synergistic effect for planktonic 
PAO1 cells  
 
To examine the effect of serum on the synergistic effect observed with 
planktonic cells, PAO1 was tested in the presence of 25% serum (added to LB 
medium). As shown in Figure 3.33, the presence of serum reduced the 
synergistic effect, observed against PAO1 in LB medium alone (Figure 3.1), to an 
additive effect. The reduced effect in serum as compared to LB media could be 
due to the difference in the buffering capabilities of the two conditions, and we 
further examined this with pH measurements for different bicarbonate 
concentrations (Table 3.3). It is important to note that in the presence of 25% 
serum, bacterial growth was notably reduced in the untreated (control) cells, as 
compared to that seen with LB medium alone. This could possible be due to 
innate bactericidal factors present in the serum [195]. It is thus also possible that 
this lack of synergistic effect is due to some other effect of the serum. In the 
future, we plan to distinguish the buffering effect of the serum from some other 
possible effect by doing these assays in serum + bicarbonate, with the same pH 
























Figure 3.33 Isobologram analysis for planktonic cells of P. aeruginosa PAO1 in 
the presence of serum (25%). 
 
 
An additive effect is observed for the combination of tobramycin and bicarbonate 
against PAO1, in the presence of serum. Points along the isobologram represent 
the growth-no growth surface. The orange shaded area represents the additive 







































































Table 3.3 Corresponding pH values for different concentrations of bicarbonate 
added to LB media and LB media containing serum (5, 10, and 25%). 
 
 






medium with  
5% serum 
Luria-Bertani 





640 8.32 ± 0.02 7.83± 0.02 7.72 ± 0.03 7.66± 0.04 
320 8.14 ± 0.01 7.77± 0.01 7.79 ± 0.01 7.72± 0.02 
160 8.06 ± 0.02 7.68± 0.03 7.69 ± 0.02 7.64± 0.01 
80 7.97 ± 0.03 7.55± 0.03 7.58 ± 0.03 7.65± 0.01 
40 7.69 ± 0.01 7.43± 0.02 7.49 ± 0.01 7.51± 0.03 
20 7.51 ± 0.01 7.26± 0.04 7.37 ± 0.02 7.38± 0.03 
10 7.35 ± 0.02 7.18± 0.01 7.27 ± 0.03 7.32± 0.02 
5 7.12 ± 0.07 7.15± 0.04 7.21 ± 0.01 7.25± 0.01 
2.5 7.03 ± 0.03 Not tested Not tested Not tested 
1.25 6.97 ± 0.03 Not tested Not tested Not tested 
0.625 6.94 ± 0.03  Not tested Not tested Not tested 











3.3.9 Combined treatment with tobramycin and bicarbonate demonstrates 
enhanced efficacy in an in vitro acute (planktonic) wound model  
 
 
Using the in vitro wound model described above, “wounds” containing 
planktonic P. aeruginosa were treated with a combination of tobramycin and 
bicarbonate and each agent (tobramycin or bicarbonate) alone. In addition, an 
untreated wound (control) was also set up. Compared to the untreated control, 
the wound treated with the combination of tobramycin and bicarbonate showed a 
2.5-fold decrease in colony counts. In comparison to the effects of tobramycin 
and bicarbonate alone, the combination treatment showed a 2-fold decrease. 
This finding is important as it indicates that the synergistic effect of this 


























Figure 3.34 In vitro wound model demonstrates the efficacy of tobramycin and 
bicarbonate against planktonic P. aeruginosa PAO1 cells. 
 
(A) An in vitro wound model, created with a ‘wound’ containing sheep blood, 
serum (10%), planktonic PAO1 cells, and LB agar, was placed in a ‘bed’ 
consisting of soft agar (0.6%), overlaid on LB agar (1.2%). Filter-paper dressings 
soaked with the treatments were applied to the ‘wound’. (B) Estimation of 
CFU/mL after overnight incubation at 37°C reveals a two-fold decrease in colony 
counts for the combination treatment as compared to treatment with tobramycin 
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3.3.10 Effect of addition of bicarbonate of the pH of media alone and media 
supplemented with serum 
Based on previous work [102, 156, 157], an increase in pH, mediated by 
alkaline compounds, is believed to enhance the efficacy of aminoglycosides.  To 
examine the effects increased pH produced by increasing concentrations of 
bicarbonate, we measured pH of LB media supplemented with the alkaline 
compounds. Further, to understand the additive, as opposed to synergistic effect, 
observed with media supplemented with serum, we measured pH of LB media 
with 10% serum. As expected, addition of bicarbonate increases the pH of LB 
media (Table 3.3). Addition of the same concentrations of bicarbonate increases 
the pH in LB media containing serum, however, the effect is less in comparison 
to LB media only (Table 3.3).  This could explain the additive effect observed with 










3.3.11 Testing the effect of tobramycin and bicarbonate on biofilm cells 
using the Lubbock Chronic Wound Model (LCWM) 
 
P. aeruginosa PAO1 biofilms were grown in an in vitro model resembling 
the constituents of a chronic wound. Known as the Lubbock Chronic Wound 
Infection model (LCWM), the constituents of this media include Bolton broth, 
laked horse blood, bovine plasma, to which bacterial cells are added [193]. 
Grown biofilms were treated with combination of tobramycin and bicarbonate and 
assayed for XTT activity. As seen with biofilm cells in LB media, we found that 
tobramycin and bicarbonate produced an additive effect for biofilm cells (Figure 
3.35) in the LCWM (FIC range=0.5–1). These results reiterate that the strong 
























Figure 3.35 Isobologram analysis for biofilm cells of P. aeruginosa PAO1 in 
media with constituents resembling a chronic wound environment (Lubbock 
Chronic Wound Model). 
 
An additive effect is observed for the combination of tobramycin and bicarbonate 
against PAO1 cells. Points along the isobologram represent the growth-no 
growth surface. The orange shaded area represents the additive region and the 

































3.3.12 Ex-vivo chronic wound (biofilm) mouse model of infection 
 
To test the therapeutic potential of the tobramycin-bicarbonate 
combination, we used an ex-vivo chronic wound biofilm mouse model. This work 
was done in the laboratory of Dr. Kendra Rumbaugh at Texas Tech University 
Health Sciences Center, Lubbock, Texas. Our results (Figure 3.36) show that the 
combination of 2 µg/mL tobramycin and 160 mM bicarbonate fails to produce a 
synergistic effect in a chronic wound biofilm model infected with P. aeruginosa 
PAO1 cells. However, certain considerations relevant to these results need to be 
taken into account. This was the first time we tested this effect in a mouse model. 
Unexpectedly, 2 out of the 3 mice with chronic wounds died on the 2nd day of 
infection. While the exact cause for this is uncertain, this could be due to 
advanced age or physiological variation with a different batch of mice. As a result 
of this, we had only one replicate for the assay. Further, the concentration of 
tobramycin (2 µg/mL) and bicarbonate (160 mM) was based on our in vitro 
synergy assays. It is likely that this concentration needs to be adjusted for the ex-
vivo testing. Finally, given that our in vitro biofilm assays failed to show a 
synergistic effect, it is also possible that this combination does not synergize 







Figure 3.36 In an ex-vivo chronic biofilm wound infection model, the combination 
of tobramycin and bicarbonate fails to show a synergistic effect. 
 
A chronic wound mouse model of biofilm infection was treated ex-vivo with 2 
µg/mL tobramycin and 160 mM bicarbonate. The combination fails to produce a 
synergistic effect. Owing to the unexpected deaths of two mice, the assay was 
completed with only one replicate. The assay needs to be repeated with 

























Our results demonstrate that the combination of tobramycin and 
bicarbonate shows a strong synergistic effect against planktonic P. aeruginosa 
cells. As expected with a synergistic combination, addition of bicarbonate 
reduced the concentration of tobramycin needed to eradicate planktonic cells; it 
also significantly enhanced the rate of killing of cells in comparison to inhibitory 
concentrations of tobramycin alone. The combination of tobramycin and 
bicarbonate was at best additive against biofilm cells of P. aeruginosa, and was 
infact antagonistic in most combinations. Finally, we present an improved method 
for analyzing drug interactions using analytical dose-response surfaces, which 
allows us to more accurately estimate synergy regimes and make testable 
predictions of synergy combinations. This work opens the possibility of an 
additional role for bicarbonate therapy in CF patients, where it could augment the 
activity of tobramycin therapy against planktonic cells and early P. aeruginosa 
infections. This approach could also hold potential in the management of non-CF 
infections such as acute burn and post-surgical wounds, sepsis, urinary tract 
infections, and meningitis. These approaches could also hold promise in the 
management of acute wounds, but it is clear that more work needs to be done to 
fully understand the effects of local pH at wound infection sites [196]. 
__________________________ 
We thank Dr. Hugh Smyth (UT Pharmacy) and Dr. Kendra Rumbaugh (Texas Tech University 
Health Sciences Center, Lubbock, Texas) for their scientific input. 
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Chapter 4:  A low-cost, hands-on module to characterize 





Antibiotic resistance is a major public health problem worldwide [180]. The 
increased resistance to current antibiotics and steady decline in the development 
and approval of newer antibiotics motivate efforts to search for novel 
antimicrobial agents, especially from natural sources [198]. As part of a science 
outreach initiative, we have developed a “hands-on” experimental module to 
study and characterize antimicrobial compounds. This module was first 
implemented at the Hands-On Research in Complex Systems School held at The 
Abdus Salam International Centre for Theoretical Physics (ICTP), Trieste, Italy, 
July 2014 [199]. 
 
The Hands-On Research in Complex Systems School aims to introduce 
young scientists from developing countries to cutting-edge science in physical, 
chemical, and biological systems [199]. These two-week-long schools focus on 
using simple, low-cost, and reliable techniques to perform tabletop research in 
daily, three-hour-long laboratory sessions.  
bThis chapter was adapted from [197]. Kaushik KS, et al (2014). PLoS Biol. 13(1): e1002044. 
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In these sessions, small groups of 4-6 participants work closely with two 
instructors, who conduct the same laboratory session each day with a different 
set of participants.  
 
Typically, participants either have or are pursuing advanced degrees in a 
physical science or engineering field. More than half of the participants are 
theorists or simulators, not experimentalists.  Instructors usually develop a 
hands-on module based on a research project being pursued in their lab and 
tailor it to the requirements of this science outreach initiative. Specifically, the 
module should last three hours, and cost $150 for 60 participants over 10 days. 
 
The aim of the antibiotic resistance module is to introduce basic 
experimental microbiology concepts to an audience unfamiliar with biology, and 
to teach students to integrate physics-based quantitative analysis with biological 
data. Participants test the antimicrobial activity of different compounds to gain 
insights into the diffusive behavior, and thereby the physical size, of the active 
ingredient. The laboratory module is conducted over a three-hour time period, 
consisting of four main sections: overview of the scientific problem, introduction 
to experimental equipment and techniques, “hands-on” experiments, and 





Overview of the interdisciplinary hands-on module  
 
A. Brief overview of the scientific problem  
! The problem of antibiotic resistance 
! Need to search for novel antimicrobial agents 
! Gaining insights into the active ingredient could help develop a 
therapeutic formulation 
B. Introduction to experimental techniques to be used 
! Participants watch short video clips of the experimental techniques  
! The videos, created by us, included preparation of media, experimental 
design (disc diffusion assay), and analysis of results 
C. Performing “hands-on” experiments 
! The assistant instructor demonstrates the experimental steps  
! Following this, each participant performs the experiment individually 
! Results from previous days’ experiments are read 
D. Application of the experimental data to an analytical model 
! An analytical model is used to probe the physical characteristics of the 
active antimicrobial component  
! Participants watch video clips of additional experiments related to the 
analytical model 
! Data from biological experiments is used to determine the diffusion 
coefficient and molecular weight of the active ingredient 
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4.2 OVERVIEW OF THE SCIENTIFIC PROBLEM  
 
Before the sessions, all participants received a handout describing the 
experimental module. In the first section, the instructor provided a brief overview 
of the global problem and challenges of antibiotic resistance and the imperative 
need to discover novel antimicrobial compounds. This opened a brief discussion 
on recent efforts towards exploring natural, biological, and indigenous resources 
as antimicrobial agents [198]. Importantly, this overview emphasized the key 
feature of our laboratory module, whereby an interdisciplinary approach could aid 
the discovery and identification of novel antimicrobial compounds, especially 
those from natural sources. 
4.3 INTRODUCTION TO EXPERIMENTAL EQUIPMENT AND TECHINQUES   
 
In the second section, participants were introduced to the experimental 
equipment and techniques used in the module. We used the disc diffusion assay 
to test the antimicrobial activity of different compounds [113] a technique used in 
clinical and research microbiology laboratories to study the bacterial and fungal 
strains’ susceptibility to antibiotics. In the assay, compounds to be tested for 
antimicrobial activity are deposited on filter discs that have been placed on a 
lawn of bacterial cells. The perimeter at which the concentration of the compound 
falls below the inhibitory threshold defines the edge of the ‘zone of inhibition’ in 
which the lawn does not grow [147]. The size of this zone is set by the efficacy of 
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the antimicrobial compound against the bacterial strain on the lawn and the 
active ingredient’s diffusion. 
We created short video clips to help familiarize participants with the 
experimental tools and techniques. Before the hands-on experiment section, 
participants were introduced to the principles of sterilization, techniques for 
sterilization of media and equipment, differentiating sterile from non-sterile 
media, personal protective wear, precautions while working with a flame, levels 
of biosafety risk groups and biological containment, standard operating 
procedures for disposal of biological waste, and appropriate handling of 
biological waste spills. We reinforced these concepts at the end of the module, 
and emphasized the importance of close coordination with biological safety 
personnel. 
4.4 HANDS-ON EXPERIMENTS  
 
The hands-on sessions were conducted in improvised classrooms, so we 
used a risk group 1 (biosafety level 1) organism [200]. The bacterial strain, 
growth media, and antimicrobial compounds used are listed in Table 4.1. Briefly, 
we used E. coli DH5! , a commercial broth, and eucalyptus oil, ethanol, and 
hydrogen peroxide as antimicrobial compounds. 
 
At the start of the hands-on section, the assistant instructor demonstrated 
the experimental steps of the assay, then each participant performed the assay. 
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The experimental scheme for the hands-on laboratory section is described in 
Figure 4.1. Three days before the sessions started, E. coli DH5!  was streaked 
onto LB agar and allowed to grow at room temperature for 24-48 hours. A day 
prior to each session, overnight bacterial cultures were grown in 10 mL LB broth 
in plastic Falcon tubes (50 mL). Cultures were incubated under static conditions 
at room temperature for 16-18 hours. (The facilities available included neither a 
shaker nor incubator.) We inoculated overnight cultures for the first session, and 
participants inoculated cultures for all the other sessions. Since bacterial lawn 
growth and zones of inhibition would be visible only after overnight incubation, 
participants used experimental plates from the previous days’ session to interpret 
the results of the assay.  
 
 






E. coli DH5!  
 
Low-risk, non-pathogenic, laboratory strain  
Classified as a risk group 1 (biosafety level 









0.5% yeast extract, 1% tryptone, 1% 











Eucalyptus oil, a natural extract, is 
reported to have antimicrobial activity 
[201]. Ethanol and hydrogen peroxide are 











Figure 4.1 General scheme for the hands-on laboratory experiments. 




Participants noted the presence or absence of zones of inhibition caused 
by the test antimicrobial compounds and control and measured the width of the 
inhibition zone ( X ) as the distance from the edge of the disc to the edge of the 
zone (Figure 4.2). Temperatures of incubation, density of the bacterial lawn, 
bacterial strain used, and concentrations of the antimicrobial compound all 
influence the width of the inhibition zone. Differences in inhibition zone size 
allowed for comparison between the efficacies of different antimicrobial 
compounds and susceptibility profile of the bacterial strain. (Any open-access, 
image analysis software (such as ImageJ) could be used to measure the 
inhibition zones. Participants correctly determined that hydrogen peroxide was 
the most efficacious against the bacterial strain used, followed by ethanol, 
followed by eucalyptus oil.   
 
At the end of each experimental session, we discussed biological safety 
and biohazard waste disposal, including how these practices could be 
implemented at their home institutions.  Following each session, bacterial 
cultures and agar plates were collected in designated bags for biological waste 
(with the biohazard symbol), treated with 10% household bleach (5.25% sodium 












Figure 4.2 Representative zones of inhibition with different antimicrobial 
compounds.  
 
Using the disc diffusion assay, representative zones of inhibition observed with 
(A)  Eucalyptus oil ( X  = 2 mm), (B) 70% Ethanol ( X  = 5 mm), and (C) 3% 
Hydrogen Peroxide ( X  = 14 mm) on lawns of E. coli. Note that these are plates 
prepared by participants with no previous experimental biology experience. In (D) 
the zone of inhibition observed with the antibiotic tobramycin (10 µL of 50 mg/mL) 
is shown ( X  = 18 mm). Tobramycin was used as the molecular weight standard 
to calibrate the molecular weight of the test compound. Owing to budgetary 
constraints, participants could not be provided with antibiotics for testing 
purposes. This image is from the assay performed by the instructors to measure 
slope and critical time. For the analytical model, the width of inhibition ( X ) was 
measured as the distance from the edge of the disc to the edge of the zone. 





4.5 APPLICATION OF EXPERIMENTAL DATA TO AN ANALYTICAL MODEL 
 
An analytical model was employed to determine the physical 
characteristics of the active antimicrobial component as a way to prospect for 
novel antimicrobial agents, where insights into the active ingredient would aid the 
development of a therapeutic formulation. This model is based on the disc-
diffusion assay [147], and assumes that the active ingredient has a constant 
diffusion coefficient D  and that a threshold concentration of the active ingredient 
is required to inhibit bacterial cells.  The number of cells in the lawn increases as 
the lawn incubates, which decreases the per-cell concentration of the active 
ingredient, which therefore no longer causes inhibition after a critical time Tc  of 
incubation.  The model describes the width of the inhibition zone ( X ) as 
 X 2 = 4DTc ln(C0 )+ F(D,Tc ,Cc )              (1)                  
where C0  !is the concentration of the antimicrobial compound deposited on the 
filter disc. F  is a function independent of C0 . Cc  is the lowest concentration of 
the active ingredient required to cause measurable inhibition. The slope of X 2  as 
a function of ln(C0 )  gives D , if Tc  is known.  We relate D  to the molecular weight 




)3           (2) 
where A  is the active ingredient and I  is a known molecule that empirically 
calibrates the relationship between diffusion and molecular weight. 
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To measure the slope of X 2  as a function of ln(C0 )  decreasing 
concentrations of the antimicrobial compound are deposited on bacterial lawns.  
After overnight incubation the width of inhibition ( X ) for each concentration is 
measured. Using linear regression, the slope of X 2  as a function of ln(C0 )  is 
obtained (Figure 4.3A). To measure pre-incubation time, a given concentration of 
the antimicrobial compound is deposited on the bacterial lawn after different time 
intervals of incubation. After overnight incubation, the width of inhibition ( X ) for 
each time point is measured. Using linear regression, the time after which no 
inhibition is observed ( X  = 0 mm) is determined as the critical time of pre-
incubation (Figure 4.3B). Since these experiments are essentially variations in 
the disc-diffusion assay, the hands-on session in the module would provide 
participants the requisite skills to perform these assays. For lack of time, 
participants used data we had taken in our research lab.  Experiments were 
demonstrated using video clips and the participants were guided through each 
step in the assay. Data for hydrogen peroxide (test antimicrobial compound) and 
the known antibiotic tobramycin (MW  = 467.5 Da) was provided to the 
participants (Figure 4.4A and B). Using a linear regression tool with which they 
were already familiar (such as MS Excel), participants determined the diffusion 
coefficient and molecular weight of the test antimicrobial compound. The handout 


















Figure 4.3 Measuring slope of X 2  as a function of ln(C0 )  and critical time (Tc ) of 
pre-incubation for hydrogen peroxide.  
 
(A) To measure the slope of X 2  as a function of ln(C0 ) , decreasing 
concentrations of hydrogen peroxide are deposited and the width of inhibition ( X
) measured. Using linear regression, the slope of X 2  as a function of ln(C0 )  is 
obtained. (B) To measure pre-incubation time, a given concentration of hydrogen 
peroxide (30%) is deposited on the bacterial lawn after different time intervals of 
incubation. After overnight incubation, the width of inhibition ( X ) for each time 
point is measured. Using linear regression, the time after which no inhibition is 




















Figure 4.4 Measuring (A) Slope of X 2  as a function of ln(C0 )  and (B) Pre-








4.6 MODULE HAND OUT FOR THE PARTICIPANTS  
 
This handout was made available to participants before the hands-on 
session, using Google Drive. It contains more detailed information than we were 
able to go into during the three-hour laboratory session, as well as links to all 
videos. 
 
4.6.1 Goal of this hands-on session 
To assay the antimicrobial effects of compounds using the disc diffusion 
technique and apply an analytical model to determine the diffusion coefficient of 
the active antimicrobial component. The diffusion coefficient depends on size and 
is therefore a measure of the molecular weight of the active ingredient. 
 
4.6.2 Preparation of equipment and bacterial growth media 
 
4.6.2.1 Equipment to be procured from a commercial source 
 
Pre-sterile petri dishes (alternatively, glass petri dishes may be cleaned and 
sterilized by autoclaving) 
LB broth and agar (or individual components–tryptone, yeast extract and sodium 
chloride, and agar) 
Pre-sterile 50 mL plastic falcon tubes 
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Pre-sterile plastic pipettes (3 mL, with 0.5 mL graduations) or automated pipettes 
with tips (1-10 µL, 10-100 µL). For the automated pipettes, tips can be bought 
pre-sterile or sterilized in the autoclave. 
Pre-sterile L-cell spreaders (alternatively, a metal, reusable spreader can be 
used and sterilized by flaming with 70% ethanol) 
Glassware for making and storing LB broth 
Analytical balance (to weigh constituents of LB broth and agar) 
 
4.6.2.2 Equipment to be sterilized prior to use 
 
Filter discs (7 mm diameter, Whatman filter paper no. 1)  
Wooden sticks (for inoculation of bacterial cultures)  
Metal forceps  
Pipette tips (if using automated pipettes)  
Glass test tubes (if available, for inoculating bacterial broth cultures) 
 
The above equipment was sterilized using an autoclave (121°C for 20 min at 15 
psi) with a drying cycle. Alternatively, 70% ethanol and flame sterilization can be 
used. 
 
Preparation of bacterial growth media  
 
Luria-Bertani media is routinely used in microbiology laboratories to support 
bacterial growth. To prepare the liquid or broth form of this media, 10g tryptone, 
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5g yeast extract, 10g sodium chloride are dissolved in 500 mL distilled water, 
aliquoted into clean glass bottles and sterilized by autoclaving – i.e., by heating 
to 121°C for 20 min at 15 psi. To make LB agar, 6g of the solidifying agent agar 
is added to the above constituents before they are autoclaved. This gives an 
agar concentration of 1.2%. After sterilization by autoclaving, the molten LB agar 
is poured into pre-sterile petri dishes and allowed to set. Agar plates are then 
packed into plastic sleeves for storage at 4°C. It is preferable not to use plates 
more than 3-4 weeks old. Alternatively, instead of individual constituents, 
commercially available mixed formulations, or ready-to-use forms of LB broth or 
agar may also be used.  
 




Pre-sterile 50 mL plastic falcon tubes  
Pre-sterile plastic pipettes (3 mL, with 0.5 mL graduations)   
Sterile wooden sticks 
Sterile LB broth and LB agar plates  
Three days before the day of the experiment, the bacterial strain Escherichia coli 
DH5!  was streaked onto a plate of LB agar and allowed to grow at room 
temperature for 48 hours. The bacterial strain was shipped in soft agar (0.6%) in 
plastic cryovials to the school. Bacterial cultures are put up from these plates. 
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The bacterial strain E. coli DH5!  is considered non-pathogenic to humans. 
Classified in Risk Group 1 (Biosafety level (BSL) 1) and posing minimum risk to 
humans, this strain can be worked with on a laboratory bench top using an open 
flame and requires no additional precautions. It is important to note, that these 
guidelines apply only to BSL 1 organisms. For working with organisms that are 





Inoculation of bacterial cultures should be done near a flame using sterile 
technique. Using a pre-sterile plastic, disposable pipette (or automated pipette, if 
available), add 10 mL of LB broth into a 50 mL plastic Falcon tube or sterile glass 
tube.  With a wooden stick pick a bacterial colony from the surface of the agar 
plate and gently suspend the colony into the LB broth. Loosely cap the plastic 
tube and incubate at room temperature for 24 hours.  
 




Overnight bacterial cultures grown in LB broth  
Pre-sterile plastic pipettes (3 mL, with 0.5 mL graduations) 
 233 
LB agar plates (if stored at 4°C, allow to warm and dry at room temperature prior 
to use) 




Preparation of bacterial lawns should be done near a flame using sterile 
technique. Using a pre-sterile plastic pipette (3 mL, with 0.5 mL graduations), add 
2 large drops (~100 µL) of the bacterial culture grown in LB broth onto the 
surface of a warm, dry LB agar plate. Using an L-cell spreader gently spread the 
drop of bacterial culture over the entire surface of the agar. It is advisable to hold 
the L spreader in the dominant hand and agar plate in the non-dominant hand. 
Rotating the plate gently, make sure to cover the entire agar surface well 
including the center and rim. Spread thoroughly, repeating strokes several times. 
After spreading is complete, allow the plates to dry for a few minutes.  
 




Bacterial lawns spread on the surface of LB agar 
Sterile filter discs (7-mm diameter) 
Sterile metal forceps 
Antimicrobial test compounds  
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We will be testing three compounds – the natural extract eucalyptus oil (100%, 
Eucalyptus globulus) [201], and the chemical compounds ethanol (70%) and 
hydrogen peroxide (3%) [202]. Eucalyptus oil was procured from NOW® 
Solutions and ethanol and hydrogen peroxide were obtained from a local 




Using a metal forceps place a filter disc (7-mm diameter) on the surface of the 
bacterial lawn. Using a plastic, disposable pipette, add a drop (~50 µL) of 
eucalyptus oil or ethanol or hydrogen peroxide on the filter disc, minimizing the 
amount of spillover around the disc as much as possible. As a control, deposit a 
sterile filter disc onto the lawn but do not apply any antimicrobial compound.  
Allow the antimicrobial compounds to dry and incubate plates at room 
temperature for 24-48 hours. Make sure to label each plate appropriately using a 
Sharpie pen. This technique is called the ‘disc diffusion’ assay [113] and is 
routinely used in clinical and research microbiology laboratories to study the 
antibiotic susceptibility of bacterial strains. 
 










Following incubation at room temperature for 24-48 hours, antimicrobial efficacy 
is observed as ‘zones of inhibition’ of the bacterial lawn around the filter discs 
(Figure 3.2). Using a ruler, measure the size of the zones of inhibition from the 
edge of the filter disc to the edge of the zone. We refer to this width of the 
inhibition zone as X . Alternatively, plates can be photographed and the zones of 
inhibition can be measures using an open-source, image analysis software (such 
as ImageJ). By measuring the size of the zone of inhibition, the efficacies of 
different antimicrobial compounds and the susceptibility of different bacterial 
strains can also be compared.  
 
4.6.7 Using an analytical model to determine the physical characteristics of 
the active ingredient of an antimicrobial compound 
 
To determine the physical properties of the active ingredient of a compound ( I ) 
exhibiting antimicrobial activity, our laboratory has developed a numerical model 
based on the disc-diffusion assay [147]. 
 
The assumptions of the model include – 
 
 236 
1. The active ingredient of the antimicrobial compound is released at a 
concentration C0  at the filter disc. 
2. The active ingredient diffuses out of the disc with a constant diffusion 
coefficient D . 
3. A threshold concentration of the active ingredient is required to inhibit 
bacterial cells. 
4. The active ingredient no longer effects inhibition after a critical time Tc  of 
incubation. 
 
Assumption (4) corresponds an increase in the number of cells in the lawn that 
causes the per-cell concentration of the active ingredient to drop to sub-inhibitory 
levels. 
 
Based on this model,  
 
 X 2 = 4DTc ln(C0 )+ F(D,Tc ,Cc )              (1)                  
where C0  !is the concentration of the antimicrobial compound deposited on the 
filter disc, which we assume to be linearly proportional to the concentration of the 
active ingredient. F  is a function independent of C0 . Cc  corresponds to the 
lowest concentration of the active ingredient required to cause measurable 
inhibition. Tc  is the critical time of incubation (also called pre-incubation time) 
after which the inhibition is no longer observed. At this time, the density of the 
bacterial lawn increases to a critical level (due to bacterial growth), resulting in 
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the concentration of the active ingredient falling below the critical threshold 
concentration required to effect inhibition. As seen in equation 1, the slope of X 2  
(square of the width of inhibition) as a function of ln(C0 )gives the diffusion 
coefficient D , if critical time Tc  is known. Further, using the calculated diffusion 
coefficient D , we can determine the molecular weight (MW ) . According to the 
Stokes-Einstein equation [204], the diffusion coefficient of a molecule is inversely 
proportional to its radius.  
 
From the equations,  
D = ! BT
6"#R
!!              (2)  
where is !  Boltzman constant, T is temperature, !  is solvent viscosity and R  is 
radius of the molecule, 
and MW = N!V = N! "
4
3
#R3            (3) 
where N  is Avogadro’s number, !  is density of the molecule, V  is volume of the 




To first order, a molecule’s volume and therefore its molecular weight is 
proportional to its radius, thus for the active ingredient of antimicrobial compound 




)3           (4) 
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Owing to insufficient time, experiments to measure the slope of X 2  (square of the 
width of inhibition) as a function of ln(C0 )and pre-incubation time Tc  are 
demonstrated in these video clips. To measure the slope of X 2  as a function of 
ln(C0 )  decreasing concentrations of the antimicrobial compound are deposited 
on bacterial lawns and after overnight incubation, the width of inhibition ( X ) for 
each concentration is measured. Using linear regression, the slope of X 2  as a 
function of ln(C0 )  is obtained. To measure pre-incubation time, a given 
concentration of the antimicrobial compound is deposited on the bacterial lawn 
after different time intervals of incubation. After overnight incubation, the width of 
inhibition ( X ) for each time point is measured. Using linear regression, the time 
after which no inhibition is observed ( X  = 0 mm) is determined as the critical time 
of pre-incubation.  
 
4.6.8 Analysis of data to determine diffusion coefficient D  and molecular 
weight (MW ) of the active ingredient of compound I  
 
To provide representative data sets for analysis, we performed the above 
experiments with hydrogen peroxide (compound I ) and a known antibiotic 
tobramycin (MW = 467.5 Da). 
 
Raw Data for compound I (hydrogen peroxide) 
 
Increasing concentrations of compound I  (hydrogen peroxide) and 
corresponding sizes of zones of inhibition ( X ) (Table 4.2).  
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Hint: Use this to obtain the slope of X 2 as a function of !"!!!! as seen in equation 
(1). 
 
Increasing time of pre-incubation and corresponding sizes of the zones of 
inhibition ( X ) for compound I (hydrogen peroxide) (Table 4.3). 
Hint: Use this data to obtain the critical pre-incubation time Tc  of the active 
ingredient of compound I as seen in equation (1). 
 
Using the slope and value of Tc  obtained above, calculate the diffusion coefficient 
D  of the active ingredient of compound I . 
 
Table 4.2 Increasing concentrations of compound I  (hydrogen peroxide) and 




















Table 4.3 Increasing time of pre-incubation and corresponding sizes of the zones 
































Raw Data for known compound A  
 
The known antibiotic tobramycin (MW = 467.5 Da) was used as the standard to 
calculate the molecular weight of the active ingredient of compound I . 
 
Increasing concentrations of tobramycin and corresponding sizes of zones of 
inhibition ( X ) (Table 4.4). 
Increasing time of pre-incubation (Tc ) and corresponding sizes of the zones of 
inhibition ( X ) for tobramycin (Table 4.5). 
Using the slope and value of Tc  obtained above, calculate the diffusion coefficient 














Table 4.4 Increasing concentrations of tobramycin and corresponding sizes of 

































Table 4.5 Increasing time of pre-incubation (Tc ) and corresponding sizes of the 






























Using the value of the diffusion coefficients for compound I  and tobramycin 
calculated above and the known molecular weight of tobramycin (MW  467.5 
Da), obtain the molecular weight of the active ingredient of compound I . 
 
Important to note: The values of D  and Tc  obtained above depend on the 
bacterial strain, media and incubation conditions. It is therefore essential that the 
experiments for the test antimicrobial compound and known molecular weight 
standard be done under identical conditions. 
 
4.6.9 Solution to data analysis  
 
For compound I  
 
Slope of X 2 !as a function of ln(C0 )  for compound I (Figure 4.3). 
Using linear regression, we get the slope of X 2  as a function of ln(C0 )  (y = ax+ 
b). 
 
Pre-incubation time Tc  for compound I  (Figure 4.3). 
Using linear regression, the pre-incubation time (y-intercept) is determined as 
301 ± 39 minutes. 
 
From the above values we get the diffusion coefficient D  of the compound I !as 





Slope of X 2  as a function of ln(C0 )  for tobramycin (Figure 4.4). 
Using linear regression, we get the slope of! X 2  as a function of ln(C0 )  (y = ax+ 
b). 
 
Pre-incubation time Tc  for tobramycin (Figure 4.4). 
Using linear regression, the pre-incubation time (y-intercept) is determined as 
260 ± 28 minutes. 
From the above values we get the diffusion coefficient D  of tobramycin!as 2.9 ± 
0.5 X 10-6 cm2/sec. 
 





and the known molecular weight of tobramycin as 467.5 
Da, we get the molecular weight of the active ingredient of compound I as 128 ± 
96 Da. This is consistent with the molecular weight of hydrogen peroxide which is 
34 Da. Based on our module, we can conclude that the antimicrobial component 







4.6.10 Supplemental Videos  
 
4.6.10.1 Preparation of broth media for bacterial growth 
 
This video shows liquid LB media being prepared for bacterial growth. It 
was shown as part of the hands-on session since there were neither time nor 
facilities to prepare sterile media at the Hands-On School itself. 
 
4.6.10.2 Preparation of solid media for bacterial growth 
 
This video shows agar LB media being prepared for bacterial growth. It 
was shown as part of the hands-on session since there were neither time nor 
facilities to prepare sterile media at the Hands-On School itself. 
 
4.6.10.3 Sterilization of tools  
 
This video shows tools being sterilized. It was shown as part of the hands-
on session since there were neither time nor facilities to sterilize tools at the 
Hands-on School itself. 
 
4.6.10.4 Preparation of filter discs  
 
This video shows filter discs being made and packaged for subsequent 
sterilization. It was shown as part of the hands-on session since there were 
neither time nor facilities to sterilize discs at the Hands-On School itself. 
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4.6.10.5 Preparation of bacterial strains for shipping 
 
This video shows bacterial strains being prepared for shipping. This was 
not shown during the hands-on session but was available as a link through the 
handout. 
 
4.6.10.6  Inoculating bacterial cultures 
 
This video shows bacteria being inoculated for growth. It was shown as 
part of the hands-on session. Then the assistant instructor demonstrated 
inoculation in person, and then each participant inoculated bacteria. 
 
4.6.10.7 Performing the disc diffusion assay 
 
This video shows the disc diffusion assay being performed. It was shown 
as part of the hands-on session. It was shown as part of the hands-on session. 
Then the assistant instructor demonstrated the disc diffusion assay in person, 
and then each participant performed the assay. 
 
4.6.10.8 Experiment to measure the slope of X 2  (square of the width of 
inhibition) as a function of ln(C0 )   
 
 
This video shows the experiment, based on the disc diffusion assay, which 
measures the relationship between the width of the zone of inhibition and the 
amount of inhibitory material deposited. First the instructor presented the 
analytical model, then this video shown during the hands-on session, and then 
 248 
example data obtained from this experiment was made available to students for 
fitting to the model. 
 
4.6.10.9 Experiment to measure pre-incubation time Tc  
 
This video shows the experiment, based on the disc diffusion assay, which 
measures the critical pre-incubation time. First the instructor presented the 
analytical model, then this video was shown during the hands-on session, and 
then example data obtained from this experiment was made available to students 














4.7 PARTICIPANT FEEDBACK 
 
We did not conduct formal evaluations, but based on verbal feedback the 
participants found the module to be educational, scientifically challenging, 
engaging and interesting. As physical scientists, they had almost no prior 
familiarity with biological experiments, and none had ever performed the disc 
diffusion assay. They found the choice of the scientific problem, antibiotic 
resistance, a relevant, relatable issue and appreciated the ease of performing the 
disc diffusion assay, which helped sustain their interest and boost their 
confidence. As theoretical and quantitative scientists, almost all of them were 
familiar with the laws of diffusion and diffusion-based analytical models. 
However, several participants reported that they had never thought of applying 
these conventional physical concepts to a biological problem. Some participants 
also said that the module provoked them to think of biology as a quantitative 
discipline in contrast to standard school and undergraduate curricula, which often 










“The session was very interesting. I have heard of antibiotic resistance and 
worked with analytical models, but never thought that I could merge the two by 
applying physics to study this problem” - Ph.D. candidate (Physics) from the 
Philippines  
 
“This module was listed as my top choice as I have been offered a post-doc in a 
quantitative biology lab which works with yeast. This exercise has given me the 
confidence to work with biological organisms, and assured me that my scientific 
training has a place in biology” - Ph.D. (Mathematics) from Italy 
 
“I appreciate the effort put in to make this module exciting and informative. I 
always thought of biology experiments as complicated and expensive, requiring 
extensive skill. I never thought I would perform a biological assay, much less one 
that was both time and cost-effective” - Ph.D. (Physics) and Government 
Scientist from Cameroon 
 
“I am an advocate for open-source science in Mexico, and can see myself using 
this module as a teaching tool for school children in rural and peripheral parts of 
my country. However, given that I do have some basic biology experience, I 
would have liked to have actually performed the experiments to measure slope 
and critical time for the analytical model” - Ph.D. candidate and Synthetic 
Biologist from Mexic0 
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In one session, participants with no basic biology background had notable 
difficulty in understanding the science. This resulted in a substantial gap between 
their baseline knowledge and rudimentary concepts needed to understand this 
module. For example, one of the participants had never encountered the 
biological concept of a cell. While we did try to briefly address this lacuna in 
knowledge once we realized it, all the logical leaps that followed could not be 
explained in the limited time available. In subsequent implementations of this 
module, this could be overcome with a short, concise overview of basic biological 
concepts such as structure of a bacterial cell, bacterial growth and physiology, 
and cell death.  
 
This was the first time this module was implemented as a science 
outreach tool. As a result, the logistics of executing the module in a resource-
limited setting, such as shipping delays, a classroom and building not intended 
for biological work, and tailoring the program to suit the available budget, posed 
formidable challenges. Owing to this, we did not focus on conducting a 
systematic assessment of the impact of this module on the participants. In the 
future, we plan to incorporate an evaluation step into this module by 
implementing the use of pre- and post-session surveys (using brief 
questionnaires) to gain a quantitative estimate of the outcome of this module on 
participants’ knowledge and attitudes about biophysical research. The 
questionnaire could be designed to measure not only understanding of the 
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specific material presented (e.g., the problem of antibiotic resistance, potential 
modifications of the disc-diffusion assay, incorporating additional parameters into 
the analytical model) but also gauge changes in their perceptions of larger 
concepts such as application of quantitative techniques to biological data and 



















4.8 DISCUSSION AND CONCLUSIONS  
 
Taken together, the features of this hands-on module make it particularly 
suited for science outreach in resource-limited settings such as field areas, 
STEM camps, high-and middle-school programs, workshops, and laboratory 
training exercises. This is valuable not only to developing and emerging 
countries, but also to developed countries, where scarcity of science funding is 
constraining science education and outreach initiatives. Given the lack of 
structured training opportunities that bridge scientific fields, this module can 
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Chapter 5: Overall Conclusions and Future Directions  
 
5.1 POPULATION STRUCTURE IMPACTS THE GROWTH OF ANTIBIOTIC-RESISTANT 
MUTANTS  
 
5.1.1 Overview of results  
 
 
It has previously been shown using experimental techniques and 
mathematical models that spatial organization accelerates the development of 
antibiotic resistance in microbial populations [27, 28, 34]. However, the impact 
microbial population structure had not been explicitly addressed.  
 
In Chapter 2, I began to investigate the impact of microbial population 
structure on the survival and growth of antibiotic-resistant mutants of P. 
aeruginosa [102]. In spatially-mixed systems, the survival of antibiotic-resistant 
mutants was seen to vary non-monotonically with increasing cell density, with 
impaired survival at high-cell densities. Further, the mutant colony frequency or 
the probability of antibiotic-resistant mutant survival decreased with increasing 
cell density. In spatially-structured systems, wild-type (WT) P. aeruginosa cells 
deposited on the filter disc produced inhibition of antibiotic-resistant mutant lawns 
in their vicinity, in the presence of aminoglycoside antibiotics. Using a diffusion-
based analytical model, the inhibitory factor was determined to be a small, 
diffusible compound of low-molecular weight. A wide range of bacterial species 
including S. aureus and E. coli were found to produce inhibition. Production of 
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this IF was observed with growing cells, and in the presence of two different 
aminoglycoside antibiotics. However, the yeast strain Saccharomyces cerevisiae 
did not produce inhibition. On pH indicator agar containing bromthymol blue 
(BTB), deposition of bacterial strains resulted in a blue (alkaline) color change in 
the region of deposition. This alkaline change was observed for all bacterial 
strains that produced inhibition, and a correlation was observed between the 
width of the alkaline change and the width of inhibition. Deposition of 
Saccharomyces cerevisiae failed to produce this alkaline change, but instead 
produced a slightly acidic to no color change. All bacterial strains were grown 
overnight in Luria-Bertani medium, in which amino acids are the major source of 
carbon and nitrogen [153]. Breakdown of amino acids is known to produce 
alkaline by-products such as ammonia and amines [153]. The yeast strain 
Saccharomyces cerevisiae is incapable of using amino acids as the sole source 
of carbon, and hence was grown in Yeast-Peptone-Dextrose (YPD) medium, in 
which dextrose (a sugar) is the source of carbon [108]. Breakdown of sugars via 
fermentation produces acidic by-products. Exogenous alkaline compounds were 
seen to recapitulate this phenomenon of inhibition, notably ammonium hydroxide 
and sodium bicarbonate. Further, using an ion-selective electrode, we detected 
ammonia and or amine emission following deposition of P. aeruginosa cells on 
agar. This indicates that the IF is likely a native product of amino acid catabolism, 
likely ammonia or amines. These observations indicate that nutrient conditions 
can provide a switch to control inhibition. Using the bacterial strains P. 
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aeruginosa, S. aureus, and E. coli and the yeast strain Saccharomyces 
cerevisiae, this possibility was investigated. P. aeruginosa, S. aureus, and E. coli 
produced inhibition when grown in the presence of amino acids as the sole 
source of carbon, however, in the presence of amino acids and sugar carbon 
sources, S. aureus, and E. coli failed to produce inhibition. P. aeruginosa 
produced inhibition under both conditions, reflective of its inability to ferment 
sugars as a source of carbon. As expected, Saccharomyces cerevisiae grew 
poorly in the presence of amino acids alone, and also failed to produce inhibition 
under both conditions. Finally, it seems paradoxical that mutant cells are able to 
grow into high-density colonies on the plate without inhibiting themselves. To 
resolve this paradox, we examine the effect of spatial fluctuations in initial 
population density on the survival of resistant mutants. Guided by this model, we 
postulate that antibiotic-resistant mutants are able to grow into high-density 
colonies on antibiotic-containing agar because they are shielded from antibiotics 
by their WT neighbors. 
 
My work opens the possibility that the impact of microbial population 
structure on antibiotic-resistant mutants could open the way for novel therapeutic 





5.1.2 Future directions  
 
There are several possible future studies arising from this work.  
 
5.1.2.1 Population structure as a novel therapeutic approach  
 
 
One approach towards further understanding the potential of these 
findings as a therapeutic strategy would be to artificially structure microbial 
communities using optical trapping [52]. Using this technique in a flow-cell 
system, we could create small-scale patterned microbial communities of varying 
cell density, spatial organization, and cell types. We could modulate the nutrient 
conditions available by changing the carbon sources, and the concentration of 
aminoglycoside in the system. This would further our understanding of the 
interplay of spatial structure and nutrient conditions on antibiotic-resistant mutant 
survival at much smaller spatial scales, which would more closely resemble 
microbial communities in nature, and also more closely resemble the biofilm 
phenotype.   
 
This could pave the way for testing the impact of population structure 
using an in vivo infection model such as a murine acute or chronic wound 
infection. In this case, we could infect wounds with microbial populations that 
vary in composition, density, and metabolic capabilities. Following treatment with 
aminoglycosides and management of wound nutrient conditions, we could 
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assess the impact of population structure on the survival of antibiotic-resistant 
mutants in vivo. 
 
Together, these insights will assess the feasibility of harnessing the 
therapeutic potential of population structure to target antibiotic-resistant mutants. 
This could lead to a new approach whereby we could engineer the population 
structure and nutrient availability at infection sites to enable bacteria inhibit the 
antibiotic-resistant mutants arising in the population. For example, for 
polymicrobial infections such as P. aeruginosa and S. aureus co-infections (as in 
chronic wounds), we could design a therapeutic approach that first eradicates S. 
aureus, which is capable of fermenting sugars and producing acidic by-products. 
This would prevent a major decrease in local pH at the infection site, and enable 
P. aeruginosa alkaline metabolic by-products to enhance the efficacy of 
aminoglycosides against antibiotic-resistant mutants. Another possible option in 
the case of post-surgical wound infections would be to irrigate the wound with a 
combined solution of antibiotic and an alkaline amino acid. This would permit 
infecting P. aeruginosa strain to utilize amino acids and produce alkaline by-
products, which could enhance the efficacy of aminoglycosides. While these 
approaches hold promise, it is clear that more work needs to be done to fully 
understand the effects of local pH at wound infection sites. For example, 
increased pH early in treatment (>8.5) is associated with delayed wound healing, 
wounds that are too acidic are less likely to accept grafts [196]. 
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5.1.2.2 Mutational resistance to aminoglycosides  
 
While resistance to aminoglycoside antibiotics mediated by the production 
of aminoglycoside-modifying enzymes is a better understood mechanism, 
resistance conferred by single-nucleotide polymorphisms (SNPs) is less 
documented [85]. In this work, the spontaneously-generated antibiotic-resistant 
mutant sequenced had SNPs in EF-Tu, TrkH, and phzD [102]. We could further 
understand the mechanism of resistance by creating each of these individual 
mutations in a wild-type P. aeruginosa PA14 strain and testing the minimum 
inhibitory concentration to tobramycin for each of them. This would allow us to 














5.2 ASSESSMENT OF THE IN VITRO EFFICACY OF THE COMBINATION OF TOBRAMYCIN AND 
BICARBONATE AGAINST PLANKTONIC AND BIOFILM CELLS OF P. AERUGINOSA  
 
5.2.1 Overview of results  
 
 
My work in Chapter 2 showed that alkaline by-products of bacterial 
metabolism could enhance the efficacy of aminoglycoside antibiotics against 
antibiotic-resistant mutants of P. aeruginosa. The inhibitory factor mediating this 
effect is likely ammonia and/or amines, resulting from the catabolism of amino 
acids. Further, exogenous alkaline compounds such as sodium bicarbonate also 
produce this effect, indicating that the mechanism of inhibition is related to a pH 
change.  
 
In Cystic Fibrosis (CF), a defect in the CFTR membrane protein leads to 
defective secretion of bicarbonate in airway epithelial cells. This results in 
decreased airway surface liquid (ASL) pH, which impairs function of innate 
antimicrobial factors. Restoration of ASL pH by aerosolization of sodium 
bicarbonate was seen to improve the activity of these factors [76]. In addition, 
aerosolized bicarbonate is being evaluated for its role in facilitating the unfolding 
and thinning of mucous, thereby increasing mucociliary clearance [77].  
 
For P. aeruginosa infections, aminoglycosides, such as tobramycin, are 
the standard of care [104]. Long-term therapy and widespread usage has 
resulted in the development of resistance to this class of drugs. Further, 
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aminoglycosides cause severe toxic side effects [183]. Hence, developing 
treatment strategies to minimize the duration of treatment, therapeutic dosage, 
development of resistance while extending the lifetime of aminoglycoside usage 
is imperative. 
 
In Chapter 3, I began to evaluate the effect of sodium bicarbonate in 
enhancing the activity of aminoglycosides. Using the standard microdilution 
checkerboard assay, I examined the effect of a combination of tobramycin (an 
aminoglycoside) and sodium bicarbonate on planktonic cells of P. aeruginosa. 
Briefly, I tested an array of different combinations of tobramycin and bicarbonate, 
in addition to their effects alone on the survival of planktonic P. aeruginosa cells. 
Isobologram analysis reveals that for planktonic cells of P. aeruginosa, the 
combination has a strong synergistic effect (!FIC index <0.5). This effect is seen 
for laboratory strains PAO1 and PA14, for four different spontaneously-generated 
antibiotic-resistant mutants and for clinical CF isolates (including mucoid, dwarf, 
and class phenotypes). Further analysis revealed that a synergistic effect was 
attained at a bicarbonate concentration as low as 5 mM (corresponding to a pH 
of 7.12 ± 0.07 in sterile Luria-Bertani medium). This synergy observed was also 
tested using time-kill assays. For all strains tested, time-kill analysis revealed a 
strong synergistic effect of the specific tobramycin-bicarbonate concentration 
tested. As expected with a synergistic combination, addition of bicarbonate was 
seen to reduce the concentration of tobramycin needed to eradicate planktonic 
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cells. It was also observed to significantly enhance the rate of killing of cells in 
comparison to inhibitory concentrations of tobramycin. 
 
We next tested the effect of this synergy against biofilm cells of P. 
aeruginosa. Briefly, biofilms were grown on the bottom and sides of a microtiter 
dish for 24-hours. These pre-formed biofilms were then treated with different 
combinations of tobramycin and bicarbonate, in addition to each agent alone. 
After treatment, the biofilms were examined for metabolic activity using the XTT 
assay (in which a monotetrazolium salt is converted to the colored product 
formazan by metabolically-active cells). Based on our observations, the 
combination of tobramycin and bicarbonate was at best additive against biofilm 
cells of P. aeruginosa, and was antagonistic in most combinations.  
 
To understand the mechanism of synergy of tobramycin and bicarbonate, 
we propose a model based on the entry of tobramycin into the bacterial cell. It is 
important to note that this model is speculative, and further work needs to be 
done to test it. Tobramycin is actively transported into the cell, and the process 
depends on the proton motive force (PMF) [87]. Based on this model, following 
its addition, bicarbonate (in the form of carbonic acid) traverses the outer 
membrane of the cell to reach the periplasmic space. In this intermembarne 
space, carbonic acid dissociates to release free bicarbonate and a hydrogen ion. 
The hydrogen ion joins the cloud of protons in the periplasmic space, which are 
pumped out during transport of electrons in the electron transport chain 
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(Complexes I-IV). The bicarbonate ion is transported across the inner membrane 
via an anion exchange transporter. In the cytosol, bicarbonate sequesters 
hydrogen ions to once again form carbonic acid. The combined effect is an 
increase in the pH in the periplasmic space and a decrease in the intracellular 
pH, which increases the inflow of hydrogen ions through ATP synthase (or 
complex V). This increases the proton motive force (PMF) and synthesis of ATP, 
both of which could thereby drive the entry of tobramycin into the cell. This model 
also explains the lack of synergy observed in biofilm cells, where the presence of 
extracellular polymer could prevent the diffusion of bicarbonate into the biofilm or 
regions of low pH (as known to exist in biofilms) [16] could neutralize bicarbonate 
before it reached cellular proximity.  
 
Finally, we present a method for analyzing drug interactions using 
analytical dose-response surfaces, which examines drug combinations in greater 
detail than traditional methods [187]. Of its many advantages, this dose-response 
surface analysis allows us to more accurately estimate synergy regimes and 
make testable predictions of synergy combinations. Further, we analyze the 
difference of the measured response surface from that predicted by Loewe 
additivity [188], which provides a direct assessment of the degree of synergy and 
antagonism present. 
 
Based on this work, another additional role for bicarbonate therapy in CF 
patients could be speculated, where it would augment the activity of tobramycin 
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therapy against planktonic P. aeruginosa infections. This approach would also 
hold potential in the management of non-CF infections such as acute burn and 
post-surgical wounds, sepsis, urinary tract infections, and meningitis [55]. Our 
results indicate that this approach may however not work if biofilms are already 
established, and further work is needed to understand and overcome this aspect.  
 
5.2.2 Future directions  
 
My work on the evaluation of tobramycin and bicarbonate has provided 
insights into the in vitro efficacy of this combination against planktonic and biofilm 
cells of P. aeruginosa. This work has implications in evaluating the efficacy of this 
combination as a therapeutic approach not only for early infections in CF patients 
but also for other acute Pseudomonas infections. There are several future 
studies to take this work forward into in possible therapeutic application.  
 
5.2.2.1 Efficacy of the combination against planktonic cells in an vitro 
wound model  
 
To estimate the potential of this combination in vivo, we could first test the 
effects of the combination of tobramycin and bicarbonate in medium containing 
serum. I did a few preliminary experiments by adding 25% serum to standard LB 
media, and observed that the synergistic effect did not persist. This could be due 
to the buffering effect of serum. To test this, I measured the pH of serum with 
different concentrations of bicarbonate and compared the values with those in LB 
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media with bicarbonate. Indeed, the corresponding pH in LB media with serum is 
lower than that in LB medium alone. In the future, we could adjust the 
concentration of bicarbonate in the LB + serum media to allow for a rise in pH, 
and test synergy with tobramycin at those concentrations. An even more-realistic 
in vivo scenario would be to test the effects of the combination in wound-like 
media. Our collaborators at the laboratory of Dr. Kendra Rumbaugh at Texas 
Tech Health Sciences Center, Lubbock Texas have developed in in vitro chronic 
biofilm wound infection model [193], incorporating bovine serum, laked horse 
blood, and Bolton broth. We could modify this using composition and model to 
simulate acute wound conditions to test the synergistic effect on planktonic cells. 
We could test for synergistic effects against planktonic cells using media 
containing a similar wound composition. To actually simulate an acute we could 
create artificial wounds suspended with planktonic cells containing blood, serum, 
and media. These wounds are then embedded into agar media in petri dishes. 
This would resemble an acute wound containing free-living cells surrounded by a 
wound bed. We could then treat these artificial ‘wounds’ with dressings of 
tobramycin, bicarbonate, and the combination and enumerate the colony forming 
units (CFUs). I did some preliminary work using this system (Figure 3.16), and 
while we observe a synergistic effect, we could test more combinations, and use 






5.2.2.2 Efficacy of the combination against acute infections in an vivo 
wound model  
 
 
After in vitro testing in in vivo-like conditions, we could directly test the in 
vivo effects of the combination using a murine acute infection model [72]. Using 
an acute burn wound and sepsis model, we could treat mice with tobramycin, 
bicarbonate, and different combination at various time points following infection. 
CFUs measured from the wound site and from systemic organs such as the 
spleen, would provide an indication of the effect of the combination on local 
wound bacterial burden as well as dissemination to distant sites.  
 
5.2.2.3 Testing the proposed model for the entry-based mechanism of 
synergy  
 
We proposed a model to explain the mechanism of synergy based on 
bicarbonate increasing the PMF to drive the increased entry of tobramycin into 
the cell. This model is based on our observations of synergy and is supported by 
relevant literature. To directly test this model, we could use tobramycin 
conjugated with the fluorophore Texas Red. Tobramycin uptake by bacterial cells 
following addition of different concentration of bicarbonate could them be 







5.2.2.4 Testing the predictions of synergistic combinations from the dose-
response surface analysis 
 
 
Our analysis of tobramycin and bicarbonate interactions using the 
analytical dose-response surface method, allows us to identify synergistic 
combinations that were not directly tested in our assays for synergy.  As a next 
step, we could test these predicted combinations for synergy. Identifying 
additional synergistic combinations would expand the potential of this 














5.3 A LOW-COST, HANDS-ON MODULE TO PROVIDE INTERDISCIPLINARY RESEARCH 
EXPERIENCE  
 
5.3.1 Overview of results  
 
 
There is a paucity of structured training programs the bridge concepts 
across scientific fields. This lack is observed both in formal school and college 
curriculum, and science outreach initiatives. One possible way to overcome this 
is to design low-cost, educational modules that highlight the potential of 
interdisciplinary research. We had the opportunity to develop and conduct such a 
module for the Hands-On Research in Complex Systems School held at The 
Abdus Salam International Centre for Theoretical Physics (ICTP), Trieste, Italy, 
July 2014 [199]. For this we developed a low-cost module to characterize 
antimicrobial compounds using an interdisciplinary, biophysical approach.  This 
module was a spin-off of the research project in Chapter 1. This module was 
conducted over a two-week period with three-hour laboratory session each day. 
Each session had a new set of 4-5 participants. Participants were mostly physical 
scientists or engineers with little or no biology expertise. The module was 
designed to have two components: a hands-on experimental component and 
analysis of data. The budget for the entire module for 14 days for 60 participants 
was $150.  
 
The goal of our module was to test the antimicrobial efficacy of a range of 
compounds and apply the biological data to an analytical model to gain insights 
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into the physical characteristics of the active antimicrobial component. 
Participants tested three antimicrobial compounds ethanol (70%), hydrogen 
peroxide (30%), and eucalyptus oil for antimicrobial activity against E. coli DH5" 
using the disc-diffusion assay. They were then provided with biological data to 
apply to a diffusion-based analytical model to estimate the diffusion coefficient 
and molecular weight of the active antimicrobial component.  
 
In our experience, the module was resource-efficient and reproducible, 
and engaged the interest of the participants. Additional resources such as budget 
and time will enable several future modifications of the module.  
 
5.3.2 Future directions 
 
5.3.2.1 Modifications of the module   
 
 
As stated earlier, the entire budget for the hands-on session for 10 days 
for 60 participants was $150, which had to include consumables, equipment, and 
shipping costs. In addition, the hands-on school was conducted at the 
International Center for Theoretical Physics (ICTP), which did not have standard 
facilities to conduct biological experiments. For example, we had no access to an 
autoclave, incubator, or rotary shaker. However, if the facilities and resources are 
available, this basic experimental protocol could be advanced to achieve greater 
accuracy and resolution.  
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For junior biology researchers, the module can be expanded to study a 
wide-range of antimicrobial compounds, microbial competitive interactions, and 
prospecting for novel antibiotics. This includes testing well-known clinical 
antibiotics and a wide-range of biological extracts, and determining molecular 
weights. Using antibiotics, as test antimicrobial agents will further strengthen the 
association with antibiotic resistance. The module can also be adapted to a 
‘bioprospecting for antibiotics’ exercise, used to compare efficacies of different 
local and indigenous medicinal extracts, and antibiotics form different commercial 
sources. This is particularly important in the context of developing countries, 
where antibiotics are often sold over-the-counter (OTC), resulting in a market of 
spurious antibiotics. We discussed with the participants’ how the module could 
be adapted to compare antimicrobial efficacies of antibiotics from different 
commercial and distribution sources. In countries where local and indigenous 
compounds, such as eucalyptus oil, tea tree oil, or cinnamon bark oil, are used 
as medicinal remedies, an interesting exercise would be to use this module to 
test the antimicrobial efficacies of compounds obtained from different sources.  
 
Additionally, the module can be adapted to test intra- and inter- species 
microbial competition by depositing one bacterial species or strain on the filter 
disc laid on a lawn of another bacterial species. The analytical model would 
provide additional insights into the active microbial product producing inhibition. 
The module could be extended to testing the effect of antimicrobial compounds 
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on mixed microbial communities, including both bacterial and fungal strains. If the 
requisite biosafety levels are met, these could be environmental communities 
such as in soil, water, and air, clinical specimens from nares or throat swabs, or 
mixed laboratory cultures.  
 
The target audience for the outreach module we presented were scientists 
in physical and mathematical disciplines, mostly from the developing world and 
little to no experience with biology or with experiments in general.  Thus, the 
biology presented in this module and the concept of using physical analysis to 
understand biology were largely new to them, but the modeling itself and fitting 
the model to data were more familiar concepts, quickly digested. For a different 
audience, with more biological background, this emphasis could be modified to 
focus on teaching physical concepts of diffusion and transport and to delve into 
least-squares linear fitting more deeply. 
 
Subject to increased time and budget availability, technical modifications 
could also be included in the module. This could include the use of nonvolatile 
compounds and if available, an automated pipette could be used to deposit a 
defined volume of 10 µL on the filter disc, which would be soaked up by the filter 
disc avoiding any spillover. Alternatively, filter discs could be impregnated with a 
set amount of antimicrobial compound (diluted in a volatile solvent) and the 
solvent allowed to evaporate. The dry disc could then be placed on the plate 
using metal forceps. If available, bacterial cultures could be grown using an 
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incubator with well-controlled temperature and a rotary shaker. More hands-on 
experiments, including measurement of slope and critical time could be included. 
 
5.3.2.2 The module as part of an interdisciplinary research curriculum  
 
The Common Core is a set of academic standards in mathematics and 
language arts for grades K-12.  In the USA, 43 states, the District of Columbia, 
four territories, and the Department of Defense Educational Activity have adopted 
the Common Core standards.  The content of this module teaches concepts that 
are required in Common Core Mathematics standards for Algebra, Functions, 
and Modeling. The handout, along with additional reading, could be used to 
teach competencies required in the Language Arts standards for Literacy in 
Science & Technical Subjects. 
 
Texas has not adopted the Common Core. Instead, it uses the Texas 
Essential Knowledge and Skills (TEKS) standards.  The content of this module 
includes concepts required in the TEKS standards for Algebra I and II, 
Precalculus, Mathematical Models with Applications, Biology, Chemistry, and 
Physics.   
 
Thus, the low cost and relative ease of performance of this module could 
make it suitable for adaption for use in high schools, either as a part of the 
normal instructional curriculum or as an outreach.  
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Additionally, the module could be expanded and subsequently included as 
a component of an undergraduate research curriculum or Freshman Research 
Initiative stream. It would provide hands-on experience in biology and application 
of biological data to an analytical model, as well as introduce concepts of 
antibiotic resistance, bioprospecting, biosafety, diffusion, and the relationship 
between diffusion coefficient and molecular weight.  
5.4 FINAL DISCUSSION  
 
 
With the rising trend of antibiotic resistance, the search for novel 
therapeutic approaches has gained significance. My work has determined that 
microbial population structure inhibits the survival and growth of antibiotic-
resistant mutants of P. aeruginosa, in the presence of aminoglycoside antibiotics. 
This opens the possibility of designing treatment options that target or harness 
population structure to overcome antibiotic resistance. This effect was mediated 
by an alkaline product, which led me to test the effect of bicarbonate in 
conjunction with the antibiotic tobramycin against P. aeruginosa. This work 
determined that the combination of bicarbonate and tobramycin had a synergistic 
effect against planktonic P. aeruginosa cells. This lays the foundation for further 
studies to test the potential use of this combination against planktonic P. 
aeruginosa infections. Finally, my work has contributed a low-cost, hands-on, 
educational module to characterize antimicrobial compounds, which can be used 
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